KR101547623B1 - Organic electroluminescent device - Google Patents
Organic electroluminescent device Download PDFInfo
- Publication number
- KR101547623B1 KR101547623B1 KR1020120118500A KR20120118500A KR101547623B1 KR 101547623 B1 KR101547623 B1 KR 101547623B1 KR 1020120118500 A KR1020120118500 A KR 1020120118500A KR 20120118500 A KR20120118500 A KR 20120118500A KR 101547623 B1 KR101547623 B1 KR 101547623B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- inv
- synthesis
- mol
- compound
- Prior art date
Links
- 0 CCC*1CC(C)CC1 Chemical compound CCC*1CC(C)CC1 0.000 description 2
Classifications
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/30—Coordination compounds
- H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
- H10K85/342—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising iridium
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
- H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/18—Metal complexes
- C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K2101/00—Properties of the organic materials covered by group H10K85/00
- H10K2101/10—Triplet emission
Abstract
본 발명은 유기 전계 발광 소자에 관한 것으로, 인돌계 화합물과 이리듐 화합물을 각각 호스트/도펀트 물질로 사용한 발광층을 유기 전계 발광 소자에 도입함으로써 발광효율, 구동 전압 및 수명 등의 특성이 향상된 유기 전계 발광 소자를 제공할 수 있다.The present invention relates to an organic electroluminescent device, and more particularly, to an organic electroluminescent device using an organic electroluminescent device having improved characteristics such as luminous efficiency, driving voltage and lifetime by introducing a light emitting layer using an indole compound and an iridium compound as host / Can be provided.
Description
본 발명은 구동전압, 발광효율 및 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to an organic electroluminescent device in which characteristics such as a driving voltage, a luminous efficiency and a lifetime are improved.
1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 하여, 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광(electroluminescent, EL) 소자에 대한 연구가 이어져오다가, 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층 구조의 유기 전계 발광 소자가 제시되었다. 이후, 유기 전계 발광 소자는 소자의 효율 및 수명을 향상시키기 위하여 소자 내 특징적인 유기물층을 도입하는 형태로 발전해왔다.Electroluminescent (EL) devices, which led to blue electroluminescence using anthracene single crystals in 1965, were followed up with the observation of the organic thin film emission of Bernanose in the 1950s. In 1987, Layer and a functional layer of a light-emitting layer. Hereinafter, the organic electroluminescent device has been developed to introduce characteristic organic layers in the device to improve the efficiency and lifetime of the device.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서 정공이, 음극에서 전자가 유기물층으로 주입되어, 주입된 정공과 전자가 만나 엑시톤(exciton)이 형성되며, 형성된 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 유기물층으로 사용되는 물질은 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다.In the organic electroluminescent device, when a voltage is applied between the two electrodes, holes are injected from the anode and electrons from the cathode are injected into the organic layer, and the injected holes and electrons meet to form an exciton. When the exciton formed drops to a ground state The light comes out. The material used as the organic material layer may be classified into a light emitting material, a hole injecting material, a hole transporting material, an electron transporting material, and an electron injecting material depending on functions.
발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과, 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도판트 계를 사용할 수 있다.The luminescent material can be classified into blue, green and red luminescent materials according to luminescent colors and yellow and orange luminescent materials necessary for realizing better natural colors. Further, in order to increase the color purity and to increase the luminous efficiency through energy transfer, a host / dopant system can be used as a luminescent material.
도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 인광 도판트의 개발은 이론적으로 형광 도판트에 비해 4배까지 발광 효율을 향상시킬 수 있기 때문에, 인광 도판트 뿐만 아니라 인광 호스트에 대해서도 연구되고 있다.The dopant material can be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. The development of a phosphorescent dopant has been studied not only for a phosphorescent dopant but also for a phosphorescent host since it can theoretically improve luminescence efficiency up to four times that of a fluorescent dopant.
현재까지 정공 수송 물질. 정공 주입 물질, 전자 수송 물질 등으로는 NPB, BCP, Alq3 등이 널리 알려져 있으며, 발광 물질로는 안트라센 유도체들이 사용되고 있다. 특히, 발광 물질 중 효율 향상 측면에서 큰 장점을 가지고 있는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물은 청색(blue), 녹색(green), 적색(red) 인광 도판트 물질로 사용되고 있으며, CBP는 인광 호스트 물질로 사용되고 있다.To date, hole transport materials. NPB, BCP, and Alq 3 are widely known as hole injecting materials and electron transporting materials, and anthracene derivatives are used as light emitting materials. In particular, metal complex compounds containing Ir such as Firpic, Ir (ppy) 3 , (acac) Ir (btp) 2 and the like, which have great advantages in terms of efficiency improvement of light emitting materials, are blue, green, It is used as a red phosphorescent dopant material, and CBP is used as a phosphorescent host material.
그러나, 종래의 발광 물질들은 발광 특성이 양호하나, 유리전이온도가 낮아 열적 안정성이 좋지 않기 때문에 유기 전계 발광 소자의 수명 측면에서 만족할 만한 수준이 되지 못하는 실정이다. 따라서, 우수한 성능을 가지는 발광 물질을 포함하는 유기 전계 발광 소자의 개발이 요구되고 있다.However, conventional luminescent materials have good luminescence characteristics, but have low glass transition temperature and poor thermal stability, which is not satisfactory in terms of lifetime of an organic electroluminescent device. Therefore, development of an organic electroluminescent device including a luminescent material having excellent performance is required.
본 발명은 상기한 문제점을 해결하기 위해, 구동전압, 발광효율 및 수명 등의 특성이 향상된 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.In order to solve the above problems, it is an object of the present invention to provide an organic electroluminescent device with improved driving voltage, luminous efficiency, and life span.
상기한 목적을 달성하기 위해, 본 발명은 양극; 음극; 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중 적어도 하나는 하기 화학식 1로 표시되는 화합물과 하기 화학식 3으로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자를 제공한다.In order to achieve the above object, cathode; And at least one organic material layer interposed between the anode and the cathode, wherein at least one of the organic material layers is composed of a compound represented by the following formula (1) and a compound represented by the following formula (3) An organic electroluminescent device is provided.
[화학식 1][Chemical Formula 1]
상기 화학식 1에서,In Formula 1,
Y1 내지 Y4는 각각 독립적으로, N 또는 CR3이고, Y1과 Y2, Y2와 Y3, 또는 Y3와 Y4 중 하나는 하기 화학식 2로 표시되는 축합 고리를 형성하며,Y 1 to Y 4 are each independently N or CR 3 , and Y 1 and Y 2 , Y 2 and Y 3 , or one of Y 3 and Y 4 form a condensed ring represented by the following formula (2)
[화학식 2](2)
상기 화학식 2에서,In Formula 2,
점선은 화학식 1의 화합물과 축합이 이루어지는 부위를 의미하며, Y5 내지 Y8은 각각 독립적으로, N 또는 CR4이고,Y 5 to Y 8 each independently represent N or CR 4 ,
상기 X1 및 X2는 각각 독립적으로, O, S, Se, N(Ar1), C(Ar2)(Ar3) 및 Si(Ar4)(Ar5)로 이루어진 군에서 선택되고, 이때, X1 및 X2 중에서 적어도 하나는 N(Ar1)이며,X 1 and X 2 are each independently selected from the group consisting of O, S, Se, N (Ar 1 ), C (Ar 2 ) (Ar 3 ) and Si (Ar 4 ) (Ar 5 ) , X 1 and X 2 At least one of them is N (Ar 1 )
상기 R1 내지 R4 및 Ar1 내지 Ar5는 각각 독립적으로, 수소, 중수소, 할로겐기, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,Each of R 1 to R 4 and Ar 1 to Ar 5 is independently hydrogen, deuterium, halogen, cyano, nitro, amino, C 1 to C 40 alkyl, C 2 to C 40 alkenyl, C A C 3 to C 40 cycloalkyl group, a heterocyclic cycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkynyl group, ~ C 40 alkyloxy group of, C 6 ~ aryloxy C 60, C 1 ~ C 40 alkyl silyl group, C 6 ~ aryl silyl group of C 60, C 1 ~ C 40 group of an alkyl boron, C 6 is selected from ~ C 60 aryl boron group, the group consisting of C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl group of an amine of,
상기 R1 내지 R4는 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,R 1 to R 4 may be bonded to adjacent groups to form a condensed ring,
상기 R1 내지 R4 및 Ar1 내지 Ar5의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있다.The alkyl group, alkenyl group, alkynyl group, cycloalkyl group, heterocycloalkyl group, aryl group, heteroaryl group, alkyloxy group, aryloxy group, alkylsilyl group and arylsilyl group of R 1 to R 4 and Ar 1 to Ar 5 A halogen atom, a cyano group, a nitro group, an amino group, a C 1 to C 40 alkyl group, a C 2 to C 40 alkyl group, an aryloxy group, A C 2 to C 40 alkynyl group, a C 3 to C 40 cycloalkyl group, a substituted or unsubstituted heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 40 aryl group, a substituted or unsubstituted a heteroaryl group, C 1 ~ C 40 of the alkyloxy group, C 6 ~ C 60 of the aryloxy group, C 1 ~ C 40 alkylsilyl group, C 6 ~ C aryl silyl group of 60, C 1 ~ C 40 boron alkyl group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ from the group consisting of an aryl amine of the C 60 of the And may be substituted with at least one selected.
[화학식 3](3)
상기 화학식 3에서,In Formula 3,
X-Y는 유기 리간드로서, X는 핵원자수 3 내지 40의 헤테로아릴기이고, Y는 C6~C40의 아릴기 또는 핵원자수 3 내지 40의 헤테로아릴기이며, R11 내지 R18은 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, n 은 1 내지 3의 정수이다.X is an organic ligand, X is a heteroaryl group having 3 to 40 nuclear atoms, Y is an aryl group having 6 to 40 carbon atoms or a heteroaryl group having 3 to 40 nuclear atoms, and R 11 to R 18 are independently, hydrogen, deuterium, a halogen, a cyano group, a nitro group, an amino group, C 1 ~ C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, nuclear atoms, 3 to 40 heterocycloalkyl group of, C 6 ~ C 60 of An aryl group of 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, a C 6 to C 60 aryl silyl group, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ An arylamine group of C 60 , and may form a condensed ring by bonding with adjacent groups, and n is an integer of 1 to 3.
본 발명에서 사용되는 알킬은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 이의 비제한적인 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등이 있다.The alkyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a linear or branched saturated hydrocarbon having 1 to 40 carbon atoms, and examples thereof include methyl, ethyl, propyl, isobutyl, sec-butyl , Pentyl, iso-amyl, hexyl, and the like.
본 발명에서 사용되는 알케닐(alkenyl)은 탄소-탄소 이중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있다.The alkenyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a linear or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond. Non-limiting examples thereof include vinyl, allyl, isopropenyl, 2-butenyl, and the like.
본 발명에서 사용되는 알키닐(alkynyl)은 탄소-탄소 삼중 결합을 1개 이상 가진, 탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 에타인일(ethynyl), 2-프로파인일(2-propynyl) 등이 있다.The alkynyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a linear or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond. Non-limiting examples thereof include ethynyl, 2-propynyl, and the like.
본 발명에서 사용되는 시클로알킬은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이의 비제한적인 예로는 시클로프로필, 시클로펜틸, 시클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine)등이 있다.The cycloalkyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms (saturated cyclic hydrocarbon). Non-limiting examples thereof include cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
본 발명에서 사용되는 헤테로시클로알킬은 핵원자수 3 내지 40의 비-방향족 탄화수소(포화 고리형 탄화수소)로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O 또는 S와 같은 헤테로 원자로 치환된다. 이의 비제한적인 예로는 모르폴린, 피페라진 등이 있다.The heterocycloalkyl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from a non-aromatic hydrocarbon (saturated cyclic hydrocarbon) having 3 to 40 nuclear atoms, and includes at least one carbon of the ring, preferably 1 To three carbons are substituted with a heteroatom such as N, O or S; Non-limiting examples thereof include morpholine, piperazine, and the like.
본 발명에서 사용되는 아릴은 단독 고리 또는 2 이상의 고리가 조합된, 탄소수 6 내지 60의 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기를 의미한다. 이때, 2 이상의 고리는 서로 단순 부착되거나 축합된 형태로 부착될 수 있다. 이의 비제한적인 예로는 페닐, 비페닐, 트리페닐, 터페닐(terphenyl), 나프틸, 플루오레닐, 페난트릴, 안트라세닐, 인데닐 등이 있다.The aryl used in the present invention means a monovalent functional group obtained by removing a hydrogen atom from an aromatic hydrocarbon having 6 to 60 carbon atoms in which a single ring or two or more rings are combined. At this time, the two or more rings may be attached to each other in a simple attached or condensed form. Non-limiting examples thereof include phenyl, biphenyl, triphenyl, terphenyl, naphthyl, fluorenyl, phenanthryl, anthracenyl, indenyl and the like.
본 발명에서 사용되는 헤테로아릴은 핵원자수 5 내지 60의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 수소 원자를 제거하여 얻어지는 1가의 작용기로서, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 질소(N), 산소(O), 황(S) 또는 셀레늄(Se)과 같은 헤테로원자로 치환된다. 이때, 헤테로아릴은 2 이상의 고리가 서로 단순 부착되거나 축합된 형태로 부착될 수 있고, 나아가 아릴기와의 축합된 형태도 포함할 수 있다. 이러한 헤테로아릴의 비제한적인 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리; 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있다.The heteroaryl used in the present invention is a monovalent functional group obtained by removing a hydrogen atom from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms and is a monovalent group having at least one carbon atom, Carbon atoms are replaced by heteroatoms such as nitrogen (N), oxygen (O), sulfur (S), or selenium (Se). At this time, the heteroaryl may be attached in a form in which two or more rings are attached or condensed to each other, and may further include a condensed form with an aryl group. Non-limiting examples of such heteroaryls include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl; Such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl, and the like. ring; And 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl and the like.
본 발명에서 사용되는 알킬옥시는 RO-로 표시되는 1가의 작용기를 의미하며, 상기 R은 탄소수 1 내지 40개의 알킬로서, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 이러한 알킬옥시의 비제한적인 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있다.The alkyloxy used in the present invention means a monovalent functional group represented by RO-, wherein R is an alkyl having 1 to 40 carbon atoms and includes a linear, branched or cyclic structure . Non-limiting examples of such alkyloxy include methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy and the like.
본 발명에서 사용되는 아릴옥시는 R′O-로 표시되는 1가의 작용기를 의미하며, 상기 R′는 탄소수 6 내지 60의 아릴이다. 이러한 아릴옥시의 비제한적인 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있다.The aryloxy used in the present invention means a monovalent functional group represented by R'O-, and R 'is aryl having 6 to 60 carbon atoms. Non-limiting examples of such aryloxy include phenyloxy, naphthyloxy, diphenyloxy, and the like.
본 발명에서 사용되는 알킬실릴은 탄소수 1 내지 40의 알킬로 치환된 실릴을 의미하며, 아릴실릴은 탄소수 6 내지 60의 아릴로 치환된 실릴을 의미하고, 아릴아민은 탄소수 6 내지 60의 아릴로 치환된 아민을 의미한다.The alkylsilyl used in the present invention means silyl substituted with alkyl having 1 to 40 carbon atoms, arylsilyl means silyl substituted with aryl having 6 to 60 carbon atoms, arylamine is substituted with aryl having 6 to 60 carbon atoms ≪ / RTI >
본 발명에서 사용되는 축합 고리는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.The condensed rings used in the present invention means condensed aliphatic rings, condensed aromatic rings, condensed heteroaliphatic rings, condensed heteroaromatic rings, or a combination thereof.
본 발명의 유기 전계 발광 소자는 상기 화학식 1로 표시되는 인돌계 화합물을 발광층의 인광 호스트로, 상기 화학식 3으로 표시되는 이리듐 화합물을 발광층의 인광 도판트로 사용함에 따라 호스트-도판트 사이에서 효율적인 에너지 전달이 이루어져 발광성능, 구동전압 및 수명 등의 특성이 우수하다.The organic electroluminescent device of the present invention is characterized in that an indole compound represented by Formula 1 is used as a phosphorescent host in a light emitting layer and an iridium compound represented by Formula 3 is used as a phosphorescent dopant in a light emitting layer, And the characteristics such as light emitting performance, driving voltage and lifetime are excellent.
이하, 본 발명을 설명한다.
Hereinafter, the present invention will be described.
본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자에 있어서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물과 상기 화학식 3으로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.The present invention relates to an organic electroluminescent device comprising a cathode, a cathode, and at least one organic material layer interposed between the anode and the cathode, wherein at least one of the one or more organic material layers comprises a compound represented by the formula An organic electroluminescent device comprising a compound represented by the general formula (3) is provided.
상기 화학식 1로 표시되는 화합물은 인돌계 기본 골격에 축합 탄소고리 또는 축합 헤테로환 모이어티, 바람직하게는 축합 헤테로환 모이어티가 연결되고, 여러 치환체에 의해 에너지 레벨이 조절됨으로써 넓은 밴드갭 (sky blue ~ red)을 갖는다. 따라서, 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층에 사용할 경우 인광특성이 개선됨과 동시에 전자 및/또는 정공 수송 능력, 발광 능력을 높일 수 있다.The compound represented by the general formula (1) has a condensed carbon ring or a condensed heterocyclic moiety, preferably a condensed heterocyclic moiety, linked to the indole basic skeleton, and the energy level is controlled by various substituents, to red). Therefore, when the compound represented by the general formula (1) is used for an organic material layer of an organic electroluminescent device, phosphorescence characteristics can be improved and electron and / or hole transporting ability and light emitting ability can be enhanced.
여기서, 본 발명의 화학식 1로 표시되는 화합물은 유기물층 중 정공 수송층, 전자 수송층 및 발광층에 사용되는 것이 바람직하며, 인돌계 기본골격으로 인해 종래의 CBP에 비해 발광 호스트 물질로써 우수한 특성을 나타내기 때문에 발광층의 호스트 물질로 사용되는 것이 더욱 바람직하다.The compound represented by the general formula (1) of the present invention is preferably used in a hole transporting layer, an electron transporting layer and a light emitting layer in the organic material layer, and exhibits excellent characteristics as a light emitting host material compared to the conventional CBP due to the indole based basic skeleton. It is more preferable to use it as a host material.
구체적으로, 상기 화학식 1로 표시되는 화합물은 인돌계 기본골격에 다양한 방향족 환(aromatic ring)이 치환체로 결합되어 화합물의 분자량이 유의적으로 증대됨으로써, 유리전이온도가 향상되고 이로 인해 종래 CBP보다 높은 열적 안정성을 가질 수 있다. 또한 다양한 방향족 환 치환체로 인해 분자 전체가 바이폴라(bipolar)한 성격을 가지면서 정공과 전자의 결합력을 높일 수 있기 때문에, 종래 CBP에 비해 발광층의 호스트 재료로서의 우수한 특성을 나타낼 수 있다.Specifically, the compound represented by Formula (1) has a structure in which aromatic rings are substituted with various aromatic rings in the indole-based basic skeleton, and the molecular weight of the compound is significantly increased. As a result, the glass transition temperature is improved, And may have thermal stability. In addition, since the molecules have bipolar characteristics due to various aromatic ring substituents and can increase the bonding force between holes and electrons, they can exhibit excellent characteristics as a host material of a light emitting layer as compared with conventional CBP.
이러한 화학식 1로 표시되는 화합물의 Y1 내지 Y4에서 축합 고리를 형성하지 않는 것은 모두 CR3인 것이 바람직하고, 이때, 복수개의 R3는 서로 동일하거나 상이할 수 있다. 또한, 화학식 1로 표시되는 화합물의 Y5 내지 Y8은 모두 CR4인 것이 바람직하며, 이때, 복수개의 R4는 서로 동일하거나 상이할 수 있다.In the compounds represented by the formula (1), it is preferable that all of the groups not forming a condensed ring at Y 1 to Y 4 are CR 3 , and a plurality of R 3 s may be the same as or different from each other. It is preferable that all of Y 5 to Y 8 of the compound represented by the formula (1) are all CR 4 , and a plurality of R 4 s may be the same or different from each other.
여기서, 화합물의 넓은 밴드갭(band-gap)과 열안정성을 고려할 때, 상기 화학식 1의 R1 내지 R4는 각각 독립적으로 수소, C6~C60의 아릴기(예: 페닐, 나프틸, 비스페닐) 또는 핵원자수 5 내지 60의 헤테로아릴기(예: 피리딘)인 것이 바람직하다.Here, considering the wide band-gap and thermal stability of the compound, R 1 to R 4 in the formula (1) are each independently selected from the group consisting of hydrogen, a C 6 -C 60 aryl group (eg, phenyl, naphthyl, Biphenyl) or a heteroaryl group having 5 to 60 nuclear atoms (e.g., pyridine).
이러한 본 발명의 화학식 1로 표시되는 화합물은 하기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택되는 것이 바람직하다.The compound represented by the formula (1) of the present invention is preferably selected from the group consisting of compounds represented by the following formulas (1a) to (1f).
[화학식 1a][Formula 1a]
[화학식 1b][Chemical Formula 1b]
[화학식 1c][Chemical Formula 1c]
[화학식 1d]≪ RTI ID = 0.0 &
[화학식 1e][Formula 1e]
[화학식 1f](1f)
상기 화학식 1a 내지 1f에서, X1, X2 및 R1 내지 R4는 상기에서 정의한 바와 같다.In the above formulas (1a) to (1f), X 1 , X 2 and R 1 to R 4 are as defined above.
한편, 유기 전계 발광 소자의 발광 효율, 구동 전압 및 수명 등의 특성을 고려할 ?, 상기 화학식 1의 X1 및 X2는 각각 독립적으로, N(Ar1) 또는 S인 것이 바람직하다. 즉, X1이 N(Ar1)이고 X2가 S이거나, X1이 S이고 X2가 N (Ar1)이거나, X1 및 X2가 모두 N(Ar1)인 것이 바람직한 것이다.It is preferable that X 1 and X 2 in formula ( 1 ) are each independently N (Ar 1 ) or S, taking into consideration the characteristics such as luminous efficiency, driving voltage and lifetime of the organic electroluminescent device. That is, it is preferable that X 1 is N (Ar 1 ), X 2 is S, X 1 is S, X 2 is N (Ar 1 ), or X 1 and X 2 are both N (Ar 1 ).
이러한, 본 발명의 화학식 1로 표시되는 화합물은 보다 구체적으로, 하기 화학식 C1 내지 C66으로 표시되는 화합물로 이루어진 군에서 선택될 수 있다.More specifically, the compound represented by the formula (1) of the present invention may be selected from the group consisting of compounds represented by the following formulas (C1) to (C66).
상기 화학식 C1 내지 C66에서, R1 내지 R4는 상기에서 정의한 바와 같으며, 이때, 복수개의 R3 및 R4는 서로 동일하거나 상이할 수 있다. 또한, Ar1 내지 Ar5는 상기에서 정의한 바와 같은데, 그 중에서도 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 것이 바람직하다. 구체적으로, Ar1 내지 Ar5는 각각 독립적으로, 하기 치환체(작용기) 그룹(S1-S192)으로부터 선택되는 것이 더욱 바람직하다.In the above formulas C1 to C66, R 1 to R 4 are as defined above, and a plurality of R 3 and R 4 may be the same or different from each other. Further, Ar 1 to Ar 5 are sounds as defined above, particularly C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, and a C 6 ~ C 60 of which is selected from the group consisting of an aryl amine . More specifically, it is more preferable that each of Ar 1 to Ar 5 is independently selected from the following substituent (functional group) group (S1-S192).
한편, 상기 화학식 3으로 표시되는 화합물은 이리듐(Ir)을 중심으로, 한쪽에는 방향족 환이 연결되고, 다른 한쪽에는 유기 리간드가 연결된다. 이러한 본 발명의 화학식 3으로 표시되는 화합물은 유기 리간드가 연결되어 있기 때문에 HOMO와 삼중항 MLCT 상태의 에너지 갭을 증가시킬 수 있다. 따라서, 화학식 3으로 표시되는 화합물을 유기 전계 발광 소자의 유기물층, 구체적으로, 정공 주입층, 정공 수송층 및 발광층에 사용할 경우 인광특성이 개선됨과 색순도를 높일 수 있다.On the other hand, the compound represented by the above formula (3) has an aromatic ring connected to one side and an organic ligand connected to the other side with iridium (Ir) as a center. Since the organic ligand is connected to the compound represented by Formula 3 of the present invention, the energy gap between the HOMO and the triplet MLCT state can be increased. Accordingly, when the compound represented by the general formula (3) is used for an organic material layer of an organic electroluminescent device, specifically, a hole injecting layer, a hole transporting layer and a light emitting layer, phosphorescence characteristics can be improved and color purity can be increased.
특히, 상기 화학식 1로 표시되는 화합물과 함께 유기 전계 발광 소자에 사용할 경우 그 성능을 높일 수 있다. 즉, 유기 전계 발광 소자의 유기물층 중 발광층은 호스트/도펀트 물질로 이루어지는데, 본 발명은 호스트/도펀트 사이에 에너지가 효율적으로 전달될 수 있도록 상기 화학식 1로 표시되는 화합물을 발광층의 호스트 물질로, 상기 화학식 3으로 표시되는 화합물을 발광층의 도펀트 물질로 사용하여 구동전압, 발광 효율, 수명 특성뿐만 아니라 색순도가 우수한 유기 전계 발광 소자를 제공할 수 있는 것이다.In particular, when the compound represented by Formula 1 is used in an organic electroluminescent device, its performance can be enhanced. That is, in the organic electroluminescent device, the light emitting layer is made of a host / dopant material. In order to efficiently transfer energy between the host and the dopant, the compound represented by Formula 1 is used as a host material in the light emitting layer, The organic electroluminescent device having excellent color purity as well as driving voltage, luminous efficiency and lifetime characteristics by using the compound represented by the general formula (3) as a dopant material of the light emitting layer can be provided.
이러한 본 발명의 화학식 3으로 표시되는 화합물에서, X 및 Y는 서로 결합하여 X-Y로 표시되는 유기 리간드를 형성하는 것으로, 이때, X는 핵원자수 3 내지 40의 헤테로아릴기, 바람직하게는 N-함유 헤테로아릴기이고, Y는 C6~C40의 아릴기 또는 핵원자수 3 내지 40의 헤테로아릴기이다.In the compound of formula (3) of the present invention, X and Y are bonded to each other to form an organic ligand represented by XY, wherein X is a heteroaryl group having 3 to 40 nuclear atoms, preferably N- Containing heteroaryl group, and Y is a C 6 to C 40 aryl group or a heteroaryl group having 3 to 40 nuclear atoms.
상기 X 및 Y의 아릴기 또는 헤테로아릴기는 할로겐, 시아노기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C1~C40의 알콕시기, C6~C40의 아릴기 및 핵원자수 5 내지 40의 헤테로아릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환될 수 있다. 또한, 상기 치환기는 인접하는 기와 결합하여 축합 고리 또는 스피로 결합을 형성할 수 있다.The X and Y of the aryl group or heteroaryl group, halogen, a cyano group, an amino group, C 1 ~ C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 2 ~ C of 40 alkenyl, C alkynyl group of 2 ~ C 40, C 1 ~ C 40 alkoxy group, C 6 ~ C 40 aryl group and a nuclear atoms least one member selected from the group consisting of a heteroaryl group of from 5 to 40 substituents . ≪ / RTI > The substituent may be bonded to an adjacent group to form a condensed ring or a spiro bond.
본 발명의 화학식 3으로 표시되는 화합물은 하기 화학식 3a 내지 3d로 표시되는 화합물로 이루어진 군에서 선택되는 것이 바람직하다.The compound represented by the formula (3) of the present invention is preferably selected from the group consisting of the compounds represented by the following formulas (3a) to (3d).
[화학식 3a][Chemical Formula 3]
[화학식 3b](3b)
[화학식 3c][Chemical Formula 3c]
[화학식 3d](3d)
상기 화학식 3a 내지 3d에서, X, Y, n 및 R11 내지 R18은 상기에서 정의한 바와 동일하다.In the above formulas (3a) to (3d), X, Y, n and R 11 to R 18 are the same as defined above.
상기 Ra 및 R21 내지 R25는 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며, 상기 m은 0 내지 3의 정수이다.Wherein Ra and R 21 to R 25 each independently represent hydrogen, deuterium, halogen, cyano, nitro, amino, C 1 to C 40 alkyl, C 3 to C 40 cycloalkyl, A C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 1 to C 40 An arylsilyl group of C 6 to C 60 , a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine group, a C 6 to C 60 An arylphosphine oxide group and an arylamine group of C 6 to C 60 , and may form a condensed ring by combining with adjacent groups, and m is an integer of 0 to 3.
상기 화학식 3에서 유기 리간드인 X-Y는 유기 전계 발광 소자의 특성을 고려할 때, 하기 A1-A24로 표시되는 구조로 이루어진 군에서 선택되는 것이 바람직하다.X-Y, which is an organic ligand in Formula 3, is preferably selected from the group consisting of the structures represented by the following Al-A24 in view of the characteristics of the organic electroluminescent device.
상기 A1 내지 A24로 표시되는 구조의 R31 내지 R42는, 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있다.R 31 to R 42 in the structures represented by A 1 to A 24 each independently represent hydrogen, deuterium, halogen, cyano, nitro, amino, C 1 to C 40 alkyl, C 3 to C 40 cycloalkyl , A heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group A C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine pingi, is selected from the group consisting of C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ C 60 aryl amine, the combination adjacent groups may form a condensed ring.
이러한 본 발명의 화학식 3으로 표시되는 화합물의 구체적인 예로 하기 화합물들(1-170)을 들 수 있지만, 이에 한정되는 것은 아니다.Specific examples of the compound represented by the formula (3) of the present invention include, but are not limited to, the following compounds (1-170).
이상에서 설명한 본 발명의 화학식 1로 표시되는 화합물과 화학식 3으로 표시되는 화합물은 하기 합성예를 바탕으로 다양하게 합성할 수 있다.The compound represented by formula (1) and the compound represented by formula (3) of the present invention described above can be synthesized on the basis of the following synthesis examples.
한편, 본 발명의 유기 전계 발광 소자는 양극(anode), 음극(cathode) 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는데, 상기 1층 이상의 유기물층 중 어느 하나 이상이 상기 화학식 1 및 3으로 표시되는 화합물을 포함하는 것을 제외하고는 당업계에 공지된 물질 및 구조로 이루어질 수 있다.Meanwhile, the organic electroluminescent device of the present invention includes at least one anode, an anode, and at least one organic layer sandwiched between the anode and the cathode, Can be made of materials and structures known in the art, except for including the compounds represented by formulas (1) and (3).
구체적으로 본 발명의 유기 전계 발광 소자는 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 또한, 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층된 구조뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수도 있다.Specifically, the organic electroluminescent device of the present invention may have a structure in which a substrate, an anode, a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and a cathode are sequentially laminated. In addition to a structure in which an anode, one or more organic layers and a cathode are sequentially stacked, an insulating layer or an adhesive layer may be inserted into the interface between the electrode and the organic layer.
상기 유기물층에 해당되는 정공 주입층, 정공 수송층 및 발광층 중 하나 이상은 상기 화학식 1 및 화학식 3으로 표시되는 화합물을 포함하는 것이 바람직하다. 보다 바람직하게는 본 발명의 화학식 1로 표시되는 화합물은 발광층의 인광 호스트로, 화학식 3으로 표시되는 화합물은 발광층의 인광 도펀트로 사용될 수 있다.It is preferable that at least one of the hole injecting layer, the hole transporting layer, and the light emitting layer corresponding to the organic material layer includes the compound represented by the above formulas (1) and (3). More preferably, the compound represented by Formula 1 of the present invention may be used as a phosphorescent host of the light emitting layer and the compound represented by Formula 3 may be used as a phosphorescent dopant of the light emitting layer.
상기 기판으로는 실리콘 웨이퍼, 석영 또는 유리판, 금속판, 플라스틱 필름이나 시트 등이 사용될 수 있다.The substrate may be a silicon wafer, quartz or glass plate, a metal plate, a plastic film, or a sheet.
상기 양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자; 또는 카본블랙 등을 사용할 수 있다.Examples of the positive electrode material include metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; Metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb; Conductive polymers such as polythiophene, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT), polypyrrole and polyaniline; Or carbon black may be used.
상기 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등을 사용할 수 있다.Examples of the negative electrode material include metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin or lead or alloys thereof; A multilayer structure material such as LiF / Al or LiO 2 / Al, or the like can be used.
이외에 전자 주입층 및 전자 수송층은 당업계에 공지된 물질이라면 특별히 한정하지 않고 사용할 수 있다.In addition, the electron injection layer and the electron transport layer are not particularly limited as long as they are materials known in the art.
이러한 본 발명의 유기 전계 발광 소자의 제조방법은 당업계에 공지된 방법이라면 특별히 한정되지 않으나, 상기 유기물층은 진공증착법이나 용액 도포법에 의하여 형성될 수 있다. 여기서, 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등을 들 수 있다.
The method of manufacturing the organic electroluminescent device of the present invention is not particularly limited as long as it is a method known in the art, but the organic material layer may be formed by a vacuum evaporation method or a solution coating method. Examples of the solution coating method include a spin coating method, a dip coating method, a doctor blading method, an ink jet printing method, and a thermal transfer method.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are for illustrative purposes only and are not intended to limit the scope of the present invention.
[[ 준비예Preparation Example 1] One] ICIC -1의 합성Synthesis of -1
<단계 1> 5-(4,4,5,5-≪ Step 1 > 5- (4,4,5,5- tetramethyltetramethyl -1,3,2--1,3,2- dioxaborolandioxaborolan -2--2- ylyl )-1H-) -1H- indoleindole 의 합성Synthesis of
질소 기류 하에서 5-bromo-1H-indole (25 g, 0.128 mol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (48.58 g, 0.191 mol), Pd(dppf)Cl2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) 및 1,4-dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.(25 g, 0.128 mol), 4,4,4 ', 4', 5,5, 5 ', 5'-octamethyl-2,2'-bi (1,3 , 2-dioxaborolane) (48.58 g , 0.191 mol), mixed with Pd (dppf) Cl 2 (5.2 g, 5 mol), KOAc (37.55 g, 0.383 mol) and 1,4-dioxane (500 ml) and 130 ℃ Lt; / RTI > for 12 hours.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22.32 g, 수율 72%)을 얻었다. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 5- (4,4,5,5-tetramethyl -1,3,2-dioxaborolan-2-yl) -1H-indole (22.32 g, yield 72%).
1H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.95 (s, 1H), 8.21 (s, 1H) 1 H-NMR:? 1.24 (s, 12H), 6.45 (d, IH), 7.27 (d, IH), 7.42 s, 1 H)
<단계 2> 5-(2-<Step 2> Synthesis of 5- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
질소 기류 하에서 1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol)과 상기 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole (22 g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) 및 THF/H2O(400 ml/200 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(4.36 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. 1-bromo-2-nitrobenzene (15.23 g, 75.41 mmol) and 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- g, 90.49 mmol), NaOH (9.05 g, 226.24 mmol) and THF / H 2 O (400 ml / 200 ml) were mixed and Pd (PPh 3 ) 4 (4.36 g, 5 mol%) And the mixture was stirred at 80 ° C for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1H-indole (11.32 g, 수율 63%)을 얻었다. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 5- (2-nitrophenyl) -1H-indole (11.32 g, yield 63%).
1H-NMR: δ 6.47 (d, 1H), 7.25 (d, 1H), 7.44 (d, 1H), 7.53 (d, 1H), 7.65 (t, 1H), 7.86 (t, 1H), 7.95 (s, 1H), 8.00 (d, 1H), 8.09 (t, 1H), 8.20 (s, 1H) 1 H-NMR: δ 6.47 ( d, 1H), 7.25 (d, 1H), 7.44 (d, 1H), 7.53 (d, 1H), 7.65 (t, 1H), 7.86 (t, 1H), 7.95 ( (s, 1 H), 8.00 (d, 1 H), 8.09 (t,
<단계 3> 5-(2-≪ Step 3 > 5- (2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
질소 기류 하에서 상기 5-(2-nitrophenyl)-1H-indole (11 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol), K2CO3 (6.38 g, 46.17 mmol), Na2SO4 (6.56 g, 46.17 mmol), nitrobenzene (200 ml)를 혼합하고 190℃에서 12시간 동안 교반하였다. (11 g, 46.17 mmol), iodobenzene (14.13 g, 69.26 mmol), Cu powder (0.29 g, 4.62 mmol) and K 2 CO 3 (6.38 g, 46.17 mmol), Na 2 SO 4 (6.56 g, 46.17 mmol) and nitrobenzene (200 ml) were mixed and stirred at 190 ° C for 12 hours.
반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)-1-phenyl-1H-indole (10.30 g, 수율 71%)을 얻었다. After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . After removing the solvent from the organic layer from which water had been removed, the residue was purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain 5- (2-nitrophenyl) -1- 71%).
1H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.45 (m, 3H), 7.55 (m, 4H), 7.63 (t, 1H), 7.84 (t, 1H), 7.93 (s, 1H), 8.01 (d, 1H), 8.11 (t, 1H) 1 H-NMR: δ 6.48 ( d, 1H), 7.26 (d, 1H), 7.45 (m, 3H), 7.55 (m, 4H), 7.63 (t, 1H), 7.84 (t, 1H), 7.93 ( s, 1 H), 8.01 (d, 1 H), 8.11 (t, 1 H)
<단계 4> <Step 4> ICIC -1의 합성Synthesis of -1
질소 기류 하에서 상기 5-(2-nitrophenyl)-1-phenyl-1H-indole (5 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) 및 1,2-dichlorobenzene (50 ml)를 혼합하고 12시간 동안 교반하였다.(5 g, 15.91 mmol), triphenylphosphine (10.43 g, 39.77 mmol) and 1,2-dichlorobenzene (50 ml) were mixed in a nitrogen gas stream for 12 hours Lt; / RTI >
반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 얻어진 유기층에 대해 MgSO4로 물을 제거하고, 컬럼크로마토그래피 (Hexane:MC=3:1 (v/v))로 정제하여 IC-1 (2.38 g, 수율 53%)을 얻었다. After completion of the reaction, 1,2-dichlorobenzene was removed and extracted with dichloromethane. Water was removed from the obtained organic layer with MgSO 4 and purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain IC-1 (2.38 g, yield 53%).
1H-NMR: δ 6.99 (d, 1H), 7.12 (t, 1H), 7.27 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.50 (d, 1H), 7.60 (m, 5H), 7.85 (d, 1H), 8.02 (d, 1H), 10.59 (s, 1H) 1 H-NMR: δ 6.99 ( d, 1H), 7.12 (t, 1H), 7.27 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.50 (d, 1H), 7.60 ( (d, IH), 8.05 (d, IH)
[[ 준비예Preparation Example 2] 2] ICIC -2의 합성Synthesis of -2
상기 5-(2-nitrophenyl)-1-phenyl-1H-indole, triphenylphosphine 및 1,2-dichlorobenzene을 사용하여 상기 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-1과 구조 이성질체인 IC-2을 얻었다.Step 4 of Preparation Example 1 was carried out using the above 5- (2-nitrophenyl) -1-phenyl-1H-indole, triphenylphosphine and 1,2-dichlorobenzene to obtain IC- -2.
1H-NMR: δ 6.98 (d, 1H), 7.13 (t, 1H), 7.26 (t, 1H), 7.33 (d, 1H), 7.42 (t, 1H), 7.51 (s, 1H), 7.61 (m, 5H), 7.84 (d, 1H), 8.03 (s, 1H), 10.58 (s, 1H) 1 H-NMR: δ 6.98 ( d, 1H), 7.13 (t, 1H), 7.26 (t, 1H), 7.33 (d, 1H), 7.42 (t, 1H), 7.51 (s, 1H), 7.61 ( (d, IH), 8.03 (s, IH), 10.58 (s, IH)
[[ 준비예Preparation Example 3] 3] ICIC -3의 합성Synthesis of -3
<단계 1> 6-(4,4,5,5-≪ Step 1 > 6- (4,4,5,5- tetramethyltetramethyl -1,3,2--1,3,2- dioxaborolandioxaborolan -2--2- ylyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-bromo-1H-indole 대신 6-bromo-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.The procedure of Step 1 of Preparation Example 1 was repeated except that 6-bromo-1H-indole was used instead of 5-bromo-1H-indole to obtain 6- (4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl) -1H-indole.
1H-NMR: δ 1.25 (s, 12H), 6.52 (d, 1H), 7.16 (d, 1H), 7.21 (d, 1H), 7.49 (d, 1H), 7.53 (s, 1H), 8.15 (s, 1H) 1 H-NMR:? 1.25 (s, 12H), 6.52 (d, IH), 7.16 (d, IH), 7.21 s, 1 H)
<단계 2> 6-(2-≪ Step 2 > 6- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 2>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1H-indole을 얻었다.(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole was used instead of 5- (4,4,5,5-tetramethyl- (2-nitrophenyl) -1H-indole was obtained in the same manner as in <Step 2> of Preparation Example 1 except that dioxaborolan-2-yl) -1H-indole was used.
1H-NMR: δ 6.57 (d, 1H), 7.07 (d, 1H), 7.24 (d, 1H), 7.35 (s, 1H), 7.43 (t, 1H), 7.50 (d, 1H), 7.58 (t, 1H), 7.66 (d, 1H), 7.78 (d, 1H), 8.19 (s, 1H) 1 H-NMR: δ 6.57 ( d, 1H), 7.07 (d, 1H), 7.24 (d, 1H), 7.35 (s, 1H), 7.43 (t, 1H), 7.50 (d, 1H), 7.58 ( t, 1 H), 7.66 (d, 1 H), 7.78 (d,
<단계 3> 6-(2-≪ Step 3 > 6- (2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.The procedure of Step 3 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) -1H- -nitrophenyl) -1-phenyl-1H-indole.
1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.35 (s, 1H), 7.43 (d, 1H), 7.51 (m, 3H), 7.56 (m, 2H), 7.62 (m, 2H), 7.85 (d, 1H), 8.02 (d, 1H) 1 H-NMR: δ 6.81 ( d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.35 (s, 1H), 7.43 (d, 1H), 7.51 (m, 3H), 7.56 ( (m, 2H), 7.62 (m, 2H), 7.85 (d,
<단계 4> <Step 4> ICIC -3의 합성Synthesis of -3
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1-phenyl-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-3을 얻었다.Step 4 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) And IC-3 was obtained.
1H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.23 (t, 1H), 7.42 (d, 1H), 7.50 (m, 3H), 7.57 (m, 2H), 7.63 (m, 2H), 7.86 (d, 1H), 8.03 (d, 1H), 9.81 (s, 1H) 1 H-NMR: δ 6.80 ( d, 1H), 7.11 (t, 1H), 7.23 (t, 1H), 7.42 (d, 1H), 7.50 (m, 3H), 7.57 (m, 2H), 7.63 ( (m, 2H), 7.86 (d, 1H), 8.03 (d,
[[ 준비예Preparation Example 4] 4] ICIC -4의 합성Synthesis of -4
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1-phenyl-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-3과 구조 이성질체인 IC-4를 얻었다.Step 4 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) To obtain IC-3 and the structural isomer IC-4.
1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.43 (s, 1H), 7.51 (m, 3H), 7.58 (m, 2H), 7.64 (m, 2H), 7.85 (d, 1H), 8.02 (s, 1H), 9.82 (s, 1H) 1 H-NMR: δ 6.81 ( d, 1H), 7.12 (t, 1H), 7.22 (t, 1H), 7.43 (s, 1H), 7.51 (m, 3H), 7.58 (m, 2H), 7.64 ( (m, 2H), 7.85 (d, 1H), 8.02 (s,
[[ 준비예Preparation Example 5] 5] ICIC -5의 합성Synthesis of -5
<단계 1> 4-(4,4,5,5-<Step 1> Synthesis of 4- (4,4,5,5- tetramethyltetramethyl -1,3,2--1,3,2- dioxaborolandioxaborolan -2--2- ylyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-bromo-1H-indole 대신 4-bromo-1H-indole를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.The procedure of Step 1 of Preparation Example 1 was repeated except that 4-bromo-1H-indole was used instead of 5-bromo-1H-indole to obtain 4- (4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl) -1H-indole.
1H NMR: δ 1.26 (s, 12H), 6.43 (d, 1H), 7.26 (t, 1H), 7.48 (d, 1H), 7.74 (d, 1H), 7.85 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 1.26 (s , 12H), 6.43 (d, 1H), 7.26 (t, 1H), 7.48 (d, 1H), 7.74 (d, 1H), 7.85 (d, 1H), 8.23 (s , 1H)
<단계 2> 4-(2-<Step 2> Synthesis of 4- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-nitrophenyl)-1H-indole을 얻었다.Instead of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H- dioxaborolan-2-yl) -1H-indole, the procedure of Step 2 of Preparation Example 1 was repeated to obtain 4- (2-nitrophenyl) -1H-indole.
1H NMR: δ 6.45 (d, 1H), 7.27 (t, 1H), 7.50 (d, 1H), 7.66 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 7.99 (d, 1H), 8.04 (d, 1H), 8.24 (s, 1H) 1 H NMR: δ 6.45 (d , 1H), 7.27 (t, 1H), 7.50 (d, 1H), 7.66 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 7.99 (d , ≪ / RTI > 1H), 8.04 (d, 1H), 8.24
<단계 3> 4-(2-<Step 3> Synthesis of 4- (2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 4-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 4-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.The procedure of Step 3 of Preparation Example 1 was repeated except that 4- (2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) -1H- nitrophenyl) -1-phenyl-1H-indole.
1H NMR: δ 6.47 (d, 1H), 7.28 (t, 1H), 7.47 (m, 2H), 7.52 (m, 2H), 7.60 (m, 2H), 7.67 (t, 1H), 7.75 (d, 1H), 7.89 (m, 2H), 8.00 (d, 1H), 8.06 (d, 1H) 1 H NMR: δ 6.47 (d , 1H), 7.28 (t, 1H), 7.47 (m, 2H), 7.52 (m, 2H), 7.60 (m, 2H), 7.67 (t, 1H), 7.75 (d , 7.89 (m, 2H), 8.00 (d, IH), 8.06 (d, IH)
<단계 4> <Step 4> ICIC -5의 합성Synthesis of -5
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 4-(2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-5을 얻었다.Step 4 of Preparation Example 1 was repeated except that 4- (2-nitrophenyl) -1-phenyl-1H-indole was used in place of 5- (2-nitrophenyl) To obtain IC-5.
1H NMR: δ 6.49 (d, 1H), 7.29 (t, 1H), 7.46 (m, 2H), 7.54 (m, 2H), 7.61 (d, 1H), 7.69 (t, 1H), 7.74 (d, 1H), 7.88 (m, 2H), 8.01 (d, 1H), 8.04 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 6.49 (d , 1H), 7.29 (t, 1H), 7.46 (m, 2H), 7.54 (m, 2H), 7.61 (d, 1H), 7.69 (t, 1H), 7.74 (d , 8.01 (d, IH), 8.04 (d, IH), 8.23 (s, IH)
[[ 준비예Preparation Example 6] 6] ICIC -6의 합성Synthesis of -6
<단계 1> 7-(4,4,5,5-≪ Step 1 > 7- (4,4,5,5- tetramethyltetramethyl -1,3,2--1,3,2- dioxaborolandioxaborolan -2--2- ylyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-bromo-1H-indole 대신 7-bromo-1H-indole를 사용하는 것을 제외하고는 준비예 1의 <단계 1>과 동일한 과정을 수행하여 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 얻었다.The procedure of Step 1 of Preparation Example 1 was repeated except that 7-bromo-1H-indole was used instead of 5-bromo-1H-indole to obtain 7- (4,4,5,5-tetramethyl-1 , 3,2-dioxaborolan-2-yl) -1H-indole.
1H NMR: δ 1.25 (s, 12H), 6.43 (d, 1H), 7.25 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.71 (d, 1H), 8.22 (s, 1H) 1 H NMR: δ 1.25 (s , 12H), 6.43 (d, 1H), 7.25 (d, 1H), 7.45 (t, 1H), 7.56 (d, 1H), 7.71 (d, 1H), 8.22 (s , 1H)
<단계 2> 7-(2-≪ Step 2 > 7- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 7-(2-nitrophenyl)-1H-indole을 얻었다.(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole was used instead of 5- (4,4,5,5-tetramethyl- (2-nitrophenyl) -1H-indole was obtained in the same manner as in <Step 2> of Preparation Example 1 except that dioxaborolan-2-yl) -1H-indole was used.
1H NMR: δ 6.42 (d, 1H), 7.24 (d, 1H), 7.43 (t, 1H), 7.55 (d, 1H), 7.70 (m, 2H), 7.88 (t, 1H), 8.01 (d, 1H), 8.11 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 6.42 (d , 1H), 7.24 (d, 1H), 7.43 (t, 1H), 7.55 (d, 1H), 7.70 (m, 2H), 7.88 (t, 1H), 8.01 (d , 8.11 (d, 1 H), 8.23 (s, 1 H)
<단계 3> 7-(2-≪ Step 3 > 7- (2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 7-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 7-(2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.The procedure of Step 3 of Preparation Example 1 was repeated except that 7- (2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) -1H- nitrophenyl) -1-phenyl-1H-indole.
1H NMR: δ 6.43 (d, 1H), 7.26 (d, 1H), 7.44 (m, 3H), 7.56 (m, 4H), 7.71 (m, 2H), 7.89 (t, 1H), 8.02 (d, 1H), 8.10 (d, 1H) 1 H NMR: δ 6.43 (d , 1H), 7.26 (d, 1H), 7.44 (m, 3H), 7.56 (m, 4H), 7.71 (m, 2H), 7.89 (t, 1H), 8.02 (d , ≪ / RTI > 1H), 8.10 (d, 1H)
<단계 4> <Step 4> ICIC -6의 합성Synthesis of -6
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 7-(2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-6을 얻었다.Step 4 of Preparation Example 1 was repeated except that 7- (2-nitrophenyl) -1-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) To obtain IC-6.
1H NMR: δ 6.45 (d, 1H), 7.24 (d, 1H), 7.45 (m, 3H), 7.57 (m, 3H), 7.63 (d, 1H), 7.70 (d, 1H), 7.88 (t, 1H), 8.00 (d, 1H), 8.09 (d, 1H), 8.22 (s, 1H) 1 H NMR: δ 6.45 (d , 1H), 7.24 (d, 1H), 7.45 (m, 3H), 7.57 (m, 3H), 7.63 (d, 1H), 7.70 (d, 1H), 7.88 (t , 8.00 (d, IH), 8.09 (d, IH), 8.22 (s, IH)
[[ 준비예Preparation Example 7] 7] ICIC -7의 합성Synthesis of -7
<단계 1> 5-(5-<Step 1> 5- (5- bromobromo -2--2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
1-bromo-2-nitrobenzene 대신 2,4-dibromo-1-nitrobenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 5-(5-bromo-2-nitrophenyl)-1H-indole을 얻었다.5-bromo-2-nitrophenyl) -methanone was obtained in the same manner as in <Step 2> of Preparation Example 1 except that 2,4-dibromo-1-nitrobenzene was used instead of 1-bromo- 1H-indole.
1H NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.45 (d, 1H), 7.55 (d, 1H), 7.64 (d, 1H), 7.85 (d, 1H), 7.96 (s, 1H), 8.13 (s, 1H), 8.21 (s, 1H) 1 H NMR: δ 6.45 (d , 1H), 7.26 (d, 1H), 7.45 (d, 1H), 7.55 (d, 1H), 7.64 (d, 1H), 7.85 (d, 1H), 7.96 (s , ≪ / RTI > 1H), 8.13 (s, 1H), 8.21
<단계 2> 5-(5-≪ Step 2 > 5- (5- bromobromo -2--2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 5-(5-bromo-2-nitrophenyl)-1H-indole 을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.The procedure of Step 3 of Preparation Example 1 was repeated except that 5- (5-bromo-2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) - (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole.
1H NMR: δ 6.44 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 4H), 7.65 (d, 1H), 7.86 (d, 1H), 7.95 (s, 1H), 8.11 (s, 1H) 1 H NMR: δ 6.44 (d , 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 4H), 7.65 (d, 1H), 7.86 (d, 1H), 7.95 (s , ≪ / RTI > 1H), 8.11 (s, 1H)
<단계 3> <Step 3> ICIC -7의 합성Synthesis of -7
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-7을 얻었다.Step 4 of Preparation Example 1 was repeated except that 5- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) Gt; IC-7 < / RTI > was obtained.
1H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.38 (m, 2H), 7.45 (d, 1H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 (d, 1H), 7.85 (d, 1H), 8.10 (s, 1H), 8.23 (s, 1H) 1 H-NMR: δ 6.45 ( d, 1H), 7.26 (d, 1H), 7.38 (m, 2H), 7.45 (d, 1H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 ( (d, IH), 7.85 (d, IH), 8.10 (s, IH), 8.23
[[ 준비예Preparation Example 8] 8] ICIC -8의 합성Synthesis of -8
<단계 1> 6-(5-<Step 1> 6- (5- bromobromo -2--2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
1-bromo-2-nitrobenzene과 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 2,4-dibromo-1-nitrobenzene과 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 6-(5-bromo-2-nitrophenyl)-1H-indole을 얻었다.1-nitrobenzene and 6- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H- indole instead of 1-bromo- Step 2 of Preparation Example 1 was repeated except that 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1H-indole was used instead of 4- (5-bromo-2-nitrophenyl) -1H-indole.
1H NMR: δ 6.51 (d, 1H), 7.31 (d, 1H), 7.50 (d, 1H), 7.60 (d, 1H), 7.69 (d, 1H), 7.90 (d, 1H), 8.01 (s, 1H), 8.14 (s, 1H), 8.25 (s, 1H) 1 H NMR: δ 6.51 (d , 1H), 7.31 (d, 1H), 7.50 (d, 1H), 7.60 (d, 1H), 7.69 (d, 1H), 7.90 (d, 1H), 8.01 (s , ≪ / RTI > 1H), 8.14 (s, 1H), 8.25
<단계 2> 6-(5-≪ Step 2 > 6- (5- bromobromo -2--2- nitrophenylnitrophenyl )-1-)-One- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(5-bromo-2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 6- (5-bromo-2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) - (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole.
1H NMR: δ 6.49 (d, 1H), 7.30 (d, 1H), 7.51 (m, 3H), 7.61 (m, 4H), 7.70 (d, 1H), 7.91 (d, 1H), 8.00 (s, 1H), 8.16 (s, 1H) 1 H NMR: δ 6.49 (d , 1H), 7.30 (d, 1H), 7.51 (m, 3H), 7.61 (m, 4H), 7.70 (d, 1H), 7.91 (d, 1H), 8.00 (s , ≪ / RTI > 1H), 8.16 (s, 1H)
<단계 3> <Step 3> ICIC -8의 합성Synthesis of -8
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(5-bromo-2-nitrophenyl)-1-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-8을 얻었다.Step 4 of Preparation Example 1 was repeated except that 6- (5-bromo-2-nitrophenyl) -1-phenyl-1H-indole was used in place of 5- (2-nitrophenyl) Gt; IC-8 < / RTI > was obtained.
1H-NMR: δ 6.47 (d, 1H), 7.28 (d, 1H), 7.40 (m, 2H), 7.47 (d, 1H), 7.53 (d, 1H), 7.59 (m, 3H), 7.66 (d, 1H), 7.87 (d, 1H), 8.12 (s, 1H), 8.25 (s, 1H) 1 H-NMR: δ 6.47 ( d, 1H), 7.28 (d, 1H), 7.40 (m, 2H), 7.47 (d, 1H), 7.53 (d, 1H), 7.59 (m, 3H), 7.66 ( (d, IH), 7.87 (d, IH), 8.12 (s, IH), 8.25
[[ 준비예Preparation Example 9] 9] ICIC -9의 합성Synthesis of -9
<단계 1> 5-(2-<Step 1> 5- (2- nitrophenylnitrophenyl )-1-o-) -1-o- tolyltolyl -1H--1H- indoleindole 의 합성Synthesis of
Iodobenzene 대신 1-bromo-2-methylbenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1-o-tolyl-1H-indole을 얻었다.5- (2-nitrophenyl) -1-o-tolyl-1H-indole was obtained by following the procedure of <Step 3> of Preparation Example 1, except that 1-bromo-2-methylbenzene was used instead of iodobenzene.
1H-NMR: δ 1.92 (s, 3H), 6.47 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 3H), 7.64 (t, 1H), 7.85 (t, 1H), 7.94 (s, 1H), 8.00 (d, 1H), 8.12 (t, 1H) 1 H-NMR: δ 1.92 ( s, 3H), 6.47 (d, 1H), 7.25 (d, 1H), 7.46 (m, 3H), 7.56 (m, 3H), 7.64 (t, 1H), 7.85 ( t, 1 H), 7.94 (s, 1 H), 8.00 (d,
<단계 2> <Step 2> ICIC -- 9 의9 of 합성 synthesis
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1-o-tolyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-9를 얻었다.Step 4 of Preparation Example 1 was repeated except that 5- (2-nitrophenyl) -1-o-tolyl-1H-indole was used instead of 5- (2-nitrophenyl) The same procedure was followed to obtain IC-9.
1H-NMR: δ 1.93 (s, 3H), 6.98 (d, 1H), 7.11 (t, 1H), 7.28 (t, 1H), 7.31 (d, 1H), 7.42 (t, 1H), 7.51 (d, 1H), 7.61 (m, 4H), 7.86 (d, 1H), 8.01 (d, 1H), 10.58 (s, 1H) 1 H-NMR: δ 1.93 ( s, 3H), 6.98 (d, 1H), 7.11 (t, 1H), 7.28 (t, 1H), 7.31 (d, 1H), 7.42 (t, 1H), 7.51 ( (d, IH), 7.61 (m, 4H), 7.86 (d,
[[ 준비예Preparation Example 10] 10] ICIC -10의 합성Synthesis of -10
<단계 1> 1-(<Step 1> 1- ( biphenylbiphenyl -4--4- ylyl )-5-(2-) -5- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
Iodobenzene 대신 4-bromobiphenyl을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-4-yl)-5-(2-nitrophenyl)-1H-indole을 얻었다.(Biphenyl-4-yl) -5- (2-nitrophenyl) -1H-indole was obtained in the same manner as in <Step 3> of Preparation Example 1 except that 4-bromobiphenyl was used in place of iodobenzene.
1H-NMR: δ 6.73 (d, 1H), 7.18 (d, 1H), 7.39 (m, 2H), 7.47 (m, 3H), 7.54 (d, 1H), 7.59 (m, 3H), 7.64 (m, 4H), 7.75 (d, 2H), 7.82 (d, 1H) 1 H-NMR: δ 6.73 ( d, 1H), 7.18 (d, 1H), 7.39 (m, 2H), 7.47 (m, 3H), 7.54 (d, 1H), 7.59 (m, 3H), 7.64 ( m, 4H), 7.75 (d, 2H), 7.82 (d, IH)
<단계 2> <Step 2> ICIC -10의 합성Synthesis of -10
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-4-yl)-5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-10를 얻었다.Except that the 1- (biphenyl-4-yl) -5- (2-nitrophenyl) -1H-indole was used in place of 5- (2-nitrophenyl) Step 4 > to obtain IC-10.
1H-NMR: δ 6.75 (d, 1H), 7.20 (d, 1H), 7.42 (m, 2H), 7.51 (m, 3H), 7.56 (d, 1H), 7.62 (m, 3H), 7.68 (m, 3H), 7.76 (d, 2H), 7.85 (d, 1H), 10.45 (s, 1H) 1 H-NMR: δ 6.75 ( d, 1H), 7.20 (d, 1H), 7.42 (m, 2H), 7.51 (m, 3H), 7.56 (d, 1H), 7.62 (m, 3H), 7.68 ( (d, 2H), 7.85 (d, 1H), 10.45 (s, 1H)
[[ 준비예Preparation Example 11] 11] ICIC -11의 합성Synthesis of -11
<단계 1> <Step 1> ICIC -11-1의 합성Synthesis of -11-1
Iodobenzene 대신 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 IC-11-1을 얻었다.IC-11-1 was obtained in the same manner as in <Step 3> of Preparation Example 1 except that 1-bromo-3,5-diphenyl benzene was used in place of iodobenzene.
1H-NMR: δ 6.98 (d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (t, 2H), 7.46 (m, 6H), 7.58 (d, 1H), 7.81 (d, 4H), 7.87 (m, 4H), 7.93 (d, 1H), 7.99 (d, 1H) 1 H-NMR: δ 6.98 ( d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (t, 2H), 7.46 (m, 6H), 7.58 (d, 1H), 7.81 ( (d, IH), 7.87 (m, 4H), 7.93
<단계 2> <Step 2> ICIC -11의 합성Synthesis of -11
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 IC-11-1을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-11를 얻었다.IC-11 was obtained in the same manner as in <Step 4> of Preparation Example 1 except that IC-11-1 was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole.
1H-NMR: δ 6.97 (d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 (d, 4H), 7.86 (m, 3H), 7.92 (d, 1H), 7.98 (d, 1H), 10.60 (s, 1H) 1 H-NMR: δ 6.97 ( d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 ( (d, IH), 7.86 (d, IH), 7.86 (d,
[[ 준비예Preparation Example 12] 12] ICIC -12의 합성Synthesis of -12
<단계 1> 5-(2-<Step 1> 5- (2- nitrophenylnitrophenyl )-1-(2-() -1- (2- ( trifluoromethyltrifluoromethyl )) phenylphenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
Iodobenzene 대신 1-bromo-2-(trifluoromethyl)benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1-(2-(trifluoromethyl)phenyl)-1H-indole을 얻었다.(2-nitrophenyl) -1- (2- trifluoromethyl) benzene was prepared by following the procedure of Step 3 of Preparation Example 1, except that 1-bromo-2- (trifluoromethyl) benzene was used in place of iodobenzene. ) -1H-indole.
1H-NMR: δ 6.48 (d, 1H), 7.26 (d, 1H), 7.47 (m, 3H), 7.57 (m, 3H), 7.63 (t, 1H), 7.84 (t, 1H), 7.95 (s, 1H), 8.01 (d, 1H), 8.13 (t, 1H) 1 H-NMR:? 6.48 (d, IH), 7.26 (d, IH), 7.47 (m, 3H), 7.57 s, 1 H), 8.01 (d, 1 H), 8.13 (t, 1 H)
<단계 2> <Step 2> ICIC -12의 합성Synthesis of -12
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1-(2-(trifluoromethyl)phenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-12를 얻었다.Except that the 5- (2-nitrophenyl) -1- (2- (trifluoromethyl) phenyl) -1H-indole was used in place of 5- (2-nitrophenyl) IC-12 was obtained by performing the same procedure as in < Step 4 >.
1H-NMR: δ 6.97 (d, 1H), 7.12 (t, 1H), 7.29 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.52 (d, 1H), 7.60 (m, 4H), 7.85 (d, 1H), 8.01 (d, 1H), 10.57 (s, 1H) 1 H-NMR: δ 6.97 ( d, 1H), 7.12 (t, 1H), 7.29 (t, 1H), 7.32 (d, 1H), 7.41 (t, 1H), 7.52 (d, 1H), 7.60 ( (s, 1H), 7.85 (d, 1H), 8.01 (d,
[[ 준비예Preparation Example 13] 13] ICIC -13의 합성Synthesis of -13
<단계 1> 1-(<Step 1> 1- ( biphenylbiphenyl -3--3- ylyl )-5-(2-) -5- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
Iodobenzene 대신 3-bromobiphenyl을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-3-yl)-5-(2-nitrophenyl)-1H-indole을 얻었다.(Biphenyl-3-yl) -5- (2-nitrophenyl) -1H-indole was obtained in the same manner as in <Step 3> of Preparation Example 1 except that 3-bromobiphenyl was used instead of iodobenzene.
1H-NMR: δ 6.75 (d, 1H), 7.19 (d, 1H), 7.38 (m, 2H), 7.48 (m, 3H), 7.52 (d, 1H), 7.58 (m, 3H), 7.65 (m, 4H), 7.76 (m, 2H), 7.85 (d, 1H) 1 H-NMR: δ 6.75 ( d, 1H), 7.19 (d, 1H), 7.38 (m, 2H), 7.48 (m, 3H), 7.52 (d, 1H), 7.58 (m, 3H), 7.65 ( m, 4H), 7.76 (m, 2H), 7.85 (d, IH)
<단계 2> <Step 2> ICIC -13의 합성Synthesis of -13
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-3-yl)-5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-13를 얻었다.Except that the 1- (biphenyl-3-yl) -5- (2-nitrophenyl) -1H-indole was used in place of 5- (2-nitrophenyl) Step 4 > to obtain IC-13.
1H-NMR: δ 6.74 (d, 1H), 7.21 (d, 1H), 7.41 (m, 2H), 7.52 (m, 3H), 7.56 (d, 1H), 7.61 (m, 3H), 7.69 (m, 3H), 7.77 (m, 2H), 7.86 (d, 1H), 10.44 (s, 1H) 1 H-NMR: δ 6.74 ( d, 1H), 7.21 (d, 1H), 7.41 (m, 2H), 7.52 (m, 3H), 7.56 (d, 1H), 7.61 (m, 3H), 7.69 ( m, 3H), 7.77 (m, 2H), 7.86 (d,
[[ 준비예Preparation Example 14] 14] ICIC -14의 합성Synthesis of -14
<단계 1> 1-(<Step 1> 1- ( biphenylbiphenyl -3--3- ylyl )-6-(2-) -6- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 3-bromobiphenyl를 사용하는 것을 제외하고는 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-3-yl)-6-(2-nitrophenyl)-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1H-indole and 3-bromobiphenyl were used instead of 5- (2-nitrophenyl) -1H-indole and iodobenzene To obtain 1- (biphenyl-3-yl) -6- (2-nitrophenyl) -1H-indole.
1H-NMR: δ 6.76 (d, 1H), 7.18 (d, 1H), 7.37 (m, 2H), 7.47 (m, 3H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 (m, 4H), 7.75 (m, 2H), 7.86 (d, 1H) 1 H-NMR: δ 6.76 ( d, 1H), 7.18 (d, 1H), 7.37 (m, 2H), 7.47 (m, 3H), 7.51 (d, 1H), 7.57 (m, 3H), 7.64 ( m, 4H), 7.75 (m, 2H), 7.86 (d, IH)
<단계 2> <Step 2> ICIC -14의 합성Synthesis of -14
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-3-yl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-14을 얻었다.Except that the 1- (biphenyl-3-yl) -6- (2-nitrophenyl) -1H-indole was used in place of 5- (2-nitrophenyl) IC-14 was obtained by performing the same procedure as in < Step 4 >.
1H-NMR: δ 6.75 (d, 1H), 7.20 (d, 1H), 7.40 (m, 2H), 7.51 (m, 3H), 7.57 (d, 1H), 7.62 (m, 3H), 7.70 (m, 3H), 7.76 (m, 2H), 7.85 (d, 1H), 10.43 (s, 1H) 1 H-NMR: δ 6.75 ( d, 1H), 7.20 (d, 1H), 7.40 (m, 2H), 7.51 (m, 3H), 7.57 (d, 1H), 7.62 (m, 3H), 7.70 ( (s, 3H), 7.76 (m, 2H), 7.85 (d,
[[ 준비예Preparation Example 15] 15] ICIC -15의 합성Synthesis of -15
<단계 1> 1-(<Step 1> 1- ( biphenylbiphenyl -4--4- ylyl )-6-(2-) -6- (2- nitrophenylnitrophenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 4-bromobiphenyl을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 3>과 동일한 과정을 수행하여 1-(biphenyl-4-yl)-6-(2-nitrophenyl)-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1H-indole and 4-bromobiphenyl were used instead of 5- (2-nitrophenyl) -1H- indole and iodobenzene To obtain 1- (biphenyl-4-yl) -6- (2-nitrophenyl) -1H-indole.
1H-NMR: δ 6.74 (d, 1H), 7.19 (d, 1H), 7.40 (m, 2H), 7.46 (m, 3H), 7.55 (d, 1H), 7.58 (m, 3H), 7.63 (m, 4H), 7.75 (d, 2H), 7.83 (d, 1H) 1 H-NMR: δ 6.74 ( d, 1H), 7.19 (d, 1H), 7.40 (m, 2H), 7.46 (m, 3H), 7.55 (d, 1H), 7.58 (m, 3H), 7.63 ( m, 4H), 7.75 (d, 2H), 7.83 (d, IH)
<단계 2> <Step 2> ICIC -15의 합성Synthesis of -15
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(biphenyl-4-yl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-15을 얻었다.Except that the 1- (biphenyl-4-yl) -6- (2-nitrophenyl) -1H-indole was used in place of 5- (2-nitrophenyl) ≪ Step 4 > was performed to obtain IC-15.
1H-NMR: δ 6.74 (d, 1H), 7.19 (d, 1H), 7.43 (m, 2H), 7.52 (m, 3H), 7.57 (d, 1H), 7.63 (m, 3H), 7.69 (m, 3H), 7.75 (d, 2H), 7.86 (d, 1H), 10.46 (s, 1H) 1 H-NMR: δ 6.74 ( d, 1H), 7.19 (d, 1H), 7.43 (m, 2H), 7.52 (m, 3H), 7.57 (d, 1H), 7.63 (m, 3H), 7.69 ( (m, 3H), 7.75 (d, 2H), 7.86 (d,
[[ 준비예Preparation Example 16] 16] ICIC -16의 합성Synthesis of -16
<단계 1> <Step 1> ICIC -16-1의 합성Synthesis of -16-1
5-(2-nitrophenyl)-1-phenyl-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 IC-16-1을 얻었다.Except that 6- (2-nitrophenyl) -1H-indole and 1-bromo-3,5-diphenyl benzene were used in place of iodobenzene and 5- (2-nitrophenyl) IC-16-1 < / RTI > was obtained in the same manner as in < Step 3 >
1H-NMR: δ 6.98 (d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (m, 2H), 7.45 (m, 6H), 7.57 (d, 1H), 7.80 (d, 4H), 7.86 (m, 4H), 7.92 (d, 1H), 7.98 (d, 1H) 1 H-NMR: δ 6.98 ( d, 1H), 7.11 (t, 1H), 7.24 (t, 1H), 7.38 (m, 2H), 7.45 (m, 6H), 7.57 (d, 1H), 7.80 ( (d, IH), 7.86 (m, 4H), 7.92
<단계 2> <Step 2> ICIC -16의 합성Synthesis of -16
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 IC-16-1을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-16을 얻었다.IC-16 was obtained in the same manner as in <Step 4> of Preparation Example 1 except that IC-16-1 was used instead of 5- (2-nitrophenyl) -1-phenyl-1H-indole.
1H-NMR: δ 6.97 (d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 (d, 4H), 7.86 (m, 3H), 7.92 (d, 1H), 7.98 (d, 1H), 10.59 (s, 1H) 1 H-NMR: δ 6.97 ( d, 1H), 7.10 (t, 1H), 7.23 (t, 1H), 7.37 (t, 2H), 7.45 (m, 6H), 7.58 (d, 1H), 7.80 ( (d, IH), 7.86 (d, IH), 7.86 (m,
[[ 준비예Preparation Example 17] 17] ICIC -17의 합성Synthesis of -17
<단계 1> 6-(2-≪ Step 1 > 6- (2- nitrophenylnitrophenyl )-1-(3-() -1- (3- ( trifluoromethyltrifluoromethyl )) phenylphenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1-phenyl-1H-indole과 iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 1-bromo-3-(trifluoromethyl)benzene을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1-(3-(trifluoromethyl)phenyl)-1H-indole을 얻었다.Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1H-indole and 1-bromo-3- (trifluoromethyl) benzene were used in place of iodobenzene and 5- (2-nitrophenyl) (2-nitrophenyl) -1- (3- (trifluoromethyl) phenyl) -1H-indole was obtained in the same manner as in <Step 3>.
1H-NMR: δ 6.80 (d, 1H), 7.11 (t, 1H), 7.21 (t, 1H), 7.36 (s, 1H), 7.42 (s, 1H), 7.50 (m, 2H), 7.55 (m, 2H), 7.63 (m, 2H), 7.86 (d, 1H), 8.01 (d, 1H) 1 H-NMR: δ 6.80 ( d, 1H), 7.11 (t, 1H), 7.21 (t, 1H), 7.36 (s, 1H), 7.42 (s, 1H), 7.50 (m, 2H), 7.55 ( (m, 2H), 7.63 (m, 2H), 7.86 (d,
<단계 2> <Step 2> ICIC -17의 합성Synthesis of -17
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1-(3-(trifluoromethyl)phenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-17을 얻었다.Except that the 6- (2-nitrophenyl) -1- (3- (trifluoromethyl) phenyl) -1H-indole was used in place of 5- (2-nitrophenyl) IC-17 < / RTI > was obtained in the same manner as in < Step 4 >
1H-NMR: δ 6.81 (d, 1H), 7.12 (t, 1H), 7.24 (t, 1H), 7.43 (d, 1H), 7.51 (m, 2H), 7.58 (m, 2H), 7.64 (m, 2H), 7.85 (d, 1H), 8.02 (d, 1H), 9.82 (s, 1H) 1 H-NMR: δ 6.81 ( d, 1H), 7.12 (t, 1H), 7.24 (t, 1H), 7.43 (d, 1H), 7.51 (m, 2H), 7.58 (m, 2H), 7.64 ( (m, 2H), 7.85 (d, 1H), 8.02 (d,
[[ 준비예Preparation Example 18] 18] ICIC -18의 합성Synthesis of -18
<단계 1> 3-(5-(2-<Step 1> Synthesis of 3- (5- (2- nitrophenylnitrophenyl )-1H-) -1H- indolindole -1--One- ylyl )-9-) -9- phenylphenyl -9H--9H- carbazolecarbazole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole과 Iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 3-bromo-9-phenyl-9H-carbazole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9-phenyl-9H-carbazole을 얻었다.Except that 6- (2-nitrophenyl) -1H-indole and 3-bromo-9-phenyl-9H-carbazole were used instead of 5- (2-nitrophenyl) -1H- indole and Iodobenzene. 3- (5- (2-nitrophenyl) -1H-indol-1-yl) -9-phenyl-9H-carbazole was obtained.
GC-Mass (이론치: 479.16 g/mol, 측정치: 479 g/mol)GC-Mass (calculated: 479.16 g / mol, measured: 479 g / mol)
<단계 2> <Step 2> ICIC -18의 합성Synthesis of -18
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9-phenyl-9H-carbazole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-18을 얻었다.Except that the above 3- (5- (2-nitrophenyl) -1H-indol-1-yl) -9-phenyl-9H-carbazole was used instead of 5- (2-nitrophenyl) IC-18 was obtained in the same manner as in <Step 4> of Preparation Example 1 above.
GC-Mass (이론치: 447.17 g/mol, 측정치: 447 g/mol)GC-Mass (calculated: 447.17 g / mol, measured: 447 g / mol)
[[ 준비예Preparation Example 19] 19] ICIC -19의 합성-19 Synthesis
<단계 1> 9-(4,6-≪ Step 1 > 9- (4,6- diphenyl피덴 -1,3,5--1,3,5- triazintriazin -2--2- ylyl )-3-(5-(2-) -3- (5- (2- nitrophenylnitrophenyl )-1H-indol-1-yl)-9H-carbazole의 합성) -1H-indol-1-yl) -9H-carbazole
5-(2-nitrophenyl)-1H-indole과 Iodobenzene 대신 6-(2-nitrophenyl)-1H-indole과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 9-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9H-carbazole을 얻었다.(2-nitrophenyl) -1H-indole and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2- yl ) -9H-carbazole, the procedure of Step 3 of Preparation Example 1 was repeated to give 9- (4,6-diphenyl-1,3,5-triazin-2-yl) -3- (5- (2-nitrophenyl) -1H-indol-1-yl) -9H-carbazole.
GC-Mass (이론치: 634.21 g/mol, 측정치: 634 g/mol)GC-Mass (calculated: 634.21 g / mol, measured: 634 g / mol)
<단계 2> 3-(9-(4,6-≪ Step 2 > 3- (9- (4,6- diphenyl피덴 -1,3,5--1,3,5- triazintriazin -2--2- ylyl )-9H-) -9H- carbazolcarbazole -3--3- ylyl )-3,10-dihydropyrrolo[3,2-a]carbazole의 합성) -3,10-dihydropyrrolo [3,2-a] carbazole
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 9-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-(5-(2-nitrophenyl)-1H-indol-1-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-19을 얻었다.(2-nitrophenyl) -1-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) 1H-indol-1-yl) -9H-carbazole, IC-19 was obtained in the same manner as in <Step 4> of Preparation Example 1 above.
GC-Mass (이론치: 602.22 g/mol, 측정치: 602 g/mol)GC-Mass (theory: 602.22 g / mol, measured: 602 g / mol)
[[ 준비예Preparation Example 20] 20] ICIC -20의 합성Synthesis of -20
<단계 1> 5-<Step 1> 5- bromobromo -2--2- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
질소 기류 하에서 5-bromo-1H-indole (25 g, 0.13 mol), Iodobenzene (31.22 g, 0.15 mol), Pd(OAc)2 (1.43 g, 5 mol%), Triphenylphosphine (1.67 g, 5 mol%), KOAc (37.55 g, 0.38 mol) 및 H2O (300 ml)를 혼합하고 110℃에서 24시간 동안 교반하였다.Pd (OAc) 2 (1.43 g, 5 mol%), Triphenylphosphine (1.67 g, 5 mol%) was added to a solution of 5-bromo-1H- indole (25 g, 0.13 mol), Iodobenzene (31.22 g, 0.15 mol) , KOAc (37.55 g, 0.38 mol) and H 2 O (300 ml) were mixed and stirred at 110 ° C for 24 hours.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 5-bromo-2-phenyl-1H-indole (16.66 g, 수율 48%)을 얻었다. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 5-bromo-2-phenyl- 16.66 g, yield: 48%).
1H-NMR: δ 6.89 (dd, 1H), 7.20 (dd, 1H), 7.34 (m, 1H), 7.36 (d, 1H), 7.47 (t, 2H), 7.71 (d, 1H), 7.86 (dd, 2H), 11.74 (s, 1H) 1 H-NMR: δ 6.89 ( dd, 1H), 7.20 (dd, 1H), 7.34 (m, 1H), 7.36 (d, 1H), 7.47 (t, 2H), 7.71 (d, 1H), 7.86 ( dd, 2 H), 11.74 (s, 1 H)
<단계 2> 5-(2-<Step 2> Synthesis of 5- (2- nitrophenylnitrophenyl )-2-)-2- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
질소 기류 하에서 2-nitrophenylboronic acid (11.04 g, 66.14 mmol)과 상기 5-bromo-2-phenyl-1H-indole (15 g, 55.12 mmol), NaOH (6.61 g, 165.36 mmol) 및 THF/H2O(200 ml/100 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(3.18 g, 5 mol)를 넣고 80℃에서 12시간 동안 교반하였다. 2-phenyl-1H-indole (15 g, 55.12 mmol), NaOH (6.61 g, 165.36 mmol), and THF / H 2 O (10 mL) were added to a solution of 2-nitrophenylboronic acid (11.04 g, 66.14 mmol) a mixture of 200 ml / 100 ml), and then, Pd (PPh 3) at 40 ℃ into the 4 (3.18 g, 5 mol) was stirred at 80 ℃ for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 5:1 (v/v))로 정제하여 5-(2-nitrophenyl)-2-phenyl-1H-indole (10.74 g, 수율 62%)을 얻었다. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was added with MgSO 4 and filtered. 2-Nitrophenyl-2-phenyl-1H-indole (10.74 g, yield 62%) was obtained after purification by column chromatography (Hexane: EA = 5: 1 (v / v) ≪ / RTI >
1H-NMR: δ 6.88 (dd, 1H), 7.21 (d, 1H), 7.32 (m, 1H), 7.34 (d, 1H), 7.46 (m, 3H), 7.64 (m, 2H), 7.77 (d, 2H), 8.02 (d, 2H), 11.73 (s, 1H) 1 H-NMR: δ 6.88 ( dd, 1H), 7.21 (d, 1H), 7.32 (m, 1H), 7.34 (d, 1H), 7.46 (m, 3H), 7.64 (m, 2H), 7.77 ( d, 2H), 8.02 (d, 2H), 11.73 (s, 1H)
<단계 3> 5-(2-≪ Step 3 > 5- (2- nitrophenylnitrophenyl )-1,2-) -1,2- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 5-(2-nitrophenyl)-2-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 5- (2-nitrophenyl) -2-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) - (2-nitrophenyl) -1,2-diphenyl-1H-indole.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (theory: 390.14 g / mol, measured: 390 g / mol)
<단계 4> <Step 4> ICIC -20의 합성Synthesis of -20
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-20을 얻었다.Step 4 of Preparation Example 1 was repeated except that 5- (2-nitrophenyl) -1,2-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) And IC-20 was obtained.
GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (358.15 g / mol, measured: 358 g / mol)
[[ 준비예Preparation Example 21] 21] ICIC -21의 합성Synthesis of -21
<단계 1> 6-<Step 1> 6- chlorochloro -2--2- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-bromo-1H-indole과 Iodobenzene 대신 6-chloro-1H-indole과 bromobenzene을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 1>과 동일한 과정을 수행하여 6-chloro-2-phenyl-1H-indole을 얻었다.1H-indole and 6-chloro-1H-indole and bromobenzene were used in place of 5-bromo-1H-indole and Iodobenzene to obtain 6-chloro-2-phenyl-1H -indole.
1H-NMR: δ 6.92 (d, 1H), 7.02 (dd, 1H), 7.33 (t, 1H), 7.41 (s, 1H), 7.47 (t, 2H), 7.54 (d, 1H), 7.85 (d, 2H), 11.68 (s, 1H) 1 H-NMR: δ 6.92 ( d, 1H), 7.02 (dd, 1H), 7.33 (t, 1H), 7.41 (s, 1H), 7.47 (t, 2H), 7.54 (d, 1H), 7.85 ( d, 2 H), 11.68 (s, 1 H)
<단계 2> 6-(2-≪ Step 2 > 6- (2- nitrophenylnitrophenyl )-2-)-2- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-bromo-2-phenyl-1H-indole 대신 상기 6-chloro-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-2-phenyl-1H-indole을 얻었다.Step 2 of Preparation Example 20 was repeated except that 6-chloro-2-phenyl-1H-indole was used in place of 5-bromo-2-phenyl-1H- -nitrophenyl) -2-phenyl-1H-indole.
1H-NMR: δ 6.91 (d, 1H), 7.03 (d, 1H), 7.31 (t, 1H), 7.42 (s, 1H), 7.48 (m, 3H), 7.53 (d, 1H), 7.76 (m, 3H), 8.01 (d, 2H), 11.66 (s, 1H) 1 H-NMR: δ 6.91 ( d, 1H), 7.03 (d, 1H), 7.31 (t, 1H), 7.42 (s, 1H), 7.48 (m, 3H), 7.53 (d, 1H), 7.76 ( m, 3H), 8.01 (d, 2H), 11.66 (s, IH)
<단계 3> 6-(2-≪ Step 3 > 6- (2- nitrophenylnitrophenyl )-1,2-) -1,2- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-2-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -2-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) - (2-nitrophenyl) -1,2-diphenyl-1H-indole.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (theory: 390.14 g / mol, measured: 390 g / mol)
<단계 4> 6-(2-<Step 4> Synthesis of 6- (2- nitrophenylnitrophenyl )-1,2-) -1,2- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1,2-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-21을 얻었다.Step 4 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1,2-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) And IC-21 was obtained.
GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (358.15 g / mol, measured: 358 g / mol)
[[ 준비예Preparation Example 22] 22] ICIC -22의 합성Synthesis of -22
<단계 1> 6-<Step 1> 6- chlorochloro -3--3- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
질소 기류 하에서 6-chloro-1H-indole (25 g, 0.17 mol), bromobenzene (31.19 g, 0.20 mol), Pd(OAc)2 (1.86 g, 5 mol), Triphenylphosphine (2.17 g, 5 mol%), K2CO3 (68.64 g, 0.50 mol) 및 1,4-dioxane (300 ml)를 혼합하고 130℃에서 18시간 동안 교반하였다.Pd (OAc) 2 (1.86 g, 5 moles), triphenylphosphine (2.17 g, 5 mol%), bromobenzene (31.19 g, 0.20 mol) K 2 CO 3 (68.64 g, 0.50 mol) and 1,4-dioxane (300 ml) were mixed and stirred at 130 ° C for 18 hours.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 6-chloro-3-phenyl-1H-indole (24.5 g, 수율 65%)을 얻었다. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 6-chloro-3-phenyl- 24.5 g, yield 65%).
1H-NMR: δ 7.10 (dd, 1H), 7.25 (m, 1H), 7.43 (t, 2H), 7.49 (d, 1H), 7.67 (dd, 2H), 7.73 (d, 1H), 7.85 (d, 1H), 11.49 (s, 1H) 1 H-NMR: δ 7.10 ( dd, 1H), 7.25 (m, 1H), 7.43 (t, 2H), 7.49 (d, 1H), 7.67 (dd, 2H), 7.73 (d, 1H), 7.85 ( d, 1 H), 11.49 (s, 1 H)
<단계 2> 6-(2-≪ Step 2 > 6- (2- nitrophenylnitrophenyl )-3-) -3- phenylphenyl -1H--1H- indoleindole 의 합성Synthesis of
5-bromo-2-phenyl-1H-indole 대신 상기 6-chloro-3-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-3-phenyl-1H-indole을 얻었다.The procedure of Step 2 of Preparation Example 20 was repeated except that 6-chloro-3-phenyl-1H-indole was used in place of 5-bromo-2-phenyl- -nitrophenyl) -3-phenyl-1H-indole.
1H-NMR: δ 7.11 (d, 1H), 7.26 (m, 1H), 7.44 (t, 2H), 7.48 (m, 2H), 7.55 (m, 3H), 7.61 (d, 1H), 7.73 (d, 1H), 8.00 (d, 2H), 11.48 (s, 1H) 1 H-NMR: δ 7.11 ( d, 1H), 7.26 (m, 1H), 7.44 (t, 2H), 7.48 (m, 2H), 7.55 (m, 3H), 7.61 (d, 1H), 7.73 ( d, 1 H), 8.00 (d, 2H), 11.48 (s, 1 H)
<단계 3> 6-(2-≪ Step 3 > 6- (2- nitrophenylnitrophenyl )-1,3-) -1,3- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-3-phenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -3-phenyl-1H-indole was used instead of 5- (2-nitrophenyl) - (2-nitrophenyl) -1,3-diphenyl-1H-indole.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (theory: 390.14 g / mol, measured: 390 g / mol)
<단계 4> 6-(2-<Step 4> Synthesis of 6- (2- nitrophenylnitrophenyl )-1,3-) -1,3- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-21을 얻었다.Step 4 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -1,3-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) And IC-21 was obtained.
GC-Mass (이론치: 358.15 g/mol, 측정치: 358 g/mol)GC-Mass (358.15 g / mol, measured: 358 g / mol)
[[ 준비예Preparation Example 23] 23] ICIC -23의 합성Synthesis of -23
<단계 1> 5-<Step 1> 5- bromobromo -2,3--2,3- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
6-chloro-1H-indole 대신 5-bromo-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 22의 <단계 1>과 동일한 과정을 수행하여 5-bromo-2,3-diphenyl-1H-indole을 얻었다.The procedure of Step 1 of Preparation Example 22 was followed except that 5-bromo-2-phenyl-1H-indole was used instead of 6-chloro-1H-indole to obtain 5-bromo-2,3-diphenyl -1H-indole.
1H-NMR: δ 7.23 (d, 1H), 7.31 (t, 2H), 7.43 (m, 6H), 7.67 (d, 1H), 7.71 (d, 1H), 7.84 (d, 2H), 11.34 (s, 1H) 1 H-NMR: δ 7.23 ( d, 1H), 7.31 (t, 2H), 7.43 (m, 6H), 7.67 (d, 1H), 7.71 (d, 1H), 7.84 (d, 2H), 11.34 ( s, 1 H)
<단계 2> 5-(2-<Step 2> Synthesis of 5- (2- nitrophenylnitrophenyl )-2,3-) -2,3- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
5-bromo-2-phenyl-1H-indole 대신 상기 5-bromo-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 얻었다.The procedure of Step 2 of Preparation Example 20 was repeated except that 5-bromo-2,3-diphenyl-1H-indole was used instead of 5-bromo-2-phenyl- (2-nitrophenyl) -2,3-diphenyl-1H-indole.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (theory: 390.14 g / mol, measured: 390 g / mol)
<단계 3> 5-(2-≪ Step 3 > 5- (2- nitrophenylnitrophenyl )-1,2,3-) -1,2,3- triphenyl트리 피닐 -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 5-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 5- (2-nitrophenyl) -2,3-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) To obtain 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole.
GC-Mass (이론치: 466.17 g/mol, 측정치: 466 g/mol)GC-Mass (calculated: 466.17 g / mol, measured: 466 g / mol)
<단계 4> <Step 4> ICIC -23의 합성Synthesis of -23
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-23을 얻었다.Except that 5- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole was used in place of 5- (2-nitrophenyl) -1- 4 > to obtain IC-23.
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (calculated: 434.18 g / mol, measured: 434 g / mol)
[[ 준비예Preparation Example 24] 24] ICIC -24의 합성Synthesis of -24
<단계 1> 6-<Step 1> 6- chlorochloro -2,3--2,3- diphenyl피덴 -1H--1H- indoleindole 의 합성Synthesis of
6-chloro-1H-indole 대신 6-chloro-2-phenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 22의 <단계 1>과 동일한 과정을 수행하여 6-chloro-2,3-diphenyl-1H-indole을 얻었다.The procedure of Step 1 of Preparation Example 22 was repeated except that 6-chloro-2-phenyl-1H-indole was used instead of 6-chloro-1H-indole to obtain 6-chloro-2,3- -1H-indole.
1H-NMR: δ 7.18 (d, 1H), 7.29 (t, 2H), 7.50 (m, 6H), 7.62 (d, 1H), 7.75 (d, 1H), 7.89 (d, 2H), 11.35 (s, 1H) 1 H-NMR: δ 7.18 ( d, 1H), 7.29 (t, 2H), 7.50 (m, 6H), 7.62 (d, 1H), 7.75 (d, 1H), 7.89 (d, 2H), 11.35 ( s, 1 H)
<단계 2> 6-(2-≪ Step 2 > 6- (2-
nitrophenylnitrophenyl
)-2,3-) -2,3-
diphenyl피덴
-1H--1H-
indoleindole
의 합성Synthesis of
5-bromo-2-phenyl-1H-indole 대신 상기 6-chloro-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 20의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 얻었다.The procedure of Step 2 of Preparation Example 20 was repeated except that 6-chloro-2,3-diphenyl-1H-indole was used instead of 5-bromo-2-phenyl- (2-nitrophenyl) -2,3-diphenyl-1H-indole.
GC-Mass (이론치: 390.14 g/mol, 측정치: 390 g/mol)GC-Mass (theory: 390.14 g / mol, measured: 390 g / mol)
<단계 3> 6-(2-≪ Step 3 > 6- (2- nitrophenylnitrophenyl )-1,2,3-) -1,2,3- triphenyl트리 피닐 -1H--1H- indoleindole 의 합성Synthesis of
5-(2-nitrophenyl)-1H-indole 대신 상기 6-(2-nitrophenyl)-2,3-diphenyl-1H-indole을 사용하는 것을 제외하고는 준비예 1의 <단계 3>과 동일한 과정을 수행하여 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 얻었다.Step 3 of Preparation Example 1 was repeated except that 6- (2-nitrophenyl) -2,3-diphenyl-1H-indole was used instead of 5- (2-nitrophenyl) To obtain 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole.
GC-Mass (이론치: 466.17 g/mol, 측정치: 466 g/mol)GC-Mass (calculated: 466.17 g / mol, measured: 466 g / mol)
<단계 4> <Step 4> ICIC -24의 합성Synthesis of -24
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 6-(2-nitrophenyl)-1,2,3-triphenyl-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-24을 얻었다.Except that 6- (2-nitrophenyl) -1,2,3-triphenyl-1H-indole was used in place of 5- (2-nitrophenyl) -1- 4 > to obtain IC-24.
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (calculated: 434.18 g / mol, measured: 434 g / mol)
[[ 준비예Preparation Example 25] 25] ICIC -25의 합성Synthesis of -25
<단계 1> 1-(3-(4,6-≪ Step 1 > 1- (3- (4,6- diphenyl피덴 -1,3,5--1,3,5- triazintriazin -2--2- ylyl )) phenylphenyl )-6-(2-nitrophenyl)-1H-indole의 합성) -6- (2-nitrophenyl) -1H-indole
질소 기류 하에서 6-(2-nitrophenyl)-1H-indole (10 g, 41.97 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (17.32 g, 50.37 mmol), Pd(OAc)2 (0.47 g, 5 mol%), NaO(t-bu) (8.07 g, 83.95 mmol), P(t-bu)3 (0.85 g, 4.19 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다.(10 g, 41.97 mmol) and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (17.32 g, 50.37 mmol) in a nitrogen atmosphere. , P (t-bu) 3 (0.85 g, 4.19 mmol) and Toluene (100 ml) were added to a solution of Pd (OAc) 2 (0.47 g, 5 mol%), NaO And the mixture was stirred at 110 DEG C for 12 hours.
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole (15.8 g, 수율 69%)을 얻었다. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 1- (3- (4- 1,3,5-triazin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-indole (15.8 g, yield 69%).
GC-Mass (이론치: 545.19 g/mol, 측정치: 545 g/mol)GC-Mass (calculated: 545.19 g / mol, measured: 545 g / mol)
<단계 2> <Step 2> ICIC -25의 합성Synthesis of -25
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-25을 얻었다.Phenyl-6- (2-nitrophenyl) -1- phenyl-1H-indole in place of 5- (2-nitrophenyl) ) -1H-indole was used in place of IC-25, IC-25 was obtained in the same manner as in <Step 4> of Preparation Example 1 above.
GC-Mass (이론치: 513.20 g/mol, 측정치: 513 g/mol)GC-Mass (theory: 513.20 g / mol, measured: 513 g / mol)
[[ 준비예Preparation Example 26] 26] ICIC -26의 합성Synthesis of -26
<단계 1> 1-(3-(4,6-≪ Step 1 > 1- (3- (4,6- diphenylpyrimidindiphenylpyrimidine -2--2- ylyl )) phenylphenyl )-6-(2-) -6- (2- nitrophenylnitrophenyl )-1H-indole의 합성) -1H-indole < / RTI >
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chloro phenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 준비예 25의 <단계 1>과 동일한 과정을 수행하여 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole을 얻었다.Except that 2- (3-chloro phenyl) -4,6-diphenylpyrimidine was used in place of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5- 1 -> was carried out to obtain 1- (3- (4,6-diphenylpyrimidin-2-yl) phenyl) -6- (2-nitrophenyl) -1H-indole.
GC-Mass (이론치: 544.19 g/mol, 측정치: 544 g/mol)GC-Mass (calculated: 544.19 g / mol, measured: 544 g / mol)
<단계 2> <Step 2> ICIC -26의 합성Synthesis of -26
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-6-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-26을 얻었다.(2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl- IC-26 was obtained in the same manner as in <Step 4> of Preparation Example 1 except for the following.
GC-Mass (이론치: 512.20 g/mol, 측정치: 512 g/mol)GC-Mass (calculated: 512.20 g / mol, measured: 512 g / mol)
[[ 준비예Preparation Example 27] 27] ICIC -27의 합성-27
<단계 1> 1-(3-(4,6-≪ Step 1 > 1- (3- (4,6- diphenyl피덴 -1,3,5--1,3,5- triazintriazin -2--2- ylyl )) phenylphenyl )-5-(2-nitrophenyl)-1H-indole의 합성) -5- (2-nitrophenyl) -1H-indole < / RTI >
6-(2-nitrophenyl)-1H-indole 대신 5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 25의 <단계 1>과 동일한 과정을 수행하여 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-5-(2-nitro phenyl)-1H-indole을 얻었다.The procedure of Step 1 of Preparation Example 25 was repeated except that 5- (2-nitrophenyl) -1H-indole was used instead of 6- (2-nitrophenyl) -1H- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) -5- (2-nitro phenyl) -1H-indole.
GC-Mass (이론치: 545.19 g/mol, 측정치: 545 g/mol)GC-Mass (calculated: 545.19 g / mol, measured: 545 g / mol)
<단계 2> <Step 2> ICIC -27의 합성-27
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 <단계 1>에서 얻은 1-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-5-(2-nitro phenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-27을 얻었다.(3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenyl) - phenylalanine obtained in the above Step 1 was used instead of 5- (2-nitrophenyl) IC-27 was obtained in the same manner as in <Step 4> of Preparation Example 1 except that 5- (2-nitro phenyl) -1H-indole was used.
GC-Mass (이론치: 513.20 g/mol, 측정치: 513 g/mol)GC-Mass (theory: 513.20 g / mol, measured: 513 g / mol)
[[ 준비예Preparation Example 28] 28] ICIC -28의 합성-28 Synthesis
<단계 1> 1-(3-(4,6-≪ Step 1 > 1- (3- (4,6- diphenylpyrimidindiphenylpyrimidine -2--2- ylyl )) phenylphenyl )-5-(2-) -5- (2- nitrophenylnitrophenyl )-1H-indole의 합성) -1H-indole < / RTI >
6-(2-nitrophenyl)-1H-indole과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 5-(2-nitrophenyl)-1H-indole과 2-(3-chloro phenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 준비예 25의 <단계 1>과 동일한 과정을 수행하여 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole을 얻었다.(2-nitrophenyl) -1H-indole and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5- (4,6-diphenylpyrimidin-2-yl) phenyl) -4,6-diphenylpyrimidine was used in the same manner as in <Step 1> of Preparation Example 25, -5- (2-nitrophenyl) -1H-indole.
GC-Mass (이론치: 544.19 g/mol, 측정치: 544 g/mol)GC-Mass (calculated: 544.19 g / mol, measured: 544 g / mol)
<단계 2> <Step 2> ICIC -28의 합성-28 Synthesis
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 1-(3-(4,6-diphenylpyrimidin-2-yl)phenyl)-5-(2-nitrophenyl)-1H-indole을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 4>과 동일한 과정을 수행하여 IC-28을 얻었다.Phenyl-5- (2-nitrophenyl) -1H-indole was used instead of 5- (2-nitrophenyl) -1-phenyl- IC-28 was obtained in the same manner as in < Step 4 >
GC-Mass (이론치: 512.20 g/mol, 측정치: 512 g/mol)GC-Mass (calculated: 512.20 g / mol, measured: 512 g / mol)
[[ 준비예Preparation Example 29] 29] ICIC -29a 및 -29a and ICIC -29b의 합성 Synthesis of -29b
<단계 1> 2-(<Step 1> 2- ( benzobenzo [b]thiophen-5-[b] thiophen-5- ylyl )-4,4,5,5-) -4,4,5,5- tetramethyltetramethyl -1,3,2-dioxaborolane의 합성-1,3,2-dioxaborolane
5-bromo-1H-indole 대신 5-bromobenzo[b]thiophene를 사용하는 것을 제외하고는 준비예 1의 <단계 1>과 동일한 과정을 수행하여 2-(benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.(Benzo [b] thiophen-5-yl) - (4-fluorophenyl) -lH-indole was obtained in the same manner as in <Step 1> of Preparation Example 1 except that 5-bromobenzo [b] thiophene was used instead of 5-bromo- 4,4,5,5-tetramethyl-1,3,2-dioxaborolane.
1H NMR: δ 1.24 (s, 12H), 7.65 (d, 1H), 7.85 (d, 1H), 7.98 (d, 1H), 8.07 (d, 1H), 8.12 (s, 1H) 1 H NMR: 8 1.24 (s, 12H), 7.65 (d, IH), 7.85 (d, IH), 7.98
<단계 2> 5-(2-<Step 2> Synthesis of 5- (2- nitrophenylnitrophenyl )) benzobenzo [b][b] thiophenethiophene 의 합성Synthesis of
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 상기 2-(benzo[b]thiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 5-(2-nitrophenyl)benzo[b]thiophene을 얻었다.(Benzo [b] thiophen-5-yl) -4,4,5-thiophene instead of 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- , 2-nitrophenyl benzo [b] thiophene was obtained in the same manner as in <Step 2> of Preparation Example 1 except that 5-tetramethyl-1,3,2-dioxaborolane was used.
1H NMR: δ 7.67 (m, 2H), 7.88 (m, 2H), 7.98 (d, 1H), 8.00 (d, 1H), 8.07 (m, 2H), 8.13 (s, 1H) 1 H NMR: 8 7.67 (m, 2H), 7.88 (m, 2H), 7.98 (d,
<단계 3> <Step 3> ICIC -29a 및 -29a and ICIC -29b의 합성Synthesis of -29b
5-(2-nitrophenyl)-1-phenyl-1H-indole 대신 상기 5-(2-nitrophenyl)benzo[b]thiophene을 사용하는 것을 제외하고는 준비예 1의 <단계 4>와 동일한 과정을 수행하여 IC-29a 1.70 g (7.60 mmol, yield : 35 %)과 IC-29b 1.89 g (8.46 mmol, yield : 39%)을 얻었다.Step 4 of Preparation Example 1 was repeated except that 5- (2-nitrophenyl) benzo [b] thiophene was used instead of 5- (2-nitrophenyl) -1- 1.70 g (7.60 mmol, yield: 35%) of IC-29a and 1.89 g (8.46 mmol, yield: 39%) of IC-29b were obtained.
IC-29a의 1H-NMR : δ 7.29 (t, 1H), 7.59 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.26 (s, 1H) 1 H-NMR of the IC-29a: δ 7.29 (t , 1H), 7.59 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.26 (s, 1H)
IC-29b의 1H-NMR : δ 7.29 (t, 1H), 7.53 (m, 2H), 7.81 (m, 3H), 8.12 (m, 2H), 8.25 (s, 1H) 1 H-NMR of the IC-29b: δ 7.29 (t , 1H), 7.53 (m, 2H), 7.81 (m, 3H), 8.12 (m, 2H), 8.25 (s, 1H)
[[ 준비예Preparation Example 30] 30] ICIC -- 30 의Thirty 합성 synthesis
<단계 1> 7-(2-≪ Step 1 > 7- (2- nitrophenylnitrophenyl )) benzobenzo [b][b] thiophenethiophene 의 합성Synthesis of
질소 기류 하에서 12.2 g (35.2 mmol)의 7-bromobenzo[b]thiophene, 6.44 g (38.7 mmol)의 2-nitrophenylboronic acid, 4.22 g (105.6 mmol)의 NaOH과 300 ml/150 ml의 THF/H2O를 넣고 교반하였다. 40℃에서 2.03 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 7-(2-nitrophenyl)benzo[b]thiophene 7.38 g (28.9 mmol, yield 82 %)을 얻었다.To a solution of 12.2 g (35.2 mmol) of 7-bromobenzo [b] thiophene, 6.44 g (38.7 mmol) of 2-nitrophenylboronic acid, 4.22 g (105.6 mmol) of NaOH and 300 ml / 150 ml of THF / H 2 O And the mixture was stirred. At 40 ℃ into the Pd (PPh 3) 4 of 2.03 g (5 mol%) was stirred at 80 ℃ for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 7.38 g (28.9 mmol, yield 82%) of 7- (2-nitrophenyl) benzo [b] thiophene was obtained by column chromatography.
1H-NMR : δ 7.63 (m, 5H), 7.96 (m, 3H), 8.21 (d, 1H) 1 H-NMR: δ 7.63 ( m, 5H), 7.96 (m, 3H), 8.21 (d, 1H)
<단계 2> <Step 2> ICIC -- 30 의Thirty 합성 synthesis
질소 기류 하에서 상기 7-(2-nitrophenyl)benzo[b]thiophene 5.53 g (21.7 mmol)과 triphenylphosphine 14.2 g (54.2 mmol), 1,2-dichlorobenzene 100 ml를 넣은 후 12시간 교반하였다. 반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 추출된 유기층은 MgSO4로 물을 제거하고, 컬럼크로마토그래피를 이용하여 IC-30 3.29 g, (14.8 mmol, yield : 68 %)을 얻었다.5.53 g (21.7 mmol) of 7- (2-nitrophenyl) benzo [b] thiophene, 14.2 g (54.2 mmol) of triphenylphosphine and 100 ml of 1,2-dichlorobenzene were placed under a nitrogen stream and stirred for 12 hours. After completion of the reaction, 1,2-dichlorobenzene was removed and extracted with dichloromethane. The extracted organic layer was washed with MgSO 4 , and 3.29 g (14.8 mmol, yield: 68%) of IC-30 was obtained by column chromatography.
1H-NMR : δ 7.37 (t, 1H), 7.46 (m, 5H), 7.87 (d, 1H), 8.20 (d, 1H), 8.24 (s, 1H) 1 H-NMR: δ 7.37 ( t, 1H), 7.46 (m, 5H), 7.87 (d, 1H), 8.20 (d, 1H), 8.24 (s, 1H)
[[ 준비예Preparation Example 31] 31] ICIC -31a 및 -31a and ICIC -31b의 합성 Synthesis of -31b
<단계 1> 6-(2-≪ Step 1 > 6- (2- nitrophenylnitrophenyl )) benzobenzo [b][b] thiophenethiophene 의 합성Synthesis of
7-bromobenzo[b]thiophene 대신 6-bromobenzo[b]thiophene 12.2 g (35.2 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 1>과 동일한 과정을 수행하여 6-(2-nitrophenyl)benzo[b]thiophene 7.01 g (27.5 mmol, yield : 78%)을 얻었다.The procedure of Step 1 of Preparation Example 30 was repeated except for using 12.2 g (35.2 mmol) of 6-bromobenzo [b] thiophene instead of 7-bromobenzo [b] thiophene to obtain 6- (2-nitrophenyl) benzo [b] thiophene (7.01 g, 27.5 mmol, yield: 78%).
1H-NMR : δ 7.68 (m, 3H), 7.98 (m, 6H) 1 H-NMR: δ 7.68 ( m, 3H), 7.98 (m, 6H)
<단계 2> <Step 2> ICIC -31a과 -31a and ICIC -31b의 합성Synthesis of -31b
7-(2-nitrophenyl)benzo[b]thiophene 대신 상기 6-(2-nitrophenyl)benzo[b]thiophene 5.53 g (21.7 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 2>와 동일한 과정을 수행하여 IC-31a 1.60 g (7.16 mmol, yield : 33 %) 과 IC-31b 1.79 g (8.03 mmol, yield : 37%)을 얻었다. Step 2 of Preparation Example 30 was repeated except that 5.53 g (21.7 mmol) of 6- (2-nitrophenyl) benzo [b] thiophene was used instead of 7- (2-nitrophenyl) benzo [ To obtain 1.60 g (7.16 mmol, yield: 33%) of IC-31a and 1.79 g (8.03 mmol, yield: 37%) of IC-31b.
IC-31a 의 1H-NMR : δ 7.27 (t, 1H), 7.53 (m, 4H), 7.78 (d, 1H), 7.92 (d, 1H), 8.10 (d, 1H), 8.25 (s, 1H)The IC-31a 1 H-NMR: δ 7.27 (t, 1H), 7.53 (m, 4H), 7.78 (d, 1H), 7.92 (d, 1H), 8.10 (d, 1H), 8.25 (s, 1H )
IC-31b 의 1H-NMR : δ 7.29 (t, 1H), 7.63 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.25 (s, 1H) 1 H-NMR of the IC-31b: δ 7.29 (t , 1H), 7.63 (m, 3H), 7.79 (m, 3H), 8.11 (d, 1H), 8.25 (s, 1H)
[[ 준비예Preparation Example 32] 32] ICIC -32의 합성 Synthesis of -32
<단계 1> 4-(2-<Step 1> Synthesis of 4- (2- nitrophenylnitrophenyl )) benzobenzo [b][b] thiophenethiophene 의 합성Synthesis of
7-bromobenzo[b]thiophene 대신 4-bromobenzo[b]thiophene 12.2 g (35.2 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 1>과 동일한 과정을 수행하여 4-(2-nitrophenyl)benzo[b]thiophene 7.28 g (28.5 mmol, yield : 81%)을 얻었다.Step 2 was carried out in the same manner as in Step 1 of Preparation Example 30 except that 12.2 g (35.2 mmol) of 4-bromobenzo [b] thiophene was used instead of 7-bromobenzo [b] thiophene to obtain 4- (2-nitrophenyl) benzo 7.28 g (28.5 mmol, yield: 81%) of [b] thiophene was obtained.
1H-NMR : δ 7.68 (m, 4H), 7.89 (m, 3H), 8.01 (m, 2H) 1 H-NMR: δ 7.68 ( m, 4H), 7.89 (m, 3H), 8.01 (m, 2H)
<단계 2> <Step 2> ICIC -- 32 의32 합성 synthesis
7-(2-nitrophenyl)benzo[b]thiophene 대신 상기 4-(2-nitrophenyl)benzo[b]thiophene 5.53 g (21.7 mmol)을 사용하는 것을 제외하고는 준비예 30의 <단계 2>와 동일한 과정을 수행하여 IC-32 3.05 g (13.7 mmol, yield : 63 %)을 얻었다. Step 2 of Preparation Example 30 was repeated except that 5.53 g (21.7 mmol) of 4- (2-nitrophenyl) benzo [b] thiophene was used instead of 7- (2-nitrophenyl) benzo [ To obtain 3.05 g (13.7 mmol, yield: 63%) of IC-32.
1H-NMR : δ 7.31 (m, 2H), 7.73 (m, 4H), 7.96 (d, 1H), 8.10 (d, 1H), 8.26 (s, 1H) 1 H-NMR:? 7.31 (m, 2H), 7.73 (m, 4H), 7.96 (d,
[[ 준비예Preparation Example 33] 33] ICIC -33의 합성Synthesis of -33
<단계 1> 4-(2-<Step 1> Synthesis of 4- (2- isopropylphenylisopropylphenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하고 1-bromo-2-nitrobenzene 대신 1-bromo-2-isopropylbenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-isopropylphenyl)-1H-indole을 얻었다.Instead of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- 2-yl) -1H-indole and that 1-bromo-2-isopropylbenzene was used instead of 1-bromo-2-nitrobenzene, the procedure of Step 2 of Preparation Example 1 was repeated to obtain 4- (2-isopropylphenyl) -1H-indole.
1H NMR: δ 1.21 (s, 6H), 2.87 (m, 1H), 6.43 (d, 1H), 7.26 (t, 1H), 7.35 (m, 3H), 7.48 (d, 1H), 7.74 (m, 2H), 7.85 (d, 1H), 8.23 (s, 1H) 1 H NMR: δ 1.21 (s , 6H), 2.87 (m, 1H), 6.43 (d, 1H), 7.26 (t, 1H), 7.35 (m, 3H), 7.48 (d, 1H), 7.74 (m , 2H), 7.85 (d, 1 H), 8.23 (s, 1 H)
<단계 2> <Step 2> ICIC -33의 합성Synthesis of -33
질소 기류 하에서 상기 4-(2-isopropylphenyl)-1H-indole(5 g, 21.25 mmol)과 RhCl(PPh3)3(98.3 mg, 0.5 mol%)를 1,4-dioxane 50 ml에 녹인 다음 135℃에서 1시간 동안 교반하였다. Under nitrogen gas stream, the 4- (2-isopropylphenyl) -1H- indole (5 g, 21.25 mmol) and RhCl (PPh 3) 3 was dissolved in a 1,4-dioxane 50 ml (98.3 mg , 0.5 mol%) , and then 135 ℃ Lt; / RTI > for 1 hour.
반응 종결 후 용매를 제거하고 컬럼크로마토그래피 (Hexane:MC = 3:1 (v:v))로 정제하여 IC-33 (4 g, 수율 81%)을 얻었다.After completion of the reaction, the solvent was removed and the residue was purified by column chromatography (Hexane: MC = 3: 1 (v: v)) to obtain IC-33 (4 g, yield 81%).
1H NMR: δ 1.20 (s, 6H), 6.45 (d, 1H), 7.25 (d, 1H), 7.37 (m, 3H), 7.49 (d, 1H), 7.75 (d, 1H), 7.86 (d, 1H), 8.22 (s, 1H) 1 H NMR:? 1.20 (s, 6H), 6.45 (d, IH), 7.25 (d, IH), 7.37 , ≪ / RTI > 1H), 8.22 (s, 1H)
[[ 준비예Preparation Example 34] 34] ICIC -34의 합성Synthesis of -34
<단계 1> 4-(2-<Step 1> Synthesis of 4- (2- benzhydrylphenylbenzhydrylphenyl )-1H-) -1H- indoleindole 의 합성Synthesis of
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole 대신 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole을 사용하고 1-bromo-2-nitrobenzene 대신 (2-bromophenyl)methylene)dibenzene을 사용하는 것을 제외하고는 준비예 1의 <단계 2>와 동일한 과정을 수행하여 4-(2-benzhydrylphenyl)-1H-indole을 얻었다.Instead of 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan (4,4,5,5-tetramethyl-1,3,2-dioxaborolan- 2-yl) -1H-indole and that (2-bromophenyl) methylene) dibenzene was used instead of 1-bromo-2-nitrobenzene, the procedure of Step 2 of Preparation Example 1 was repeated to obtain 4 - (2-benzhydrylphenyl) -1H-indole.
1H NMR: δ 2.88 (m, 1H), 6.44 (d, 1H), 7.27 (m, 6H), 7.34 (m, 8H), 7.47 (d, 1H), 7.75 (m, 2H), 7.86 (d, 1H), 8.21 (s, 1H) 1 H NMR: δ 2.88 (m , 1H), 6.44 (d, 1H), 7.27 (m, 6H), 7.34 (m, 8H), 7.47 (d, 1H), 7.75 (m, 2H), 7.86 (d , ≪ / RTI > 1H), 8.21 (s, 1H)
<단계 2> <Step 2> ICIC -34의 합성Synthesis of -34
4-(2-isopropylphenyl)-1H-indole 대신 상기 4-(2-benzhydrylphenyl)-1H-indole을 사용하여 준비예 33의 <단계 2>와 동일한 과정을 수행하여 IC-34을 얻었다.The procedure of Step 2 of Preparation Example 33 was followed except that 4- (2-benzhydrylphenyl) -1H-indole was used instead of 4- (2-isopropylphenyl) -1H-indole to obtain IC-34.
1H NMR: δ 6.43 (d, 1H), 7.26 (m, 5H), 7.34 (m, 8H), 7.46 (d, 1H), 7.76 (m, 2H), 7.85 (d, 1H), 8.20 (s, 1H) 1 H NMR: δ 6.43 (d , 1H), 7.26 (m, 5H), 7.34 (m, 8H), 7.46 (d, 1H), 7.76 (m, 2H), 7.85 (d, 1H), 8.20 (s , 1H)
[[ 준비예Preparation Example 35] 35] ICIC -- 35 의Thirty-five 합성 synthesis
<단계 1> 6-(2-≪ Step 1 > 6- (2- bromophenylbromophenyl )-7-) -7- chlorochloro -1H--1H- indoleindole 의 합성Synthesis of
질소 기류 하에서 9.13 g (39.6 mmol)의 6-bromo-7-chloro-1H-indole, 9.54 g (47.5 mmol)의 2-bromophenylboronic acid, 4.75 g (118.8 mmol)의 NaOH과 200 ml/100 ml의 THF/H2O를 넣고 교반하였다. 40℃에서 2.29 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 6-(2-bromophenyl)-7-chloro-1H-indole 8.86 g (28.9 mmol, yield: 73 %)을 얻었다.Bromo-7-chloro-1H-indole, 9.54 g (47.5 mmol) of 2-bromophenylboronic acid, 4.75 g (118.8 mmol) of NaOH and 200 ml / 100 ml of THF / H 2 O were added and stirred. At 40 ℃ into the Pd (PPh 3) 4 of 2.29 g (5 mol%) was stirred at 80 ℃ for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 8.86 g (28.9 mmol, yield: 73%) of 6- (2-bromophenyl) -7-chloro-1H- indole was obtained by column chromatography.
1H-NMR : δ 6.45 (d, 1H), 7.35 (m, 3H), 7.74 (m, 3H), 8.06 (d, 1H), 8.64 (s, 1H) 1 H-NMR:? 6.45 (d, 1 H), 7.35 (m, 3H), 7.74
<단계 2> <Step 2> ethylethyl 3-(2-(7- 3- (2- (7- chlorochloro -1H--1H- indolindole -6--6- ylyl )) phenylthio메틸THIO ) ) propanoatepropanoate 의 합성Synthesis of
질소 기류 하에서 7.45 g (24.3 mmol)의 6-(2-bromophenyl)-7-chloro-1H-indole, 3.59 g (26.77 mmol)의 ethyl 3-mercaptopropanoate, 167 mg (0.18 mmol)의 Pd2dba3, 197 mg (0.37 mmol)의 dpephos, 8.4 g (61 mmol)의 K2CO3를 100 ml의 Toluene에 넣고 110℃에서 15시간 교반하였다.(24.3 mmol) of 6- (2-bromophenyl) -7-chloro-1H-indole, 3.59 g (26.77 mmol) of ethyl 3-mercaptopropanoate, 167 mg (0.18 mmol) of Pd 2 dba 3 , 197 mg (0.37 mmol) of dpephos and 8.4 g (61 mmol) of K 2 CO 3 were added to 100 ml of toluene and the mixture was stirred at 110 ° C for 15 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 ethyl 3-(2-(7-chloro-1H-indol-6-yl)phenylthio)propanoate 6.38 g (17.7 mmol, yield: 72 %)을 얻었다.After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 6.38 g (17.7 mmol, yield: 72%) of ethyl 3- (2- (7-chloro-1H-indol-6-yl) phenylthio) propanoate was obtained by column chromatography.
1H-NMR : δ 1.29 (t, 3H), 2.58 (t, 2H), 3.12 (t, 2H), 4.12 (q, 2H), 6.25 (d, 1H), 7.37 (m, 4H), 7.70 (m, 2H), 8.06 (d, 1H), 8.60 (s, 1H) 1 H-NMR: δ 1.29 ( t, 3H), 2.58 (t, 2H), 3.12 (t, 2H), 4.12 (q, 2H), 6.25 (d, 1H), 7.37 (m, 4H), 7.70 ( m, 2 H), 8.06 (d, 1 H), 8.60 (s, 1 H)
<단계 3> <Step 3> ICIC -35의 합성Synthesis of -35
질소 기류 하에서 6.34 g (15.4 mmol)의 ethyl 3-(2-(7-chloro-1H-indol-6-yl)phenylthio)propanoate, 2.60 g (23.2 mmol)의 potassium tert-butoxide를 100 ml의 THF에 넣고 50℃에서 8시간 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 IC-35 2.30 g (10.3 mmol, yield: 67 %)을 얻었다.To a solution of 6.34 g (15.4 mmol) of ethyl 3- (2- (7-chloro-1H-indol-6-yl) phenylthio) propanoate and 2.60 g (23.2 mmol) potassium tert- And the mixture was stirred at 50 ° C for 8 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 2.30 g (10.3 mmol, yield: 67%) of IC-35 was obtained by column chromatography.
1H-NMR : δ 6.44 (d, 1H), 7.25 (d, 1H), 7.51 (m, 3H), 8.00 (m, 2H), 8.40 (d, 1H), 8.63 (s, 1H) 1 H-NMR: δ 6.44 ( d, 1H), 7.25 (d, 1H), 7.51 (m, 3H), 8.00 (m, 2H), 8.40 (d, 1H), 8.63 (s, 1H)
[[ 준비예Preparation Example 36] 36] ICIC -36의 합성Synthesis of -36
<단계 1> 2-(<Step 1> 2- ( benzofuranbenzofuran -5--5- ylyl )-4,4,5,5-) -4,4,5,5- tetramethyltetramethyl -1,3,2--1,3,2- dioxaborolanedioxaborolane 의 합성Synthesis of
질소 기류 하에서 5-bromobenzofuran (25 g, 0.126 mol), 4,4,4',4',5,5, 5',5'-octamethyl-2,2'-bi(1,3,2-dioxaborolane) (38.67 g, 0.152 mol), Pd(dppf)Cl2 (3.11 g, 3 mol%), KOAc (37.36 g, 0.381 mol) 및 1,4-dioxane (500 ml)를 혼합하고 130℃에서 12시간 동안 교반하였다.A solution of 5-bromobenzofuran (25 g, 0.126 mol), 4,4,4 ', 4', 5,5,5 ', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane (38.67 g, 0.152 mol), Pd (dppf) Cl 2 (3.11 g, 3 mol%), KOAc (37.36 g, 0.381 mol) and 1,4- dioxane Lt; / RTI >
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 10:1 (v/v))로 정제하여 2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (23.23 g, 수율 75%)을 얻었다. After completion of the reaction, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and the residue was purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to give 2- (benzofuran- 4,5,5-tetramethyl-1,3,2-dioxaborolane (23.23 g, yield 75%).
1H-NMR: δ 1.25 (s, 12H), 6.46 (d, 1H), 7.28 (d, 1H), 7.43 (d, 1H), 7.53 (d, 1H), 7.98 (s, 1H) 1 H-NMR:? 1.25 (s, 12H), 6.46 (d, IH), 7.28 (d, IH), 7.43
<단계 2> 5-(2-<Step 2> Synthesis of 5- (2- nitrophenylnitrophenyl )) benzofuranbenzofuran 의 합성Synthesis of
질소 기류 하에서 1-bromo-2-nitrobenzene (15.86 g, 78.52 mmol)과 상기 2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (23 g, 94.23 mmol), K2CO3 (32.56 g, 235.57 mmol) 및 1,4-dioxane/H2O(400 ml/200 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(4.54 g, 5 mol%)를 넣고 110℃에서 12시간 동안 교반하였다. Benzofuran-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane (23 g, 78.52 mmol) was added to a solution of 1-bromo- 94.23 mmol), K 2 CO 3 (32.56 g, 235.57 mmol) and 1,4-dioxane / H 2 O, and then, Pd (PPh 3 at 40 ℃ mix (400 ml / 200 ml)) 4 (4.54 g, 5 mol%) was added thereto, and the mixture was stirred at 110 ° C for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 5-(2-nitrophenyl)benzofuran (12.40 g, 수율 66%)을 얻었다. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 5- (2-nitrophenyl) benzofuran (12.40 g, yield 66%).
1H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 (s, 1H), 8.01 (d, 1H), 8.06 (t, 1H) 1 H-NMR: δ 6.45 ( d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 ( s, 1 H), 8.01 (d, 1 H), 8.06 (t, 1 H)
<단계 3> <Step 3> ICIC -36의 합성Synthesis of -36
질소 기류 하에서 상기 5-(2-nitrophenyl)benzofuran (10 g, 41.80 mmol), triphenylphosphine (27.41 g, 104.50 mmol) 및 1,2-dichlorobenzene (150 ml)를 혼합하고 12시간 동안 교반하였다.5- (2-Nitrophenyl) benzofuran (10 g, 41.80 mmol), triphenylphosphine (27.41 g, 104.50 mmol) and 1,2-dichlorobenzene (150 ml) were mixed under a nitrogen stream and stirred for 12 hours.
반응 종료 후 1,2-dichlorobenzene를 제거하고 디클로로메탄으로 추출하였다. 얻어진 유기층에 대해 MgSO4로 물을 제거하고, 컬럼크로마토그래피 (Hexane:MC=3:1 (v/v))로 정제하여 IC-36 (4.76 g, 수율 55%)을 얻었다.After completion of the reaction, 1,2-dichlorobenzene was removed and extracted with dichloromethane. Water was removed from the obtained organic layer with MgSO 4 and purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain IC-36 (4.76 g, yield 55%).
1H-NMR: δ 6.51 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 (d, 1H), 8.05 (t, 1H), 10.58 (s, 1H) 1 H-NMR: δ 6.51 ( d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 ( d, 1 H), 8.05 (t, 1 H), 10.58 (s, 1 H)
[[ 준비예Preparation Example 37] 37] ICIC -37의 합성Synthesis of -37
<단계 1> 2-(<Step 1> 2- ( benzofuranbenzofuran -6--6- ylyl )-4,4,5,5-) -4,4,5,5- tetramethyltetramethyl -1,3,2--1,3,2- dioxaborolanedioxaborolane 의 합성Synthesis of
5-bromobenzofuran 대신 6-bromobenzofuran을 사용하는 것을 제외하고는 상기 준비예 1의 <단계 1>과 동일한 과정을 수행하여 2-(benzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.The procedure of Step 1 of Preparation Example 1 was repeated except that 6-bromobenzofuran was used instead of 5-bromobenzofuran to prepare 2- (benzofuran-6-yl) -4,4,5,5-tetramethyl-1 , 3,2-dioxaborolane.
1H-NMR: δ 1.25 (s, 12H), 6.46 (d, 1H), 7.28 (d, 1H), 7.43 (d, 1H), 7.53 (d, 1H), 7.98 (s, 1H) 1 H-NMR:? 1.25 (s, 12H), 6.46 (d, IH), 7.28 (d, IH), 7.43
<단계 2> 6-(2-≪ Step 2 > 6- (2- nitrophenylnitrophenyl )) benzofuranbenzofuran 의 합성Synthesis of
2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 상기 2-(benzofuran-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)benzofuran을 얻었다.Benzofuran-6-yl) -4,4,5,5-tetramethyl-1 (2-benzofuran-5-yl) -4,4,5,5-tetramethyl- (2-nitrophenyl) benzofuran was obtained by following the procedure of <Step 2> of Preparation Example 36, except that 3,2-dioxaborolane was used.
1H-NMR: δ 6.45 (d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 (s, 1H), 8.01 (d, 1H), 8.06 (t, 1H) 1 H-NMR: δ 6.45 ( d, 1H), 7.26 (d, 1H), 7.42 (d, 1H), 7.52 (d, 1H), 7.66 (t, 1H), 7.85 (t, 1H), 7.96 ( s, 1 H), 8.01 (d, 1 H), 8.06 (t, 1 H)
<단계 3> <Step 3> ICIC -37의 합성Synthesis of -37
5-(2-nitrophenyl)benzofuran 대신 6-(2-nitrophenyl)benzofuran을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 3>과 동일한 과정을 수행하여 IC-37를 얻었다.IC-37 was obtained in the same manner as in <Step 3> of Preparation Example 36 except that 6- (2-nitrophenyl) benzofuran was used instead of 5- (2-nitrophenyl) benzofuran.
1H-NMR: δ 6.51 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 (d, 1H), 8.05 (t, 1H), 10.58 (s, 1H) 1 H-NMR: δ 6.51 ( d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.68 (t, 1H), 7.86 (t, 1H), 8.00 ( d, 1 H), 8.05 (t, 1 H), 10.58 (s, 1 H)
[[ 준비예Preparation Example 38] 38] ICIC -38의 합성Synthesis of -38
<단계 1> <Step 1> dibenzodibenzo [b,d]furan-3-[b, d] furan-3- amineamine 의 합성Synthesis of
질소 기류 하에서 3-bromodibenzo[b,d]furan (7.41 g, 30.0 mmol)을 THF 100 ml 에 녹인 후, 28 % aqueous ammonia (10.2 ml, 150 mmol) 과 Cu (0.10 g, 5 mol%)를 넣고, 110℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피 (Hexane:EA=10:1 (v/v))로 정제하여 dibenzo[b,d]furan-3-amine 4.45 g (yield : 81%)을 얻었다.(10.0 ml, 150 mmol) and Cu (0.10 g, 5 mol%) were added to a solution of 3-bromodibenzo [b, d] furan (7.41 g, 30.0 mmol) , And the mixture was stirred at 110 DEG C for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . The solvent of the filtered organic layer was removed and the residue was purified by column chromatography (Hexane: EA = 10: 1 (v / v)) to obtain 4.45 g (yield: 81%) of dibenzo [b, d] furan-3-amine.
1H-NMR: δ 5.32 (s, 2H), 6.33 (d, 1H), 7.34 (m, 2H), 7.43 (s, 1H), 7.65 (d, 2H), 7.89 (d, 1H) 1 H-NMR: δ 5.32 ( s, 2H), 6.33 (d, 1H), 7.34 (m, 2H), 7.43 (s, 1H), 7.65 (d, 2H), 7.89 (d, 1H)
<단계 2> 3H-≪ Step 2 > 3H- benzofurobenzofuro [2,3-e]indole의 합성[2,3-e] indole
질소 기류 하에서 dibenzo[b,d]furan-3-amine (4.45 g, 24.29 mmol)을 H2O/dioxane (10 ml / 90 ml) 에 녹인 후, triethanolammonium chloride (0.45 g, 2.43 mmol) 과 RuCl3`H2O (0.055 g, 0.2 mmol)과 PPh3 (0.191 g, 0.7 mmol), SnCl2`2H2O (0.548 g, 2.43 mmol)을 넣고, 180℃에서 20시간 동안 교반하였다. 반응 종결 후 aqueous 5% HCl 에 반응물을 붓고, 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피(Hexane:MC=1:1 (v/v))로 정제하여 IC-38 2.7 g (yield : 53%)을 얻었다.(4.45 g, 24.29 mmol) was dissolved in H 2 O / dioxane (10 ml / 90 ml) and then triethanolammonium chloride (0.45 g, 2.43 mmol) and RuCl 3 put the `H 2 O (0.055 g, 0.2 mmol) and PPh 3 (0.191 g, 0.7 mmol ), SnCl 2` 2H 2 O (0.548 g, 2.43 mmol), and stirred at 180 ℃ for 20 hours. After the reaction was completed, the reaction mixture was poured into aqueous 5% HCl, extracted with methylene chloride, and charged with MgSO 4 . The solvent of the filtered organic layer was removed and the residue was purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to obtain IC-38 2.7 g (yield: 53%).
1H-NMR: δ 6.45 (d, 1H), 7.13 (d, 1H), 7.27 (d, 1H), 7.35 (m, 2H), 7.66 (d, 1H), 7.88 (d, 2H), 10.46 (s, 1H) 1 H-NMR: δ 6.45 ( d, 1H), 7.13 (d, 1H), 7.27 (d, 1H), 7.35 (m, 2H), 7.66 (d, 1H), 7.88 (d, 2H), 10.46 ( s, 1 H)
[[ 준비예Preparation Example 39] 39] ICIC -39의 합성Synthesis of -39
<단계 1> 5,5-≪ Step 1 > 5,5- dimethyldimethyl -5H--5H- dibenzodibenzo [b,d]silol-3-[b, d] silol-3- amineamine 의 합성Synthesis of
3-bromodibenzo[b,d]furan 대신 3-bromo-5,5-dimethyl-5H-dibenzo[b,d] silole을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 1>과 동일한 과정을 수행하여 5,5-dimethyl-5H-dibenzo[b,d]silol-3-amine을 얻었다.The same procedure as in <Step 1> of Preparation Example 38 was carried out except that 3-bromo-5,5-dimethyl-5H-dibenzo [b, d] silole was used instead of 3-bromodibenzo [b, 5,5-dimethyl-5H-dibenzo [b, d] silol-3-amine.
1H-NMR: δ 0.68 (s, 6H), 5.31 (s, 2H), 6.68 (d, 1H), 6.80 (s, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 (t, 1H), 7.64 (d, 1H), 7.91 (d, 1H) 1 H-NMR: δ 0.68 ( s, 6H), 5.31 (s, 2H), 6.68 (d, 1H), 6.80 (s, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 ( t, 1 H), 7.64 (d, 1 H), 7.91 (d, 1 H)
<단계 2> <Step 2> ICIC -39의 합성Synthesis of -39
dibenzo[b,d]furan-3-amine 대신 상기 5,5-dimethyl-5H-dibenzo[b,d]silol-3-amine을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 2>과 동일한 과정을 수행하여 IC-39를 얻었다.Step 2 of Preparation Example 38 was repeated except that 5,5-dimethyl-5H-dibenzo [b, d] silol-3-amine was used in place of dibenzo [b, d] furan- And IC-39 was obtained.
1H-NMR: δ0.66 (s, 6H), 6.45 (d, 1H), 7.27 (d, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 (t, 1H), 7.79 (d, 1H), 7.89 (d, 1H), 7.97 (d, 1H), 10.42 (s, 1H) 1 H-NMR: δ0.66 (s , 6H), 6.45 (d, 1H), 7.27 (d, 1H), 7.33 (t, 1H), 7.52 (d, 1H), 7.61 (t, 1H), 7.79 (d, IH), 7.89 (d, IH), 7.97 (d, IH), 10.42
[[ 준비예Preparation Example 40] 40] ICIC -40의 합성Synthesis of -40
<단계 1> 5,5-≪ Step 1 > 5,5- diphenyl피덴 -5H--5H- dibenzodibenzo [b,d]silol-3-[b, d] silol-3- amineamine 의 합성Synthesis of
3-bromodibenzo[b,d]furan 대신 3-bromo-5,5-diphenyl-5H-dibenzo[b,d] silole을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 1>과 동일한 과정을 수행하여 5,5-diphenyl-5H-dibenzo[b,d]silol-3-amine을 얻었다.The same procedure as in <Step 1> of Preparation Example 38 was carried out except that 3-bromo-5,5-diphenyl-5H-dibenzo [b, d] silole was used instead of 3-bromodibenzo [b, 5,5-diphenyl-5H-dibenzo [b, d] silol-3-amine.
1H-NMR: δ 5.33 (s, 2H), 6.67 (d, 1H), 6.81 (s, 1H), 7.31 (t, 1H), 7.37 (m, 4H), 7.46 (m, 4H), 7.54 (m, 3H), 7.62 (t, 1H), 7.66 (d, 1H), 7.92 (d, 1H) 1 H-NMR: δ 5.33 ( s, 2H), 6.67 (d, 1H), 6.81 (s, 1H), 7.31 (t, 1H), 7.37 (m, 4H), 7.46 (m, 4H), 7.54 ( (m, 3H), 7.62 (t, IH), 7.66 (d, IH), 7.92
<단계 2> <Step 2> ICIC -40의 합성Synthesis of -40
dibenzo[b,d]furan-3-amine 대신 상기 5,5-diphenyl-5H-dibenzo[b,d]silol-3-amine을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 2>과 동일한 과정을 수행하여 IC-40을 얻었다.Step 2 of Preparation Example 38 was repeated except that 5,5-diphenyl-5H-dibenzo [b, d] silol-3-amine was used in place of dibenzo [b, d] furan- And IC-40 was obtained.
1H-NMR: δ 6.44 (d, 1H), 7.26 (d, 1H), 7.35 (m, 5H), 7.47 (m, 4H), 7.53 (m, 3H), 7.62 (t, 1H), 7.78 (d, 1H), 7.90 (d, 1H), 7.96 (d, 1H), 10.41 (s, 1H) 1 H-NMR: δ 6.44 ( d, 1H), 7.26 (d, 1H), 7.35 (m, 5H), 7.47 (m, 4H), 7.53 (m, 3H), 7.62 (t, 1H), 7.78 ( (d, IH), 7.90 (d, IH), 7.96 (d, IH), 10.41
[[ 준비예Preparation Example 41] 41] ICIC -41의 합성Synthesis of -41
<단계 1> <Step 1> ICIC -41의 합성Synthesis of -41
dibenzo[b,d]furan-3-amine 대신 dibenzo[b,d]selenophen-3-amine을 사용하는 것을 제외하고는 상기 준비예 38의 <단계 2>과 동일한 과정을 수행하여 IC-41을 얻었다.The same procedure as in <Step 2> of Preparation Example 38 was carried out except that dibenzo [b, d] selenophen-3-amine was used instead of dibenzo [b, d] furan- .
1H-NMR: δ 6.47 (d, 1H), 7.15 (d, 1H), 7.26 (d, 1H), 7.36 (m, 2H), 7.67 (d, 1H), 7.89 (d, 2H), 10.45 (s, 1H) 1 H-NMR: δ 6.47 ( d, 1H), 7.15 (d, 1H), 7.26 (d, 1H), 7.36 (m, 2H), 7.67 (d, 1H), 7.89 (d, 2H), 10.45 ( s, 1 H)
[[ 준비예Preparation Example 42] 42] ICIC -42의 합성Synthesis of -42
<단계 1> 2-(<Step 1> 2- ( benzobenzo [b]selenophen-5-[b] selenophen-5- ylyl )-4,4,5,5-) -4,4,5,5- tetramethyltetramethyl -1,3,2-dioxaborolane의 합성-1,3,2-dioxaborolane
5-bromobenzofuran 대신 5-bromobenzo[b]selenophene을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 1>과 동일한 과정을 수행하여 2-(benzo[b]selenophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.Benzo [b] selenophen-5-yl) -4,4-dioxolan-4-one was obtained by following the procedure of Step 1 of Preparation Example 36, except that 5-bromobenzo [b] selenophene was used instead of 5-bromobenzofuran. , 5,5-tetramethyl-1,3,2-dioxaborolane.
1H-NMR: δ 1.26 (s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 8.00 (s, 1H) 1 H-NMR: δ 1.26 ( s, 12H), 6.45 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 8.00 (s, 1H)
<단계 2> 5-(2-<Step 2> Synthesis of 5- (2- nitrophenylnitrophenyl )) benzobenzo [b][b] selenopheneselenophene 의 합성Synthesis of
2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 상기 2-(benzo[b]selenophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 2>와 동일한 과정을 수행하여 5-(2-nitrophenyl)benzo[b]selenophene을 얻었다.Benzo [b] selenophen-5-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane instead of 2- (benzofuran- (2-nitrophenyl) benzo [b] selenophene was obtained in the same manner as in <Step 2> of Preparation Example 36 except that -tetramethyl-1,3,2-dioxaborolane was used.
1H-NMR: δ 6.44 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.51 (d, 1H), 7.65 (t, 1H), 7.84 (t, 1H), 7.94 (s, 1H), 8.00 (d, 1H), 8.05 (t, 1H) 1 H-NMR: δ 6.44 ( d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.51 (d, 1H), 7.65 (t, 1H), 7.84 (t, 1H), 7.94 ( s, 1 H), 8.00 (d, 1 H), 8.05 (t, 1 H)
<단계 3> <Step 3> ICIC -42의 합성Synthesis of -42
5-(2-nitrophenyl)benzofuran 대신 5-(2-nitrophenyl)benzo[b]selenophene 을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 3>과 동일한 과정을 수행하여 IC-42를 얻었다.IC-42 was obtained in the same manner as in <Step 3> of Preparation Example 36 except that 5- (2-nitrophenyl) benzo [b] selenophene was used instead of 5- (2-nitrophenyl) benzofuran.
1H-NMR: δ 6.52 (d, 1H), 7.26 (d, 1H), 7.44 (d, 1H), 7.55 (d, 1H), 7.69 (t, 1H), 7.85 (t, 1H), 7.96 (d, 1H), 8.03 (t, 1H), 10.56 (s, 1H) 1 H-NMR: δ 6.52 ( d, 1H), 7.26 (d, 1H), 7.44 (d, 1H), 7.55 (d, 1H), 7.69 (t, 1H), 7.85 (t, 1H), 7.96 ( d, 1 H), 8.03 (t, 1 H), 10.56 (s, 1 H)
[[ 준비예Preparation Example 43] 43] ICIC -43의 합성Synthesis of -43
<단계 1> 2-(<Step 1> 2- ( benzobenzo [b]selenophen-6-[b] selenophen-6- ylyl )-4,4,5,5-) -4,4,5,5- tetramethyltetramethyl -1,3,2-dioxaborolane의 합성-1,3,2-dioxaborolane
5-bromobenzofuran 대신 6-bromobenzo[b]selenophene을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 1>과 동일한 과정을 수행하여 2-(benzo[b]selenophen-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 얻었다.Benzo [b] selenophen-6-yl) -4,4-dioxolan-4-one was obtained by following the procedure of Step 1 of Preparation Example 36, except that 6-bromobenzo [b] selenophene was used instead of 5-bromobenzofuran. , 5,5-tetramethyl-1,3,2-dioxaborolane.
1H-NMR: δ 1.24 (s, 12H), 6.45 (d, 1H), 7.28 (d, 1H), 7.44 (d, 1H), 7.57 (d, 1H), 7.96 (s, 1H) 1 H-NMR:? 1.24 (s, 12H), 6.45 (d, IH), 7.28 (d, IH), 7.44
<단계 2> 6-(2-≪ Step 2 > 6- (2- nitrophenylnitrophenyl )) benzobenzo [b][b] selenopheneselenophene 의 합성Synthesis of
2-(benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 2-(benzo[b]selenophen-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 2>와 동일한 과정을 수행하여 6-(2-nitrophenyl)benzo[b]selenophene을 얻었다.Benzo [b] selenophen-6-yl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane in place of 2- (benzofuran-5- (2-nitrophenyl) benzo [b] selenophene was obtained by following the procedure of <Step 2> of Preparation Example 36, except that tetramethyl-1,3,2-dioxaborolane was used.
1H-NMR: δ 6.46 (d, 1H), 7.26 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.67 (t, 1H), 7.86 (t, 1H), 7.93 (s, 1H), 8.02 (d, 1H), 8.08 (t, 1H) 1 H-NMR: δ 6.46 ( d, 1H), 7.26 (d, 1H), 7.43 (d, 1H), 7.54 (d, 1H), 7.67 (t, 1H), 7.86 (t, 1H), 7.93 ( s, 1 H), 8.02 (d, 1 H), 8.08 (t, 1 H)
<단계 3> <Step 3> ICIC -43의 합성Synthesis of -43
5-(2-nitrophenyl)benzofuran 대신 6-(2-nitrophenyl)benzo[b]selenophene 을 사용하는 것을 제외하고는 상기 준비예 36의 <단계 3>과 동일한 과정을 수행하여 IC-43를 얻었다.IC-43 was obtained in the same manner as in <Step 3> of Preparation Example 36 except that 6- (2-nitrophenyl) benzo [b] selenophene was used instead of 5- (2-nitrophenyl) benzofuran.
1H-NMR: δ 6.52 (d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.52 (d, 1H), 7.67 (t, 1H), 7.85 (t, 1H), 8.01 (d, 1H), 8.09 (t, 1H), 10.55 (s, 1H)
1 H-NMR: δ 6.52 ( d, 1H), 7.27 (d, 1H), 7.43 (d, 1H), 7.52 (d, 1H), 7.67 (t, 1H), 7.85 (t, 1H), 8.01 ( d, 1 H), 8.09 (t, 1 H), 10.55 (s, 1 H)
[[ 합성예Synthetic example 1] One] InvInv -1의 합성Synthesis of -1
질소 기류 하에서 IC-1 (3 g, 10.63 mmol), 3-bromobiphenyl (3.72 g, 15.94 mmol), Cu powder (0.07 g, 1.06 mmol), K2CO3 (1.47 g, 10.63 mmol), Na2SO4 (1.51 g, 10.63 mmol), nitrobenzene (100 ml)를 혼합하고 200℃에서 24시간 동안 교반하였다. IC-1 (3 g, 10.63 mmol) in a nitrogen atmosphere, 3-bromobiphenyl (3.72 g, 15.94 mmol), Cu powder (0.07 g, 1.06 mmol), K 2 CO 3 (1.47 g, 10.63 mmol), Na 2 SO 4 (1.51 g, 10.63 mmol) and nitrobenzene (100 ml) were mixed and stirred at 200 ° C for 24 hours.
반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 1:1 (v/v))로 정제하여 목적 화합물인 Inv-1 (2.26 g, 수율 49 %)을 얻었다. After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer from which the water had been removed, and the residue was purified by column chromatography (Hexane: MC = 1: 1 (v / v)) to give 2.26 g (yield: 49%) of the target compound Inv-1.
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (calculated: 434.18 g / mol, measured: 434 g / mol)
[[ 합성예Synthetic example 2] 2] InvInv -2의 합성Synthesis of -2
3-bromobiphenyl 대신 3-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-2 (2.13 g, 46 %)를 얻었다.Inv-2 (2.13 g, 46%) was obtained in the same manner as in Synthesis Example 1, except that 3- (4-bromophenyl) pyridine was used in place of 3-bromobiphenyl.
GC-Mass (이론치: 435.17 g/mol, 측정치: 435.17 g/mol)GC-Mass (calculated: 435.17 g / mol, measured: 435.17 g / mol)
[[ 합성예Synthetic example 3] 3] InvInv -3의 합성Synthesis of -3
질소 기류 하에서 IC-1 (3 g, 10.63 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (4.38 g, 12.75 mmol), Pd(OAc)2 (0.12 g, 5 mol%), NaO(t-bu) (2.04 g, 21.25 mmol), P(t-bu)3 (0.21 g, 1.06 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다.(3 g, 10.63 mmol), 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine (4.38 g, 12.75 mmol), Pd (OAc) 2 (2.01 g, 21.25 mmol), P (t-bu) 3 (0.21 g, 1.06 mmol) and Toluene (100 ml) were mixed and heated at 110 ° C for 12 hours Lt; / RTI >
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 2:1 (v/v))로 정제하여 목적 화합물인 Inv-3 (4.89 g, 수율 78 %)을 얻었다. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, and then water was removed with MgSO 4. The residue was purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to obtain 4.79 g %).
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 4] 4] InvInv -4의 합성Synthesis of -4
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-4 (4.97 g, 79 %)를 얻었다.Instead of 2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) -1,3,5-triazine in place of 2- (3-chlorophenyl) (4.97 g, 79%) was obtained in the same manner as in Synthesis Example 3, except that the compound represented by Inv-4 was used.
GC-Mass (이론치: 591.22 g/mol, 측정치: 591 g/mol)GC-Mass (calculated: 591.22 g / mol, measured: 591 g / mol)
[[ 합성예Synthetic example 5] 5] InvInv -5의 합성Synthesis of -5
3-bromobiphenyl 대신 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-5 (3.21 g, 50 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that 2- (3-bromo-5-methylphenyl) -4,6-diphenyl-1,3,5-triazine was used in place of 3-bromobiphenyl, -5 (3.21 g, 50%).
GC-Mass (이론치: 603.24 g/mol, 측정치: 603 g/mol)GC-Mass (theory: 603.24 g / mol, measured: 603 g / mol)
[[ 합성예Synthetic example 6] 6] InvInv -6의 합성Synthesis of -6
3-bromobiphenyl 대신 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-6 (3.47 g, 49 %)를 얻었다.The same procedure as in Synthesis Example 1 was carried out except that 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine was used in place of 3-bromobiphenyl, -6 (3.47 g, 49%).
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 7] 7] InvInv -7의 합성Synthesis of -7
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-7 (5.38 g,76 %)를 얻었다.2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) -1,3,5-triazine was used instead of 2- (3-chlorophenyl) (Inv-7) (5.38 g, 76%) was obtained in the same manner as in Synthesis Example 3, except that
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 8] 8] InvInv -8의 합성Synthesis of -8
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chlorophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-8 (4.63 g, 74 %)를 얻었다.The procedure of Synthesis Example 3 was repeated except that 2- (3-chlorophenyl) -4,6-diphenylpyrimidine was used instead of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine Inv-8 (4.63 g, 74%) was obtained as a target compound.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)
[[ 합성예Synthetic example 9] 9] InvInv -9의 합성Synthesis of -9
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)pyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-9 (4.83 g, 77 %)를 얻었다.Except that 2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) pyrimidine was used instead of 2- (3-chlorophenyl) -4,6-diphenyl- The procedure of Synthetic Example 3 was repeated to obtain the target compound Inv-9 (4.83 g, 77%).
GC-Mass (이론치: 590.22 g/mol, 측정치: 590 g/mol)GC-Mass (calculated: 590.22 g / mol, measured: 590 g / mol)
[[ 합성예Synthetic example 10] 10] InvInv -10의 합성Synthesis of -10
3-bromobiphenyl 대신 4-(5-bromobiphenyl-3-yl)-2,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-10 (3.53 g, 50 %)를 얻었다.Inv-10 (3.53 g, 50%) was obtained in the same manner as in Synthesis Example 1 except that 4- (5-bromobiphenyl-3-yl) -2,6-diphenylpyrimidine was used in place of 3-bromobiphenyl. ).
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (calculated: 664.26 g / mol, measured: 664 g / mol)
[[ 합성예Synthetic example 11] 11] InvInv -11의 합성Synthesis of -11
3-bromobiphenyl 대신 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-11 (3.39 g, 47 %)를 얻었다.The same procedure as in Synthesis Example 1 was carried out except that 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole was used instead of 3-bromobiphenyl The target compound Inv-11 (3.39 g, 47%) was obtained.
GC-Mass (이론치: 678.25 g/mol, 측정치: 678 g/mol)GC-Mass (calculated: 678.25 g / mol, measured: 678 g / mol)
[[ 합성예Synthetic example 12] 12] InvInv -12의 합성Synthesis of -12
3-bromobiphenyl 대신 (4-bromophenyl)diphenylborane을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-12 (2.44 g, 44 %)를 얻었다.Inv-12 (2.44 g, 44%) was obtained in the same manner as in Synthesis Example 1, except that (4-bromophenyl) diphenylborane was used in place of 3-bromobiphenyl.
GC-Mass (이론치: 522.23 g/mol, 측정치: 522 g/mol)GC-Mass (calculated: 522.23 g / mol, measured: 522 g / mol)
[[ 합성예Synthetic example 13] 13] InvInv -13의 합성Synthesis of -13
3-bromobiphenyl 대신 (4-bromophenyl)diphenylphosphine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-13 (2.59 g, 45 %)를 얻었다.Inv-13 (2.59 g, 45%) was obtained in the same manner as in Synthesis Example 1, except that (4-bromophenyl) diphenylphosphine was used in place of 3-bromobiphenyl.
GC-Mass (이론치: 542.19 g/mol, 측정치: 542 g/mol)GC-Mass (calculated: 542.19 g / mol, measured: 542 g / mol)
[[ 합성예Synthetic example 14] 14] InvInv -14의 합성Synthesis of -14
2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 (4-chlorophenyl)triphenylsilane을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-14 (4.92 g, 75 %)를 얻었다.Except that (4-chlorophenyl) triphenylsilane was used in place of 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine, 14 (4.92 g, 75%).
GC-Mass (이론치: 616.23 g/mol, 측정치: 616 g/mol)GC-Mass (theory: 616.23 g / mol, measured: 616 g / mol)
[[ 합성예Synthetic example 15] 15] InvInv -15의 합성Synthesis of -15
IC-1 대신 IC-2를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-15 (4.51 g, 72 %)를 얻었다.Inv-15 (4.51 g, 72%) was obtained in the same manner as in Synthesis Example 3, except that IC-2 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 16] 16] InvInv -16의 합성Synthesis of -16
IC-1 대신 IC-3을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-16 (2.35 g, 51 %)를 얻었다.Inv-16 (2.35 g, 51%) was obtained in the same manner as in Synthesis Example 1, except that IC-3 was used instead of IC-1.
GC-Mass (이론치: 434.18 g/mol, 측정치: 434 g/mol)GC-Mass (calculated: 434.18 g / mol, measured: 434 g / mol)
[[ 합성예Synthetic example 17] 17] InvInv -17의 합성Synthesis of -17
IC-1과 3-bromobiphenyl 대신 IC-3과 3-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-17 (2.45 g, 53 %)를 얻었다.Inv-17 (2.45 g, 53%) was obtained in the same manner as in Synthesis Example 1, except that IC-3 and 3- (4-bromophenyl) pyridine were used instead of IC-1 and 3-bromobiphenyl. .
GC-Mass (이론치: 435.17 g/mol, 측정치: 435 g/mol)GC-Mass (calculated: 435.17 g / mol, measured: 435 g / mol)
[[ 합성예Synthetic example 18] 18] InvInv -18의 합성Synthesis of -18
IC-1 대신 IC-3을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-18 (4.32 g, 69 %)를 얻었다.Inv-18 (4.32 g, 69%) was obtained in the same manner as in Synthesis Example 3, except that IC-3 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 19] 19] InvInv -19의 합성-19 Synthesis
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-19 (4.53 g, 72 %)를 얻었다.IC-1 and 2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) -4,6-diphenyl- -1,3,5-triazine was used in place of the compound obtained in Synthesis Example 3 to obtain the desired compound Inv-19 (4.53 g, 72%).
GC-Mass (이론치: 591.22 g/mol, 측정치: 591 g/mol)GC-Mass (calculated: 591.22 g / mol, measured: 591 g / mol)
[[ 합성예Synthetic example 20] 20] InvInv -20의 합성Synthesis of -20
IC-1과 3-bromobiphenyl 대신 IC-3과 2-(3-bromo-5-methylphenyl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-20 (2.95 g, 46 %)를 얻었다.Except that IC-3 and 2- (3-bromo-5-methylphenyl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl in Synthesis Example 1 (Inv-20, 2.95 g, 46%) was obtained.
GC-Mass (이론치: 603.24 g/mol, 측정치: 603 g/mol)GC-Mass (theory: 603.24 g / mol, measured: 603 g / mol)
[[ 합성예Synthetic example 21] 21] InvInv -21의 합성Synthesis of -21
IC-1과 3-bromobiphenyl 대신 IC-3과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-21 (3.18 g, 45 %)를 얻었다.Except that IC-3 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl in Synthesis Example 1 (3.18 g, 45%) of the desired compound, Inv-21, was obtained.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 22] 22] InvInv -22의 합성Synthesis of -22
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-22 (6.07 g, 77 %)를 얻었다.IC-1 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) -4,6-diphenyl- -1,3,5-triazine, the procedure of Synthesis Example 3 was repeated to obtain the desired compound, Inv-22 (6.07 g, 77%).
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 23] 23] InvInv -23의 합성Synthesis of -23
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2-(3-chlorophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-23 (4.69 g, 75 %)를 얻었다.Except using IC-3 and 2- (3-chlorophenyl) -4,6-diphenylpyrimidine instead of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5-triazine The same procedure as in Synthesis Example 3 was carried out to obtain the target compound Inv-23 (4.69 g, 75%).
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)
[[ 합성예Synthetic example 24] 24] InvInv -24의 합성Synthesis of -24
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 2-(3-chlorophenyl)-4,6-di(pyridin-2-yl)pyrimidine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-24 (4.46 g, 71 %)를 얻었다.IC-1 and 2- (3-chlorophenyl) -4,6-di (pyridin-2-yl) -4,6-diphenyl- pyrimidine, the target compound Inv-24 (4.46 g, 71%) was obtained by carrying out the same procedure as in Synthesis Example 3 above.
GC-Mass (이론치: 590.22 g/mol, 측정치: 590 g/mol)GC-Mass (calculated: 590.22 g / mol, measured: 590 g / mol)
[[ 합성예Synthetic example 25] 25] InvInv -25의 합성Synthesis of -25
IC-1과 3-bromobiphenyl 대신 IC-3과 4-(5-bromobiphenyl-3-yl)-2,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-25 (3.04 g, 43 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-3 and 4- (5-bromobiphenyl-3-yl) -2,6-diphenylpyrimidine were used instead of IC-1 and 3-bromobiphenyl, -25 (3.04 g, 43%).
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (calculated: 664.26 g / mol, measured: 664 g / mol)
[[ 합성예Synthetic example 26] 26] InvInv -26의 합성Synthesis of -26
IC-1과 3-bromobiphenyl 대신 IC-3과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-26 (2.96 g, 41 %)를 얻었다.Except for using IC-3 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole instead of IC-1 and 3-bromobiphenyl. The procedure of Example 1 was followed to obtain the target compound Inv-26 (2.96 g, 41%).
GC-Mass (이론치: 678.25 g/mol, 측정치: 678 g/mol)GC-Mass (calculated: 678.25 g / mol, measured: 678 g / mol)
[[ 합성예Synthetic example 27] 27] InvInv -27의 합성-27
IC-1과 3-bromobiphenyl 대신 IC-3과 (4-bromophenyl) diphenylborane을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-27 (2.66 g, 48 %)를 얻었다.Inv-27 (2.66 g, 48%) was obtained in the same manner as in Synthesis Example 1 except that IC-3 and (4-bromophenyl) diphenylborane were used instead of IC-1 and 3-bromobiphenyl .
GC-Mass (이론치: 522.23 g/mol, 측정치: 522 g/mol)GC-Mass (calculated: 522.23 g / mol, measured: 522 g / mol)
[[ 합성예Synthetic example 28] 28] InvInv -28의 합성-28 Synthesis
IC-1과 3-bromobiphenyl 대신 IC-3과 (4-bromophenyl) diphenylphosphine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-28 (2.54 g, 44 %)를 얻었다.Inv-28 (2.54 g, 44%) was obtained in the same manner as in Synthesis Example 1 except that IC-3 and (4-bromophenyl) diphenylphosphine were used instead of IC-1 and 3-bromobiphenyl .
GC-Mass (이론치: 542.19 g/mol, 측정치: 542 g/mol)GC-Mass (calculated: 542.19 g / mol, measured: 542 g / mol)
[[ 합성예Synthetic example 29] 29] InvInv -29의 합성Synthesis of -29
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-3과 (4-chlorophenyl)triphenylsilane을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-29 (4.65 g, 71 %)를 얻었다.Except that IC-3 and (4-chlorophenyl) triphenylsilane were used in place of IC-1 and 2- (3-chlorophenyl) -4,6-diphenyl-1,3,5- To obtain the target compound Inv-29 (4.65 g, 71%).
GC-Mass (이론치: 616.23 g/mol, 측정치: 616 g/mol)GC-Mass (theory: 616.23 g / mol, measured: 616 g / mol)
[[ 합성예Synthetic example 30] 30] InvInv -30의 합성Synthesis of -30
IC-1 대신 IC-4를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-30 (4.70 g, 75 %)를 얻었다.Inv-30 (4.70 g, 75%) was obtained in the same manner as in Synthesis Example 3 except that IC-4 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 31] 31] InvInv -31의 합성Synthesis of -31
IC-1 대신 IC-5를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-31 (4.57 g, 73 %)를 얻었다.Inv-31 (4.57 g, 73%) was obtained in the same manner as in Synthesis Example 3 except that IC-5 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 32] 32] InvInv -32의 합성Synthesis of -32
IC-1 대신 IC-6을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-32 (4.82 g, 77 %)를 얻었다.Inv-32 (4.82 g, 77%) was obtained in the same manner as in Synthesis Example 3, except that IC-6 was used instead of IC-1.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 33] 33] InvInv -33의 합성Synthesis of -33
질소 기류 하에서 IC-7 (5 g, 13.84 mmol)과 phenylboronic acid (2.03 g, 16.61 mmol), NaOH (1.66 g, 41.52 mmol) 및 THF/H2O(100 ml/500 ml)를 혼합한 다음, 40℃에서 Pd(PPh3)4(0.80 g, 5 mol%)를 넣고 80℃에서 12시간 동안 교반하였다. The mixture was mixed with IC-7 (5 g, 13.84 mmol), phenylboronic acid (2.03 g, 16.61 mmol), NaOH (1.66 g, 41.52 mmol) and THF / H 2 O (100 ml / 500 ml) Pd (PPh 3 ) 4 (0.80 g, 5 mol%) was added thereto at 40 ° C, and the mixture was stirred at 80 ° C for 12 hours.
반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 여과하였다. 얻어진 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:EA = 3:1 (v/v))로 정제하여 3,7-diphenyl-3,10-dihydropyrrolo[3,2-a]carbazole을 얻었다.After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was added with MgSO 4 and filtered. The solvent was removed from the obtained organic layer and then purified by column chromatography (Hexane: EA = 3: 1 (v / v)) to obtain 3,7-diphenyl-3,10-dihydropyrrolo [3,2-a] carbazole.
상기 3,7-diphenyl-3,10-dihydropyrrolo[3,2-a]carbazole을 IC-1 대신 사용하여 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-33 (6.27 g, 68 %)를 얻었다.Inv-33 (6.27 g, 68%) was obtained in the same manner as in Synthesis Example 3 except that 3,7-diphenyl-3,10-dihydropyrrolo [3,2-a] carbazole was used instead of IC- .
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 34] 34] InvInv -34의 합성Synthesis of -34
phenylboronic acid 대신 9-phenyl-9H-carbazol-3-ylboronic acid을 사용하는 것을 제외하고는 상기 합성예 33과 동일한 과정을 수행하여 목적 화합물인 Inv-34 (7.94 g, 69 %)를 얻었다.Inv-34 (7.94 g, 69%) was obtained in the same manner as in Synthesis Example 33 except that 9-phenyl-9H-carbazol-3-ylboronic acid was used in place of phenylboronic acid.
GC-Mass (이론치: 830.32 g/mol, 측정치: 830 g/mol)GC-Mass (calculated: 830.32 g / mol, measured: 830 g / mol)
[[ 합성예Synthetic example 35] 35] InvInv -35의 합성Synthesis of -35
IC-7 대신 IC-8을 사용하는 것을 제외하고는 상기 합성예 33과 동일한 과정을 수행하여 목적 화합물인 Inv-35 (6.64 g, 72 %)를 얻었다.Inv-35 (6.64 g, 72%) was obtained in the same manner as in Synthesis Example 33 except that IC-8 was used instead of IC-7.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 36] 36] InvInv -36의 합성Synthesis of -36
IC-7과 phenylboronic acid 대신 IC-8과 9-(4,6-diphenylpyridin-2-yl)-9H-carbazol-3-ylboronic acid을 사용하는 것을 제외하고는 상기 합성예 33과 동일한 과정을 수행하여 목적 화합물인 Inv-36 (10.22 g, 75 %)를 얻었다.The same procedure as in Synthesis Example 33 was carried out except that IC-7 and IC-8 and 9- (4,6-diphenylpyridin-2-yl) -9H-carbazol-3-ylboronic acid were used instead of phenylboronic acid The target compound Inv-36 (10.22 g, 75%) was obtained.
GC-Mass (이론치: 983.37 g/mol, 측정치: 983 g/mol)GC-Mass (theory: 983.37 g / mol, measurement: 983 g / mol)
[[ 합성예Synthetic example 37] 37] InvInv -37의 합성Synthesis of -37
IC-1 대신 IC-9를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-37 (4.34 g, 71 %)를 얻었다.Inv-37 (4.34 g, 71%) was obtained in the same manner as in Synthesis Example 3, except that IC-9 was used instead of IC-1.
GC-Mass (이론치: 603.24 g/mol, 측정치: 603 g/mol)GC-Mass (theory: 603.24 g / mol, measured: 603 g / mol)
[[ 합성예Synthetic example 38] 38] InvInv -38의 합성Synthesis of -38
IC-1과 3-bromobiphenyl 대신 IC-9와 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-38 (3.58 g, 52 %)를 얻었다.Except that IC-9 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl in Synthesis Example 1 (Inv-38, 3.58 g, 52%) was obtained.
GC-Mass (이론치: 679.27 g/mol, 측정치: 679 g/mol)GC-Mass (calculated: 679.27 g / mol, measured: 679 g / mol)
[[ 합성예Synthetic example 39] 39] InvInv -39의 합성Synthesis of -39
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-9와 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-39 (5.20 g, 68 %)를 얻었다.IC-1 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) -4,6-diphenyl- -1,3,5-triazine was used in place of the target compound, Inv-39 (5.20 g, 68%) was obtained in the same manner as in Synthesis Example 3.
GC-Mass (이론치: 775.30 g/mol, 측정치: 775 g/mol)GC-Mass (calculated: 775.30 g / mol, measured: 775 g / mol)
[[ 합성예Synthetic example 40] 40] InvInv -40의 합성Synthesis of -40
IC-1 대신 IC-10을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-40 (3.90 g, 70 %)를 얻었다.Inv-40 (3.90 g, 70%) was obtained in the same manner as in Synthesis Example 3, except that IC-10 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 41] 41] InvInv -41의 합성Synthesis of -41
IC-1과 3-bromobiphenyl 대신 IC-10과 2-(4-bromophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-41 (2.67 g, 48 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-10 and 2- (4-bromophenyl) -4,6-diphenylpyrimidine were used in place of IC-1 and 3-bromobiphenyl, g, 48%).
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (calculated: 664.26 g / mol, measured: 664 g / mol)
[[ 합성예Synthetic example 42] 42] InvInv -42의 합성Synthesis of -42
IC-1 대신 IC-11을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-42 (3.74 g, 73 %)를 얻었다.Inv-42 (3.74 g, 73%) was obtained in the same manner as in Synthesis Example 3 except that IC-11 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 43] 43] InvInv -43의 합성Synthesis of -43
IC-1과 3-bromobiphenyl 대신 IC-11과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-43 (2.94 g, 52 %)를 얻었다.Except that IC-11 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl in Synthesis Example 1 To obtain the target compound Inv-43 (2.94 g, 52%).
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (theory: 817.32 g / mol, measured: 817 g / mol)
[[ 합성예Synthetic example 44] 44] InvInv -44의 합성Synthesis of -44
IC-1과 3-bromobiphenyl 대신 IC-11과 3,3'-(5-bromo-1,3-phenylene)dipyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-44 (2.34 g, 51 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-11 and 3,3 '- (5-bromo-1,3-phenylene) dipyridine were used instead of IC-1 and 3-bromobiphenyl, -44 (2.34 g, 51%).
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (calculated: 664.26 g / mol, measured: 664 g / mol)
[[ 합성예Synthetic example 45] 45] InvInv -45의 합성Synthesis of -45
IC-1과 3-bromobiphenyl 대신 IC-11과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-45 (2.81 g, 49 %)를 얻었다.Except that IC-11 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) -9H-carbazole were used instead of IC-1 and 3-bromobiphenyl. The procedure of Example 1 was repeated to obtain the target compound Inv-45 (2.81 g, 49%).
GC-Mass (이론치: 830.32 g/mol, 측정치: 830 g/mol)GC-Mass (calculated: 830.32 g / mol, measured: 830 g / mol)
[[ 합성예Synthetic example 46] 46] InvInv -46의 합성Synthesis of -46
IC-1 대신 IC-12를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-46 (4.05 g, 72 %)를 얻었다.Inv-46 (4.05 g, 72%) was obtained in the same manner as in Synthesis Example 3, except that IC-12 was used instead of IC-1.
GC-Mass (이론치: 657.21 g/mol, 측정치: 657 g/mol)GC-Mass (657.21 g / mol, measured: 657 g / mol)
[[ 합성예Synthetic example 47] 47] InvInv -47의 합성Synthesis of -47
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-12와 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-47 (3.66 g, 65 %)를 얻었다.IC-1 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin) instead of IC-12 and 2- (3-chlorophenyl) -2-yl) -9H-carbazole was used in place of the target compound, Inv-47 (3.66 g, 65%) was obtained in the same manner as in Synthesis Example 3.
GC-Mass (이론치: 657.21 g/mol, 측정치: 657 g/mol)GC-Mass (657.21 g / mol, measured: 657 g / mol)
[[ 합성예Synthetic example 48] 48] InvInv -48의 합성Synthesis of -48
IC-1과 3-bromobiphenyl 대신 IC-12와 2-(3-bromophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-48 (2.64 g, 47 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-12 and 2- (3-bromophenyl) -4,6-diphenylpyrimidine were used instead of IC-1 and 3-bromobiphenyl, g, 47%).
GC-Mass (이론치: 656.22 g/mol, 측정치: 656 g/mol)GC-Mass (calculated: 656.22 g / mol, measured: 656 g / mol)
[[ 합성예Synthetic example 49] 49] InvInv -49의 합성Synthesis of -49
IC-1 대신 IC-13을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-49 (3.90 g, 70 %)를 얻었다.Inv-49 (3.90 g, 70%) was obtained in the same manner as in Synthesis Example 3, except that IC-13 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 50] 50] InvInv -50의 합성Synthesis of -50
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-13과 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-50 (5.00 g, 73 %)를 얻었다.IC-1 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) -4,6-diphenyl- -1,3,5-triazine was used in place of the target compound, Inv-50 (5.00 g, 73%) was obtained in the same manner as in Synthesis Example 3.
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (theory: 817.32 g / mol, measured: 817 g / mol)
[[ 합성예Synthetic example 51] 51] InvInv -51의 합성Synthesis of -51
IC-1 대신 IC-14를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-51 (3.85 g, 69 %)를 얻었다.Inv-51 (3.85 g, 69%) was obtained in the same manner as in Synthesis Example 3, except that IC-14 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 52] 52] InvInv -52의 합성Synthesis of -52
IC-1과 3-bromobiphenyl 대신 IC-15와 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-52 (2.90 g, 52 %)를 얻었다.The same procedure as in Synthesis Example 1 was carried out except that IC-15 and 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl Inv-52 (2.90 g, 52%) as a target compound was obtained.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 53] 53] InvInv -53의 합성Synthesis of -53
IC-1 대신 IC-15를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-53 (3.85 g, 69 %)를 얻었다.Inv-53 (3.85 g, 69%) was obtained by carrying out the same procedure as in Synthesis Example 3, except that IC-15 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 54] 54] InvInv -54의 합성Synthesis of -54
IC-1과 3-bromobiphenyl 대신 IC-15와 2-(4-bromophenyl)-5-phenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-54 (2.66 g, 54 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-15 and 2- (4-bromophenyl) -5-phenylpyrimidine were used instead of IC-1 and 3-bromobiphenyl to obtain the desired compound Inv-54 (2.66 g, 54%).
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)
[[ 합성예Synthetic example 55] 55] InvInv -55의 합성Synthesis of -55
IC-1 대신 IC-16을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-55 (3.48 g, 68 %)를 얻었다.Inv-55 (3.48 g, 68%) was obtained in the same manner as in Synthesis Example 3, except that IC-16 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 56] 56] InvInv -56의 합성Synthesis of -56
IC-1과 3-bromobiphenyl 대신 IC-16과 2-(4-bromophenyl)pyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-56 (1.99 g, 49 %)를 얻었다.(1.99 g, 49%) was obtained by carrying out the same processes as in Synthesis Example 1 except that IC-16 and 2- (4-bromophenyl) pyrimidine were used instead of IC-1 and 3-bromobiphenyl. .
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)
[[ 합성예Synthetic example 57] 57] InvInv -57의 합성Synthesis of -57
IC-1 대신 IC-17을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-57 (4.00 g, 71 %)를 얻었다.Inv-57 (4.00 g, 71%) was obtained in the same manner as in Synthesis Example 3, except that IC-17 was used instead of IC-1.
GC-Mass (이론치: 657.21 g/mol, 측정치: 657 g/mol)GC-Mass (657.21 g / mol, measured: 657 g / mol)
[[ 합성예Synthetic example 58] 58] InvInv -58의 합성Synthesis of -58
IC-1과 3-bromobiphenyl 대신 IC-17과 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-58 (2.89 g, 46 %)를 얻었다.Except that IC-17 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl. (Inv-58, 2.89 g, 46%) was obtained.
GC-Mass (이론치: 733.25 g/mol, 측정치: 733 g/mol)GC-Mass (733.25 g / mol, measured: 733 g / mol)
[[ 합성예Synthetic example 59] 59] InvInv -59의 합성Synthesis of -59
IC-1 대신 IC-18을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-59 (3.49 g, 69 %)를 얻었다.Inv-59 (3.49 g, 69%) was obtained by carrying out the same procedure as in Synthesis Example 3, except that IC-18 was used instead of IC-1.
GC-Mass (이론치: 754.28 g/mol, 측정치: 754 g/mol)GC-Mass (calculated: 754.28 g / mol, measured: 754 g / mol)
[[ 합성예Synthetic example 60] 60] InvInv -60의 합성Synthesis of -60
IC-1과 3-bromobiphenyl 대신 IC-18과 3-bromo-9-(4,6-diphenyl-1,3,5-triazin-2-yl)-9H-carbazole을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-60 (2.49 g, 44 %)를 얻었다.Except that IC-1 and 3-bromobiphenyl were replaced by IC-18 and 3-bromo-9- (4,6-diphenyl-1,3,5-triazin-2-yl) The procedure of Example 1 was repeated to obtain the target compound Inv-60 (2.49 g, 44%).
GC-Mass (이론치: 843.31 g/mol, 측정치: 843 g/mol)GC-Mass (calculated: 843.31 g / mol, measured: 843 g / mol)
[[ 합성예Synthetic example 61] 61] InvInv -61의 합성Synthesis of -61
IC-1과 3-bromobiphenyl 대신 IC-19와 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-61 (1.62 g, 48 %)를 얻었다.Inv-61 (1.62 g, 48%) was obtained in the same manner as in Synthesis Example 1 except that IC-19 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 678.25 g/mol, 측정치: 678 g/mol)GC-Mass (calculated: 678.25 g / mol, measured: 678 g / mol)
[[ 합성예Synthetic example 62] 62] InvInv -62의 합성Synthesis of -62
IC-1과 3-bromobiphenyl 대신 IC-19와 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-62 (1.94 g, 47 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-19 and 1-bromo-3,5-diphenyl benzene were used instead of IC-1 and 3-bromobiphenyl to obtain the desired compound Inv-62 (1.94 g, 47 %).
GC-Mass (이론치: 830.32 g/mol, 측정치: 830 g/mol)GC-Mass (calculated: 830.32 g / mol, measured: 830 g / mol)
[[ 합성예Synthetic example 63] 63] InvInv -63의 합성Synthesis of -63
IC-1 대신 IC-20을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-63 (3.79 g, 68 %)를 얻었다.Inv-63 (3.79 g, 68%) was obtained in the same manner as in Synthesis Example 3 except that IC-20 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 64] 64] InvInv -64의 합성Synthesis of -64
IC-1 대신 IC-21을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-64 (4.18 g, 75 %)를 얻었다.Inv-64 (4.18 g, 75%) was obtained in the same manner as in Synthesis Example 3, except that IC-21 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665.26 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665.26 g / mol)
[[ 합성예Synthetic example 65] 65] InvInv -65의 합성Synthesis of -65
IC-1과 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine 대신 IC-21과 2,4-di(biphenyl-3-yl)-6-(3-chlorophenyl)-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-65 (5.07 g, 74 %)를 얻었다.IC-1 and 2,4-di (biphenyl-3-yl) -6- (3-chlorophenyl) -4,6-diphenyl- -1,3,5-triazine, the procedure of Synthetic Example 3 was repeated to give the target compound Inv-65 (5.07 g, 74%).
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (theory: 817.32 g / mol, measured: 817 g / mol)
[[ 합성예Synthetic example 66] 66] InvInv -66의 합성Synthesis of -66
IC-1 대신 IC-22를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-66 (4.01 g, 72 %)를 얻었다.Inv-66 (4.01 g, 72%) was obtained in the same manner as in Synthesis Example 3, except that IC-22 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 67] 67] InvInv -67의 합성Synthesis of -67
IC-1과 3-bromobiphenyl 대신 IC-22과 2-(3-bromophenyl)-4,6-diphenylpyrimidine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-67 (2.84 g, 51 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-22 and 2- (3-bromophenyl) -4,6-diphenylpyrimidine were used instead of IC-1 and 3-bromobiphenyl, g, 51%).
GC-Mass (이론치: 664.26 g/mol, 측정치: 664 g/mol)GC-Mass (calculated: 664.26 g / mol, measured: 664 g / mol)
[[ 합성예Synthetic example 68] 68] InvInv -68의 합성Synthesis of -68
IC-1 대신 IC-23을 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-68 (3.74 g, 73 %)를 얻었다.Inv-68 (3.74 g, 73%) was obtained in the same manner as in Synthesis Example 3, except that IC-23 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 69] 69] InvInv -69의 합성Synthesis of -69
IC-1과 3-bromobiphenyl 대신 IC-23을 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-69 (2.71 g, 48 %)를 얻었다.The same procedure as in Synthesis Example 1 was carried out except that IC-23 was used instead of IC-1 and 3-bromobiphenyl and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5- To obtain the target compound Inv-69 (2.71 g, 48%).
GC-Mass (이론치: 817.32 g/mol, 측정치: 817 g/mol)GC-Mass (theory: 817.32 g / mol, measured: 817 g / mol)
[[ 합성예Synthetic example 70] 70] InvInv -70의 합성Synthesis of -70
IC-1과 3-bromobiphenyl 대신 IC-24와 2-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-70 (2.07 g, 51 %)를 얻었다.Inv-70 (2.07 g, 51%) was prepared in the same manner as in Synthesis Example 1, except that IC-24 and 2- (4-bromophenyl) pyridine were used instead of IC-1 and 3-bromobiphenyl. .
GC-Mass (이론치: 587.24 g/mol, 측정치: 587 g/mol)GC-Mass (calculated: 587.24 g / mol, measured: 587 g / mol)
[[ 합성예Synthetic example 71] 71] InvInv -71의 합성Synthesis of -71
IC-1 대신 IC-24를 사용하는 것을 제외하고는 상기 합성예 3과 동일한 과정을 수행하여 목적 화합물인 Inv-71 (4.00 g, 78 %)를 얻었다.Inv-71 (4.00 g, 78%) was obtained in the same manner as in Synthesis Example 3, except that IC-24 was used instead of IC-1.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 72] 72] InvInv -72의 합성Synthesis of -72
IC-1과 3-bromobiphenyl 대신 IC-25와 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-72 (1.83 g, 53 %)를 얻었다.Inv-72 (1.83 g, 53%) was obtained in the same manner as in Synthesis Example 1 except that IC-25 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 73] 73] InvInv -73의 합성Synthesis of -73
IC-1과 3-bromobiphenyl 대신 IC-25와 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-73 (2.25 g, 52 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-25 and 1-bromo-3,5-diphenyl benzene were used instead of IC-1 and 3-bromobiphenyl to obtain the desired compound Inv-73 (2.25 g, 52 %).
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 74] 74] InvInv -74의 합성Synthesis of -74
IC-1 대신 IC-25를 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-74 (1.91 g, 49 %)를 얻었다.Inv-74 (1.91 g, 49%) was obtained in the same manner as in Synthesis Example 1, except that IC-25 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)
GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 75] 75] InvInv -75의 합성Synthesis of -75
IC-1과 3-bromobiphenyl 대신 IC-26과 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-75 (1.55 g, 45 %)를 얻었다.Inv-75 (1.55 g, 45%) was obtained in the same manner as in Synthesis Example 1 except that IC-26 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)
[[ 합성예Synthetic example 76] 76] InvInv -76의 합성Synthesis of -76
IC-1과 3-bromobiphenyl 대신 IC-26과 4-(4-bromophenyl)pyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-76 (1.83 g, 47 %)를 얻었다.Inv-76 (1.83 g, 47%) was obtained in the same manner as in Synthesis Example 1, except that IC-26 and 4- (4-bromophenyl) pyridine were used instead of IC-1 and 3-bromobiphenyl. .
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 77] 77] InvInv -77의 합성Synthesis of -77
IC-1과 3-bromobiphenyl 대신 IC-27과 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-77 (1.48 g, 43 %)를 얻었다.Inv-77 (1.48 g, 43%) was obtained in the same manner as in Synthesis Example 1, except that IC-27 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 589.23 g/mol, 측정치: 589 g/mol)GC-Mass (calculated: 589.23 g / mol, measured: 589 g / mol)
[[ 합성예Synthetic example 78] 78] InvInv -78의 합성Synthesis of -78
IC-1 대신 IC-27을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-78 (1.87 g, 48 %)를 얻었다.Inv-78 (1.87 g, 48%) was obtained by carrying out the same procedure as in Synthesis Example 1, except that IC-27 was used instead of IC-1.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665 g / mol)
[[ 합성예Synthetic example 79] 79] InvInv -79의 합성Synthesis of -79
IC-1 과 3-bromobiphenyl 대신 IC-27과 4-bromobiphenyl을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-79 (1.75 g, 45 %)를 얻었다.Inv-79 (1.75 g, 45%) was obtained in the same manner as in Synthesis Example 1 except that IC-27 and 4-bromobiphenyl were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 665.26 g/mol, 측정치: 665.26 g/mol)GC-Mass (calculated: 665.26 g / mol, measured: 665.26 g / mol)
[[ 합성예Synthetic example 80] 80] InvInv -80의 합성Synthesis of -80
IC-1 과 3-bromobiphenyl 대신 IC-27과 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-80 (2.12 g, 49 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-27 and 1-bromo-3,5-diphenyl benzene were used instead of IC-1 and 3-bromobiphenyl to obtain the desired compound Inv-80 (2.12 g, 49 %).
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 81] 81] InvInv -81의 합성Synthesis of -81
IC-1 과 3-bromobiphenyl 대신 IC-28과 iodobenzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-81 (1.79 g, 52 %)를 얻었다.Inv-81 (1.79 g, 52%) was obtained in the same manner as in Synthesis Example 1 except that IC-28 and iodobenzene were used instead of IC-1 and 3-bromobiphenyl.
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)
[[ 합성예Synthetic example 82] 82] InvInv -82의 합성Synthesis of -82
IC-1 과 3-bromobiphenyl 대신 IC-28과 1-bromo-3,5-diphenyl benzene을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-82 (1.99 g, 46 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-28 and 1-bromo-3,5-diphenyl benzene were used instead of IC-1 and 3-bromobiphenyl to obtain the desired compound Inv-82 (1.99 g, 46 %).
GC-Mass (이론치: 740.29 g/mol, 측정치: 740 g/mol)GC-Mass (calculated: 740.29 g / mol, measured: 740 g / mol)
[[ 합성예Synthetic example 83] 83] InvInv -83의 합성Synthesis of -83
IC-1 과 3-bromobiphenyl 대신 IC-14와 2-(5-bromobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-83 (3.54 g, 57 %)를 얻었다.Except that IC-14 and 2- (5-bromobiphenyl-3-yl) -4,6-diphenyl-1,3,5-triazine were used instead of IC-1 and 3-bromobiphenyl in Synthesis Example 1 (Inv-83, 3.54 g, 57%) was obtained.
GC-Mass (이론치: 741.29 g/mol, 측정치: 741 g/mol)GC-Mass (741.29 g / mol, measured: 741 g / mol)
[[ 합성예Synthetic example 84] 84] InvInv -84의 합성Synthesis of -84
IC-1과 3-bromobiphenyl 대신 IC-20과 2,2'-(5-bromo-1,3-phenylene)dipyridine을 사용하는 것을 제외하고는 상기 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-84 (2.61 g, 53 %)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-20 and 2,2 '- (5-bromo-1,3-phenylene) dipyridine were used instead of IC-1 and 3-bromobiphenyl, -84 (2.61 g, 53%).
GC-Mass (이론치: 588.23 g/mol, 측정치: 588 g/mol)GC-Mass (calculated: 588.23 g / mol, measured: 588 g / mol)
[[ 합성예Synthetic example 85] 85] InvInv -85의 합성Synthesis of -85
질소 기류 하에서 IC-29a (2.23 g, 10.0 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (3.21 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) 및 DMF(30 ml)를 혼합하고 상온에서 3시간 동안 교반하였다. 반응이 종결된 후 물을 넣고 고체 화합물을 filter한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 Inv-85 (3.77 g, yield : 83%)를 얻었다.(2.23 g, 10.0 mmol), 2-chloro-4,6-diphenyl-1,3,5-triazine (3.21 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) and DMF 30 ml) were mixed and stirred at room temperature for 3 hours. After completion of the reaction, water was added thereto, and the solid compound was filtered and purified by column chromatography to obtain the target compound Inv-85 (3.77 g, yield: 83%).
GC-Mass (이론치: 454.55 g/mol, 측정치: 454 g/mol)GC-Mass (theory: 454.55 g / mol, measured: 454 g / mol)
[[ 합성예Synthetic example 86] 86] InvInv -86의 합성Synthesis of -86
질소 기류 하에서 IC-29a (2.23 g, 10.0 mmol), 2-(4-bromophenyl)-4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) 및 DMF(30 ml)를 혼합하고 상온에서 3시간 동안 교반하였다. 반응이 종결된 후 물을 넣고 고체 화합물을 filter한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 Inv-86 (3.45 g, yield : 65%)을 얻었다.(2.26 g, 10.0 mmol), 2- (4-bromophenyl) -4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH ) And DMF (30 ml) were mixed and stirred at room temperature for 3 hours. After the reaction was completed, water was added and the solid compound was filtered and purified by column chromatography to obtain the target compound Inv-86 (3.45 g, yield: 65%).
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (calculated: 530.64 g / mol, measured: 530 g / mol)
[[ 합성예Synthetic example 87] 87] InvInv -87의 합성Synthesis of -87
질소 기류 하에서 IC-29a (2.23 g, 10.0 mmol), 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH (0.29 g, 12.0 mmol) 및 DMF(30 ml)를 혼합하고 상온에서 3시간 동안 교반하였다. 반응이 종결된 후 물을 넣고 고체 화합물을 filter한 후, 컬럼 크로마토그래피로 정제하여 목적 화합물인 Inv-87 (3.77 g, yield : 71%)을 얻었다.(2.26 g, 10.0 mmol), 2- (3-bromophenyl) -4,6-diphenyl-1,3,5-triazine (4.66 g, 12.0 mmol), NaH ) And DMF (30 ml) were mixed and stirred at room temperature for 3 hours. After completion of the reaction, water was added thereto, and the solid compound was filtered and purified by column chromatography to obtain the target compound Inv-87 (3.77 g, yield: 71%).
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (calculated: 530.64 g / mol, measured: 530 g / mol)
[[ 합성예Synthetic example 88] 88] InvInv -88의 합성Synthesis of -88
IC-29a 대신 IC-29b (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-88 (3.45 g, yield : 65%)을 얻었다.Inv-88 (3.45 g, yield: 65%) was obtained by following the same procedure as in Synthesis Example 87 except that IC-29b (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (calculated: 530.64 g / mol, measured: 530 g / mol)
[[ 합성예Synthetic example 89] 89] InvInv -89의 합성Synthesis of -89
IC-29a 대신 IC-30 (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-89 (3.33 g, yield : 63%)을 얻었다.Inv-89 (3.33 g, yield: 63%) was obtained by following the same procedure as Synthesis Example 87, except that IC-30 (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (calculated: 530.64 g / mol, measured: 530 g / mol)
[[ 합성예Synthetic example 90] 90] InvInv -90의 합성Synthesis of -90
IC-29a 대신 IC-31a (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-90 (3.18 g, yield : 60%)을 얻었다.Inv-90 (3.18 g, yield: 60%) was obtained by following the same procedure as in Synthesis Example 87 except that IC-31a (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (calculated: 530.64 g / mol, measured: 530 g / mol)
[[ 합성예Synthetic example 91] 91] InvInv -91의 합성Synthesis of -91
IC-29a 대신 IC-31b (2.23 g, 10.0 mmol)를 사용하는 것을 제외하고는 합성예 87과 동일한 과정을 수행하여 Inv-91 (3.28 g, yield : 62%)을 얻었다.Inv-91 (3.28 g, yield: 62%) was obtained by following the same procedure as in Synthesis Example 87 except that IC-31b (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (calculated: 530.64 g / mol, measured: 530 g / mol)
[[ 합성예Synthetic example 92] 92] InvInv -92의 합성Synthesis of -92
IC-29a 대신 IC-32 (2.23 g, 10.0 mmol)을 사용하는 것을 제외하고는 합성예 87와 동일한 과정을 수행하여 Inv-92 (3.50 g, yield : 77%)을 얻었다.Inv-92 (3.50 g, yield: 77%) was obtained by following the same procedure as in Synthesis Example 87 except that IC-32 (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 454.55 g/mol, 측정치: 454 g/mol)GC-Mass (theory: 454.55 g / mol, measured: 454 g / mol)
[[ 합성예Synthetic example 93] 93] InvInv -93의 합성Synthesis of -93
IC-1 대신 IC-33을 사용하고 2-bromo-4,6-diphenylpyridine 대신 1-bromo-4-phenylisoquinoline을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-93(3.26 g, 수율 58%)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-33 was used instead of IC-1 and 1-bromo-4-phenylisoquinoline was used instead of 2-bromo-4,6-diphenylpyridine. 3.26 g, yield: 58%).
GC-Mass (이론치: 436.19 g/mol, 측정치: 436 g/mol)GC-Mass (calculated: 436.19 g / mol, measured: 436 g / mol)
[[ 합성예Synthetic example 94] 94] InvInv -94의 합성Synthesis of -94
IC-1 대신 IC-34을 사용하고 2-bromo-4,6-diphenylpyridine 대신 4-bromo-2,6-diphenylpyridine을 사용하는 것을 제외하고는 합성예 1과 동일한 과정을 수행하여 목적 화합물인 Inv-94(3.11 g, 수율 63%)를 얻었다.The procedure of Synthesis Example 1 was repeated except that IC-34 was used instead of IC-1 and 4-bromo-2,6-diphenylpyridine was used instead of 2-bromo-4,6-diphenylpyridine. 94 (3.11 g, yield 63%).
GC-Mass (이론치: 586.24 g/mol, 측정치: 586 g/mol)GC-Mass (calculated: 586.24 g / mol, measured: 586 g / mol)
[[ 합성예Synthetic example 95] 95] InvInv -- 95 의95's 합성 synthesis
IC-29a 대신 IC-35 (2.23 g, 10.0 mmol)을 사용하는 것을 제외하고는 합성예 87와 동일한 과정을 수행하여 목적 화합물인 Inv-95 (3.40 g, yield : 64%)를 얻었다.Inv-95 (3.40 g, yield: 64%) was obtained by carrying out the same procedure as in Synthesis Example 87 except that IC-35 (2.23 g, 10.0 mmol) was used instead of IC-29a.
GC-Mass (이론치: 530.64 g/mol, 측정치: 530 g/mol)GC-Mass (calculated: 530.64 g / mol, measured: 530 g / mol)
[[ 합성예Synthetic example 96] 96] InvInv -96의 합성Synthesis of -96
질소 기류 하에서 IC-36 (3 g, 14.48 mmol), 2-(3-chlorophenyl)-4,6-diphenyl-1,3,5-triazine (5.97 g, 17.37 mmol), Pd(OAc)2 (0.16 g, 5 mol%), NaO(t-bu) (2.78 g, 28.95 mmol), P(t-bu)3 (0.29 g, 1.45 mmol) 및 Toluene (100 ml)을 혼합하고 110℃에서 12시간 동안 교반하였다.(5.97 g, 17.37 mmol), Pd (OAc) 2 (0.16 g, 17.37 mmol), IC-36 (3 g, 14.48 mmol) (2.78 g, 28.95 mmol), P (t-bu) 3 (0.29 g, 1.45 mmol) and Toluene (100 ml) were mixed and heated at 110 ° C. for 12 hours Lt; / RTI >
반응이 종결된 후 에틸아세테이트로 추출한 다음 MgSO4로 수분을 제거하고, 컬럼크로마토그래피 (Hexane:EA = 2:1 (v/v))로 정제하여 Inv-96 (5.59 g, 수율 75 %)을 얻었다. After the reaction was completed, the reaction mixture was extracted with ethyl acetate, the water was removed with MgSO 4 and purified by column chromatography (Hexane: EA = 2: 1 (v / v)) to obtain Inv-96 (5.59 g, yield 75% .
GC-Mass (이론치: 514.18 g/mol, 측정치: 514 g/mol)GC-Mass (calculated: 514.18 g / mol, measured: 514 g / mol)
[[ 합성예Synthetic example 97] 97] InvInv -97의 합성Synthesis of -97
IC-36 대신 IC-37을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-97 (5.29 g, 71 %)를 얻었다.Inv-97 (5.29 g, 71%) was obtained in the same manner as in Synthesis Example 96 except that IC-37 was used instead of IC-36.
GC-Mass (이론치: 514.18 g/mol, 측정치: 514 g/mol)GC-Mass (calculated: 514.18 g / mol, measured: 514 g / mol)
[[ 합성예Synthetic example 98] 98] InvInv -98의 합성Synthesis of -98
IC-36 대신 IC-38을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-98(5.44 g, 73 %)를 얻었다.Inv-98 (5.44 g, 73%) was obtained in the same manner as in Synthesis Example 96 except that IC-38 was used instead of IC-36.
GC-Mass (이론치: 514.18 g/mol, 측정치: 514 g/mol)GC-Mass (calculated: 514.18 g / mol, measured: 514 g / mol)
[[ 합성예Synthetic example 99] 99] InvInv -99의 합성Synthesis of -99
IC-36 대신 IC-39을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-99(4.62 g, 69 %)를 얻었다.Inv-99 (4.62 g, 69%) was obtained in the same manner as in Synthesis Example 96, except that IC-39 was used instead of IC-36.
GC-Mass (이론치: 556.21 g/mol, 측정치: 556 g/mol)GC-Mass (calculated: 556.21 g / mol, measured: 556 g / mol)
[[ 합성예Synthetic example 100] 100] InvInv -100의 합성Synthesis of -100
IC-36 대신 IC-40을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-100 (3.66 g, 67 %)를 얻었다.Inv-100 (3.66 g, 67%) was obtained in the same manner as in Synthesis Example 96 except that IC-40 was used instead of IC-36.
GC-Mass (이론치: 680.24 g/mol, 측정치: 680 g/mol)GC-Mass (calculated: 680.24 g / mol, measured: 680 g / mol)
[[ 합성예Synthetic example 101] 101] InvInv -101의 합성Synthesis of -101
IC-36 대신 IC-41을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-101(4.87 g, 76 %)를 얻었다.Inv-101 (4.87 g, 76%) was obtained in the same manner as in Synthesis Example 96 except that IC-41 was used instead of IC-36.
GC-Mass (이론치: 578.10 g/mol, 측정치: 578 g/mol)GC-Mass (calculated: 578.10 g / mol, measured: 578 g / mol)
[[ 합성예Synthetic example 102] 102] InvInv -102의 합성Synthesis of -102
IC-36 대신 IC-42을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-102(4.75 g, 74 %)를 얻었다.Inv-102 (4.75 g, 74%) was obtained in the same manner as in Synthesis Example 96, except that IC-42 was used instead of IC-36.
GC-Mass (이론치: 578.10 g/mol, 측정치: 578 g/mol)GC-Mass (calculated: 578.10 g / mol, measured: 578 g / mol)
[[ 합성예Synthetic example 103] 103] InvInv -103의 합성Synthesis of -103
IC-36 대신 IC-43을 사용하는 것을 제외하고는 상기 합성예 96과 동일한 과정을 수행하여 목적 화합물인 Inv-103 (4.68 g, 73 %)를 얻었다.Inv-103 (4.68 g, 73%) was obtained in the same manner as in Synthesis Example 96 except that IC-43 was used instead of IC-36.
GC-Mass (이론치: 578.10 g/mol, 측정치: 578 g/mol)GC-Mass (calculated: 578.10 g / mol, measured: 578 g / mol)
[[ 합성예Synthetic example 104] 104] InvInv -104의 합성Synthesis of -104
질소 기류 하에서 IC-1 (10g, 35.44 mmol), 2-chloro-4-phenylquinazoline (10.2 g, 42.53 mmol), Cu powder (0.22 g, 3.544 mmol), K2CO3 (9.8 g, 70.88mmol), Na2SO4 (10 g, 70.88 mmol), nitrobenzene (350ml)를 혼합하고 190℃에서 12시간 동안 교반하였다.2-chloro-4-phenylquinazoline (10.2 g, 42.53 mmol), Cu powder (0.22 g, 3.544 mmol), K 2 CO 3 (9.8 g, 70.88 mmol) Na 2 SO 4 (10 g, 70.88 mmol) and nitrobenzene (350 ml) were mixed and stirred at 190 ° C for 12 hours.
반응 종결 후 nitrobenzene을 제거하고 메틸렌클로라이드로 유기층을 분리하여 MgSO4를 사용하여 물을 제거하였다. 물이 제거된 유기층에서 용매를 제거한 후 컬럼 크로마토그래피 (Hexane:MC = 3:1 (v/v))로 정제하여 Inv-104 (8.6 g, 수율 50%)을 얻었다.After completion of the reaction, the nitrobenzene was removed. The organic layer was separated with methylene chloride, and water was removed using MgSO 4 . The solvent was removed from the organic layer from which water had been removed and then purified by column chromatography (Hexane: MC = 3: 1 (v / v)) to obtain Inv-104 (8.6 g, yield 50%).
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol)GC-Mass (calculated: 486.18 g / mol, measured: 486 g / mol)
[[ 합성예Synthetic example 105] 105] InvInv -105의 합성Synthesis of -105
2-chloro-4-phenylquinazoline 대신 2-chloro-4-(4-(naphthalen-1-yl)phenyl)quinazoline 를 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-105을 얻었다.Inv-105 was obtained in the same manner as in Synthesis Example 104 except that 2-chloro-4- (4- (naphthalen-1-yl) phenyl) quinazoline was used in place of 2-chloro-4-phenylquinazoline.
GC-Mass (이론치: 612.23 g/mol, 측정치: 612 g/mol)GC-Mass (calculated: 612.23 g / mol, measured: 612 g / mol)
[[ 합성예Synthetic example 106] 106] InvInv -106의 합성Synthesis of -106
IC-1 대신 IC-2를 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-106을 얻었다.Inv-106 was obtained in the same manner as in Synthesis Example 104 except that IC-2 was used instead of IC-1.
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol) GC-Mass (calculated: 486.18 g / mol, measured: 486 g / mol)
[[ 합성예Synthetic example 107] 107] InvInv -107의 합성Synthesis of -107
IC-1 대신 IC-4를 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-107를 얻었다.Inv-107 was obtained in the same manner as in Synthesis Example 104 except that IC-4 was used instead of IC-1.
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol) GC-Mass (calculated: 486.18 g / mol, measured: 486 g / mol)
[[ 합성예Synthetic example 108] 108] InvInv -108의 합성Synthesis of -108
IC-1 대신 IC-5를 사용한 것을 제외하고는 상기 합성예 104와 동일한 과정을 수행하여 Inv-108 를 얻었다.Inv-108 was obtained in the same manner as in Synthesis Example 104 except that IC-5 was used instead of IC-1.
GC-Mass (이론치: 486.18 g/mol, 측정치: 486 g/mol) GC-Mass (calculated: 486.18 g / mol, measured: 486 g / mol)
[[ 합성예Synthetic example 109] 화합물 1의 합성 109] Synthesis of compound 1
<단계 1> 2,5-<Step 1> 2,5- DiphenylpyridineDiphenylpyridine 의 합성Synthesis of
질소 기류 하에서 23.70 g (0.1 mol)의 2,5-dibromopyridine, 30.48 g (0.25 mol)의 phenylboronic acid, 41.46 g (0.3 mol)의 무수 K2CO3와 800 ml/300 ml의 toluene/H2O를 넣고 교반하였다. 40℃에서 5.78 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 2,5-Diphenylpyridine (L1) 19.20 g (yield: 83 %)을 얻었다.A mixture of 23.70 g (0.1 mol) of 2,5-dibromopyridine, 30.48 g (0.25 mol) of phenylboronic acid, 41.46 g (0.3 mol) of anhydrous K 2 CO 3 and 800 ml / 300 ml of toluene / H 2 O And the mixture was stirred. At 40 ℃ into the Pd (PPh 3) 4 of 5.78 g (5 mol%) was stirred at 80 ℃ for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 19.20 g (yield: 83%) of 2,5-diphenylpyridine (L1) was obtained by column chromatography.
<단계 2> 2,5-≪ Step 2 > DiphenylpyridinatoDiphenylpyridinato iridiumiridium dimerdimer 의 합성Synthesis of
질소 기류 하에서 5.0 g (13.8 mmol)의 IrCl3·xH2O와 상기 L1(9.6 g, 41.4 mmol)을 120 ml의 2-methoxyethanol과 40 ml의 물 혼합용매에 넣어 20 시간 동안 환류시켰다. 반응혼합물을 실온까지 온도를 내린 후 생성된 침전물을 여과하고 아세톤과 에탄올 1:1 비율의 용매로 생성물을 정제하여 D1 (9.31 g, 수율 98 %)을 얻었다.5.0 g (13.8 mmol) of IrCl 3 .xH 2 O and L1 (9.6 g, 41.4 mmol) were refluxed in a mixed solvent of 120 ml of 2-methoxyethanol and 40 ml of water under a nitrogen stream for 20 hours. The reaction mixture was cooled to room temperature, and the resulting precipitate was filtered, and the product was purified with a solvent mixture of acetone and ethanol in a ratio of 1: 1 to obtain D1 (9.31 g, yield 98%).
<단계 3> 용매 ≪ Step 3 > 배위Coordination 양이온성Cationic 중간체의 합성 Synthesis of intermediates
상기 D1 (8.0 g, 5.81 mmol)과 AgPF6 (3.67 g, 14.53 mmol)을 메틸렌클로라이드 300 ml와 메탄올 100 ml의 혼합용매에 넣어주고 질소 기류하에서 6시간동안 실온에서 교반시킨다. 반응 혼합물을 셀라이트를 통과시켜 AgCl를 제거하고 여액을 감압 증류하여 90 % 정도의 용매를 제거한 다음 추가로 에틸에테르와 헥산을 넣어주어 목적하는 중간체 화합물 I1 (8.62 g, 수율 86 %)을 분리하였다. The D1 (8.0 g, 5.81 mmol) and AgPF 6 (3.67 g, 14.53 mmol) were added to a mixed solvent of methylene chloride (300 ml) and methanol (100 ml), and the mixture was stirred at room temperature for 6 hours in a nitrogen stream. The reaction mixture was passed through Celite to remove AgCl and the filtrate was distilled under reduced pressure to remove about 90% of the solvent. Then, ethyl ether and hexane were further added to obtain the desired intermediate compound I1 (8.62 g, yield 86%) .
<단계 4> 화합물 1의 합성<Step 4> Synthesis of Compound 1
상기 중간체 화합물 I1 (8.62 g, 10.0 mmol)와 L1 (6.94 g, 30 mmol)을 300 ml의 에탄올에 넣어 20시간 동안 질소 대기 하에서 환류시켰다. 반응이 종결된 후 여과하여 얻어진 침전물을 컬럼 크로마토그래피로 정제하여 목적 화합물인 compound 1 (8.12 g, 수율 92 %)을 얻었다.The intermediate compound I1 (8.62 g, 10.0 mmol) and L1 (6.94 g, 30 mmol) were refluxed in 300 ml of ethanol under a nitrogen atmosphere for 20 hours. After completion of the reaction, the precipitate obtained by filtration was purified by column chromatography to obtain the target compound compound 1 (8.12 g, yield 92%).
GC-Mass (이론치: 883.07 g/mol, 측정치: 883 g/mol)GC-Mass (calculated: 883.07 g / mol, measured: 883 g / mol)
[[ 합성예Synthetic example 110] 화합물 9의 합성 110] Synthesis of Compound 9
<단계 1> 2-<Step 1> 2- phenylpyridine페닐 피딘 의 합성Synthesis of
2,5-dibromopyridine 대신 2-bromopyridine을 사용한 것을 제외하고 상기 합성예 104의 <단계 1과> 동일한 방법을 이용하여 L2 (13.2 g, 수율 85 %)를 얻었다.L2 (13.2 g, yield 85%) was obtained in the same manner as in <Step 1> of the synthesis example 104 except that 2-bromopyridine was used in place of 2,5-dibromopyridine.
<단계 2> 2- ≪ Step 2 > 2- phenylpyridinatophenylpyridinato iridiumiridium dimerdimer 의 합성Synthesis of
L1 대신 상기 L2을 사용한 것을 제외하고 상기 합성예 104의 <단계 2>와 동일한 방법을 이용하여 D2 (7.59 g, 수율 92 %)를 얻었다.D2 (7.59 g, yield 92%) was obtained in the same manner as in <Step 2> of Preparation Example 104, except that the above-mentioned L2 was used instead of L1.
<단계 3> 용매 ≪ Step 3 > 배위Coordination 양이온성Cationic 중간체의 합성 Synthesis of intermediates
D1 대신 상기 D2를 사용한 것을 제외하고 상기 합성예 104의 <단계 3>과 동일한 방법을 이용하여 중간체 화합물 I2 (6.28 g, 수율 85 %)를 얻었다.Intermediate compound I2 (6.28 g, yield 85%) was obtained in the same manner as in <Step 3> of Preparation Example 104 except that D2 was used instead of D1.
<단계 4> 화합물 9의 합성<Step 4> Synthesis of Compound 9
I1 대신 상기 I2를 사용한 것을 제외하고 상기 합성예의 <단계 4>와 동일한 방법을 이용하여 목적 화합물인 compound 9 (6.07 g, 수율 83 %)를 얻었다.Compound 9 (6.07 g, yield 83%) was obtained in the same manner as in <Step 4> of the above Synthesis Example except that I2 was used instead of I1.
GC-Mass (이론치: 730.88 g/mol, 측정치:731 g/mol)GC-Mass (calculated: 730.88 g / mol, measured: 731 g / mol)
[[ 합성예Synthetic example 111] 화합물 149의 제조 111] Preparation of Compound 149
<단계 1> 2-<Step 1> 2- biphenylbiphenyl -3--3- ylyl -- pyridine피리딘 의 합성Synthesis of
phenylboronic acid 대신 3-biphenylboronic acid를 사용한 것을 제외하고 상기 합성예 105의 <단계 1>과 동일한 방법을 이용하여 L3 (20.59 g, 수율 89 %)를 얻었다.L3 (20.59 g, yield 89%) was obtained in the same manner as in <Step 1> of Preparation Example 105, except that 3-biphenylboronic acid was used in place of phenylboronic acid.
<단계 2> 화합물 149의 합성<Step 2> Synthesis of Compound 149
질소 기류 하에서 5.0 g (10.0 mmol)의 Ir(acac)3와 상기 L3 (6.94 g, 30.0 mmol)을 glycerol 30 ml에 넣고 24 시간 동안 환류시켰다. 반응이 종결된 후 여과하여 얻어진 침전물을 컬럼 크로마토그래피로 정제하여 목적 화합물인 compound 149 (2.47 g, 수율 28 %)을 얻었다.5.0 g (10.0 mmol) of Ir (acac) 3 and L3 (6.94 g, 30.0 mmol) were added to glycerol (30 ml) under a nitrogen stream and refluxed for 24 hours. After completion of the reaction, the precipitate obtained by filtration was purified by column chromatography to obtain the target compound compound 149 (2.47 g, 28% yield).
GC-Mass (이론치: 883.07 g/mol, 측정치: 883 g/mol)GC-Mass (calculated: 883.07 g / mol, measured: 883 g / mol)
[[ 합성예Synthetic example 112] 화합물 164의 합성 112] Synthesis of Compound 164
<단계 1> 2-<Step 1> 2- phenylquinolinephenylquinoline 의 합성Synthesis of
질소 기류 하에서 20.8 g (0.1 mol)의 2-bromoquinoline, 14.63 g (0.12 mol)의 phenylboronic acid, 41.46 g (0.3 mol)의 무수 K2CO3와 800 ml/300 ml의 toluene/H2O를 넣고 교반하였다. 40℃에서 5.78 g (5 mol%)의 Pd(PPh3)4를 넣고 80℃에서 12시간 동안 교반하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 2-phenylquinoline (L4) 16.40 g (yield: 80 %)을 얻었다.Insert the 20.8 g (0.1 mol) 2- bromoquinoline, 14.63 g (0.12 mol) phenylboronic acid, 41.46 g (0.3 mol) of anhydrous K 2 CO 3 and toluene / H 2 O in 800 ml / 300 ml of the under nitrogen gas stream, Lt; / RTI > At 40 ℃ into the Pd (PPh 3) 4 of 5.78 g (5 mol%) was stirred at 80 ℃ for 12 hours. After completion of the reaction, the reaction mixture was extracted with methylene chloride, and the mixture was filtered with MgSO 4 . After removing the solvent of the filtered organic layer, 16.40 g (yield: 80%) of 2-phenylquinoline (L4) was obtained by column chromatography.
<단계 2> 2-≪ Step 2 > 2- phenylquinolinatophenylquinolinato iridiumiridium dimerdimer 의 합성Synthesis of
질소 기류 하에서 5.0 g (13.8 mmol)의 IrCl3·xH2O와 상기 L4 (8.49 g, 41.4 mmol)을 120 ml의 2-methoxyethanol과 40 ml의 물 혼합용매에 넣어 20 시간 동안 환류시켰다. 반응혼합물을 실온까지 온도를 내린 후 생성된 침전물을 여과하고 아세톤과 에탄올 1:1 비율의 용매로 생성물을 정제하여 D4 (8.49 g, 수율 95 %)을 얻었다.5.0 g (13.8 mmol) of IrCl 3 .xH 2 O and L4 (8.49 g, 41.4 mmol) were refluxed in a mixed solvent of 120 ml of 2-methoxyethanol and 40 ml of water under a nitrogen stream for 20 hours. The reaction mixture was cooled to room temperature, and the resulting precipitate was filtered, and the product was purified with a solvent mixture of acetone and ethanol at a ratio of 1: 1 to obtain D4 (8.49 g, yield 95%).
<단계 3> 화합물 164의 합성<Step 3> Synthesis of Compound 164
상기 D4 (5.01 g, 5.81 mmol)과 2,4-pentanedione (1.74 g, 17.4 mmol ), 무수 Na2CO3(4.82 g, 34.86 mol)을 120 ml의 2-ethoxyethanol에 넣어 환류시켰다. 반응혼합물을 실온까지 온도를 내린 후 생성된 침전물을 여과하고, 컬럼 크로마토그래피로 분리, 재결정하여 목적물인 compound 164 (2.64 g, 수율 92 %)을 얻었다.The D4 (5.01 g, 5.81 mmol), 2,4-pentanedione (1.74 g, 17.4 mmol) and anhydrous Na 2 CO 3 (4.82 g, 34.86 mol) were added to 120 ml of 2-ethoxyethanol and refluxed. The reaction mixture was cooled to room temperature, and the resulting precipitate was filtered and separated by column chromatography to obtain recrystallized compound 164 as a target compound (2.64 g, yield 92%).
GC-Mass (이론치: 496.09 g/mol, 측정치: 496 g/mol)
GC-Mass (calculated: 496.09 g / mol, measured: 496 g / mol)
[[ 실시예Example 1 ~ 103] 유기 1 ~ 103] Organic 전계Field 발광 소자의 제작 Fabrication of light emitting device
합성예 1-103에서 합성한 화합물 Inv-1 ~ Inv-103 및 합성예 109의 compound 1을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 전계 발광 소자를 제작하였다.The compound 1 of Inv-1 to Inv-103 synthesized in Synthesis Example 1-103 and the compound 1 of Synthesis Example 109 were subjected to high purity sublimation purification by a conventionally known method, and then a green organic electroluminescent device was fabricated according to the following procedure.
먼저, ITO (Indium tin oxide)가 1500 Å두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, glass substrate coated with ITO (Indium tin oxide) thin film of 1500 Å thickness was cleaned with distilled water ultrasonic wave. After the distilled water was washed, the substrate was ultrasonically washed with a solvent such as isopropyl alcohol, acetone, or methanol, dried and transferred to a UV OZONE cleaner (Power Sonic 405, Hoshin Tech), the substrate was cleaned using UV for 5 minutes, The substrate was transferred.
이렇게 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/Inv-1 ~ Inv-103의 각각의 화합물(90%) + 합성예 109의 화합물 1(10%) (300nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제작하였다.
Each compound (90%) of m-MTDATA (60 nm) / TCTA (80 nm) / Inv-1 to Inv-103 + Compound 1 (10%) (300 nm) / Alq 3 (30 nm) / LiF (1 nm) / Al (200 nm) were stacked in this order to fabricate an organic electroluminescent device.
[[ 실시예Example 104 ~ 114] 유기 104 ~ 114] Organic 전계Field 발광 소자의 제작 Fabrication of light emitting device
발광층 형성시 발광 호스트 물질로서 화합물 Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv-31, Inv-87을, 발광 도펀트 물질로서 합성예 110의 compound 9를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제작하였다.
Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv- 87 was prepared in the same manner as in Example 1, except that compound 9 of Synthesis Example 110 was used as the luminescent dopant material, thereby preparing a green organic electroluminescent device.
[[ 실시예Example 115 ~ 125] 유기 115 ~ 125] Organic 전계Field 발광 소자의 제작 Fabrication of light emitting device
발광층 형성시 발광 호스트 물질로서 화합물 Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv-31, Inv-87을, 발광 도펀트 물질로서 합성예 111의 compound 149를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제작하였다.
Inv-3, Inv-5, Inv-6, Inv-7, Inv-8, Inv-18, Inv-21, Inv-23, Inv-30, Inv- A green organic electroluminescent device was fabricated in the same manner as in Example 1 except that the compound 149 of Synthesis Example 111 was used as the luminescent dopant material.
[[ 실시예Example 126 ~ 131] 유기 126 ~ 131] Organic 전계Field 발광 소자의 제작 Fabrication of light emitting device
발광층 형성시 발광 호스트 물질로서 화합물 Inv-18, Inv-104, Inv-105, Inv-106, Inv-107, Inv-108을, 발광 도펀트 물질로서 합성예 112의 compound 164를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제작하였다.
Except that compound Inv-18, Inv-104, Inv-105, Inv-106, Inv-107 and Inv-108 were used as the luminescent host material in the formation of the light emitting layer and compound 164 of Synthesis Example 112 was used as the luminescent dopant substance A green organic electroluminescent device was fabricated in the same manner as in Example 1.
[[ 비교예Comparative Example 1] 유기 1] Organic 전계Field 발광 소자의 제작 Fabrication of light emitting device
발광층 형성시 발광 호스트 물질로서 화합물 Inv-1 대신 CBP를, 발광 도펀트 물질로서 합성예 109의 compound 1 대신 Ir(ppy)3를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 전계 발광 소자를 제작하였다.
The procedure of Example 1 was repeated, except that CBP was used instead of Compound Inv-1 as a luminescent host material in the formation of the light emitting layer, and Ir (ppy) 3 was used in place of compound 1 of Synthesis Example 109 as a luminescent dopant material. Respectively.
[[ 비교예Comparative Example 2] 유기 2] Organic 전계Field 발광 소자의 제작 Fabrication of light emitting device
발광층 형성시 발광 호스트 물질로서 화합물 Inv-18 대신 CBP를, 발광 도펀트 물질로서 합성예 112의 화합물 164 대신 Ir(piq)2(acac)를 사용하는 것을 제외하고는 실시예 126과 동일한 과정으로 녹색 유기 전계 발광 소자를 제작하였다.The procedure of Example 126 was repeated except that CBP was used instead of Compound Inv-18 as a luminescent host material in the formation of the light emitting layer and Ir (piq) 2 (acac) was used in place of Compound 164 of Synthetic Example 112 as a luminescent dopant material. An electroluminescent device was fabricated.
사용된 m-MTDATA, TCTA, Ir(ppy)3, Ir(piq)2(acac), CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir (ppy) 3 , Ir (piq) 2 (acac), CBP and BCP used are as follows.
[[ 평가예Evaluation example 1] One]
실시예 1-125 및 비교예 1에서 제작한 각각의 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 발광피크, 전류효율을 측정하고, 그 결과를 하기 표 1에 나타내었다. The driving voltage, the emission peak and the current efficiency at the current density of 10 mA / cm 2 were measured for each of the organic electroluminescent devices manufactured in Examples 1-125 and Comparative Example 1, and the results are shown in Table 1 below.
상기 표 1에 나타난 바와 같이, 본 발명에 따른 화합물(Inv-1~Inv-103)을 유기 전계 발광 소자의 호스트로, 본 발명에 따른 화합물(화합물 1, 9 및 149)을 유기 전계 발광 소자의 도펀트로 발광층을 사용하였을 경우 종래 CBP를 사용한 유기 전계 발광 소자(비교예1)와 비교해 볼 때 효율 및 구동전압 면에서 보다 우수한 성능을 나타내며 도펀트에 따라 다양한 발광 파장을 가짐을 알 수 있다.
As shown in Table 1, compounds (Inv-1 to Inv-103) according to the present invention were used as hosts of organic electroluminescent devices and compounds (compounds 1, 9 and 149) When the light emitting layer is used as a dopant, the organic electroluminescent device using the CBP exhibits superior performance in terms of efficiency and driving voltage as compared with the organic electroluminescent device using the conventional CBP (Comparative Example 1), and has various emission wavelengths depending on the dopant.
[[ 평가예Evaluation example 2] 2]
실시예 126-131 및 비교예 2에서 제작한 각각의 유기 전계 발광 소자에 대하여 전류밀도 10 mA/㎠에서의 구동전압, 발광피크, 전류효율을 측정하고, 그 결과를 하기 표 2에 나타내었다.The driving voltage, the emission peak and the current efficiency at the current density of 10 mA / cm 2 were measured for each of the organic electroluminescent devices manufactured in Examples 126-131 and Comparative Example 2. The results are shown in Table 2 below.
상기 표2에 나타난 바와 같이, 본 발명에 따른 화합물(Inv-18, Inv-104~Inv-108)을 유기 전계 발광 소자의 호스트로, 본 발명에 따른 화합물(화합물 164)을 유기 전계 발광 소자의 도펀트로 하여 발광층에 적용하였을 경우 종래 CBP를 사용한 유기 전계 발광 소자(비교예2)와 비교해 볼 때 효율 및 구동전압 면에서 보다 우수한 성능을 나타냄을 알 수 있다.As shown in Table 2, the compounds (Inv-18, Inv-104 to Inv-108) according to the present invention were used as hosts of organic electroluminescent devices, It can be seen that the organic electroluminescent device of the present invention exhibits superior performance in terms of efficiency and driving voltage as compared with the organic electroluminescent device using the conventional CBP (Comparative Example 2).
Claims (8)
상기 1층 이상의 유기물층 중 적어도 하나는 하기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택된 화합물과, 하기 화학식 3으로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자:
[화학식 1a]
[화학식 1b]
[화학식 1c]
[화학식 1d]
[화학식 1e]
[화학식 1f]
상기 화학식 1a 내지 1f에서,
X1 및 X2는 각각 독립적으로, S, 또는 N(Ar1)이고, 이때, X1 및 X2 중에서 적어도 하나는 N(Ar1)이며,
R1 내지 R4 및 Ar1는 각각 독립적으로, 수소, 중수소, 할로겐기, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되며, 복수의 R3는 서로 동일하거나 상이하고, 복수의 R4 는 서로 동일하거나 상이하며,
상기 R1 내지 R4 및 Ar1의 알킬기, 알케닐기, 알키닐기, 시클로알킬기, 헤테로시클로알킬기, 아릴기, 헤테로아릴기, 알킬옥시기, 아릴옥시기, 알킬실릴기, 아릴실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 아릴포스핀옥사이드기 및 아릴아민기는 각각 독립적으로, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C40의 아릴기, 핵원자수 5 내지 40의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택된 1종 이상으로 치환될 수 있으며,
[화학식 3]
상기 화학식 3에서,
X-Y는 유기 리간드로서, X는 핵원자수 3 내지 40의 헤테로아릴기이고, Y는 C6~C40의 아릴기 또는 핵원자수 3 내지 40의 헤테로아릴기이며,
R11 내지 R18은 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,
n은 1 내지 3의 정수이다.anode; cathode; And at least one organic material layer interposed between the anode and the cathode,
Wherein at least one of the one or more organic material layers comprises a compound selected from the group consisting of compounds represented by the following formulas (1a) to (1f) and a compound represented by the following formula (3)
[Formula 1a]
[Chemical Formula 1b]
[Chemical Formula 1c]
≪ RTI ID = 0.0 &
[Formula 1e]
(1f)
In the above general formulas (1a) to (1f)
X 1 and X 2 are each independently S or N (Ar 1 ), wherein at least one of X 1 and X 2 is N (Ar 1 )
R 1 to R 4 and Ar 1 are each independently, hydrogen, deuterium, a halogen group, a cyano group, a nitro group, an alkenyl group of an amino group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 of the group, C 2 ~ C 40 the alkynyl group, C 3 ~ C 40 cycloalkyl group, the number of nuclear atoms of 3 to 40 of the heterocycloalkyl of the alkyl group, C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, C 1 ~ C 40 An alkyloxyl group, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group, a C 6 to C 60 aryl boron group, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C 6 ~ is selected from the group consisting of an aryl amine of the C 60, a plurality of R 3 are the same or different, , Plural R < 4 > s are the same or different from each other,
Wherein R 1 to R 4 and an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a heterocycloalkyl group, an aryl group, a heteroaryl group, an alkyloxy group, an aryloxy group, an alkylsilyl group, an arylsilyl group, an alkyl boronic of Ar 1 A halogen atom, a cyano group, a nitro group, an amino group, a C 1 to C 40 alkyl group, a C 2 to C 40 alkene group, an aryloxy group, an aryloxy group, A C 2 to C 40 alkynyl group, a C 3 to C 40 cycloalkyl group, a heterocyclic cycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 40 aryl group, a heteroaryl group having 5 to 40 nuclear atoms , A C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, a C 6 to C 60 arylsilyl group, a C 1 to C 40 alkylboron group , C group 6 to C 60 aryl boron, C 6 to C 60 aryl phosphine of pingi, C 6 to C 60 aryl phosphine oxide group, and a C 6 to C 60 aryl amine group selected from the group consisting of 1 It may be substituted with at least,
(3)
In Formula 3,
X is an organic ligand, X is a heteroaryl group having 3 to 40 nuclear atoms, Y is an aryl group having 6 to 40 carbon atoms or a heteroaryl group having 3 to 40 nuclear atoms,
R 11 to R 18 are each independently selected from the group consisting of hydrogen, deuterium, halogen, cyano, nitro, amino, C 1 to C 40 alkyl, C 3 to C 40 cycloalkyl, An alkyl group, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 1 to C 40 alkylsilyl group, C 6 ~ C aryl silyl group of 60, C 1 ~ C 40 group of an alkyl boron, C 6 ~ C group 60 arylboronic of, C 6 ~ C 60 aryl phosphine group, C 6 ~ aryl phosphine of C 60 is selected from the group consisting of pins oxide groups and C 6 ~ C 60 aryl amine, combine adjacent groups may form a fused ring,
n is an integer of 1 to 3;
상기 화학식 3으로 표시되는 화합물은 하기 화학식 3a 내지 3d로 표시되는 화합물로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자:
[화학식 3a]
[화학식 3b]
[화학식 3c]
[화학식 3d]
상기 화학식 3a 내지 3d에서, X, Y, n 및 R11 내지 R18은 제1항에서 정의한 바와 같으며,
상기 Ra 및 R21 내지 R25는 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있으며,
상기 m은 0 내지 3의 정수이다.The method according to claim 1,
Wherein the compound represented by Formula 3 is selected from the group consisting of compounds represented by the following Chemical Formulas 3a to 3d:
[Chemical Formula 3]
(3b)
[Chemical Formula 3c]
(3d)
Wherein X, Y, n and R < 11 > to R < 18 > are as defined in claim 1,
Wherein Ra and R 21 to R 25 each independently represent hydrogen, deuterium, halogen, cyano, nitro, amino, C 1 to C 40 alkyl, C 3 to C 40 cycloalkyl, A C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, a C 6 to C 60 aryloxy group, a C 1 to C 40 An arylsilyl group of C 6 to C 60 , a C 1 to C 40 alkylboron group, a C 6 to C 60 arylboron group, a C 6 to C 60 arylphosphine group, a C 6 to C 60 An arylphosphine oxide group and an arylamine group having 6 to 60 carbon atoms, and may be bonded to adjacent groups to form a condensed ring,
M is an integer of 0 to 3;
상기 Ar1은 C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자.The method according to claim 1,
The organic electroluminescent device, characterized in that said Ar 1 is selected from the group consisting of an arylamine C 6 ~ C 60 aryl group, the number of nuclear atoms of 5 to 60 heteroaryl group, and a C 6 ~ C 60.
상기 화학식 3의 X-Y는 하기 A1 내지 A24로 표시되는 구조로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자:
상기 R31 내지 R42 는 각각 독립적으로, 수소, 중수소, 할로겐, 시아노기, 니트로기, 아미노기, C1~C40의 알킬기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C1~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 아릴포스핀옥사이드기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 인접한 기와 결합하여 축합 고리를 형성할 수 있다.The method according to claim 1,
Wherein XY in Formula 3 is selected from the group consisting of structures represented by the following Al to A24:
The R 31 to R 42 Are each independently, hydrogen, deuterium, a halogen, a cyano group, a nitro group, an amino group, C 1 ~ C 40 alkyl group, C 3 ~ C 40 cycloalkyl group, a number of nuclear atoms of 3 to 40 heterocycloalkyl group, C 6 ~ of for C 60 aryl group, the nuclear atoms of 5 to 60 heteroaryl group, C 1 ~ C 40 alkyloxy group of, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyl silyl group, C 6 ~ group C 60 aryl silyl group, C 1 ~ alkyl boron C 40 of, C 6 ~ C group 60 arylboronic of, C 6 ~ C 60 aryl phosphine group, C 6 ~ C 60 aryl phosphine oxide group, and a C of An arylamine group having 6 to 60 carbon atoms, and may be bonded to adjacent groups to form a condensed ring.
상기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택된 화합물과, 상기 화학식 3으로 표시되는 화합물을 포함하는 유기물층은 정공 주입층, 정공 수송층 및 발광층으로 이루어진 군에서 선택되는 것을 특징으로 하는 유기 전계 발광 소자.The method according to claim 1,
Wherein the organic compound layer comprising a compound selected from the group consisting of the compounds represented by the above formulas (1a) to (1f) and the compound represented by the above formula (3) is selected from the group consisting of a hole injecting layer, a hole transporting layer and a light emitting layer device.
상기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택된 화합물과, 상기 화학식 3으로 표시되는 화합물을 포함하는 유기물층은 발광층이며,
상기 화학식 1a 내지 1f로 표시되는 화합물로 이루어진 군에서 선택된 화합물은 상기 발광층의 호스트 물질이고, 상기 화학식 3으로 표시되는 화합물은 상기 발광층의 도펀트 물질인 것을 특징으로 하는 유기 전계 발광 소자.The method according to claim 1,
The organic compound layer including the compound represented by the above Chemical Formulas 1a to 1f and the compound represented by the Chemical Formula 3 is a light emitting layer,
Wherein the compound selected from the group consisting of the compounds represented by Chemical Formulas 1 a to 1f is a host material of the light emitting layer and the compound represented by Chemical Formula 3 is a dopant material of the light emitting layer.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120118500A KR101547623B1 (en) | 2012-10-24 | 2012-10-24 | Organic electroluminescent device |
PCT/KR2013/007669 WO2014065498A1 (en) | 2012-10-24 | 2013-08-27 | Organic electroluminescent device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120118500A KR101547623B1 (en) | 2012-10-24 | 2012-10-24 | Organic electroluminescent device |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140052418A KR20140052418A (en) | 2014-05-07 |
KR101547623B1 true KR101547623B1 (en) | 2015-08-26 |
Family
ID=50544844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120118500A KR101547623B1 (en) | 2012-10-24 | 2012-10-24 | Organic electroluminescent device |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR101547623B1 (en) |
WO (1) | WO2014065498A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102261104B1 (en) * | 2012-12-26 | 2021-06-04 | 에스에프씨 주식회사 | An electroluminescent compound and an electroluminescent device comprising the same |
KR102191019B1 (en) * | 2012-12-26 | 2020-12-14 | 에스에프씨 주식회사 | An electroluminescent compound and an electroluminescent device comprising the same |
KR102201319B1 (en) * | 2014-01-14 | 2021-01-11 | 삼성전자주식회사 | Condensed cyclic compound and organic light emitting device including the same |
KR101998435B1 (en) * | 2014-06-09 | 2019-07-09 | 주식회사 두산 | Organic electro luminescence device |
US20160155962A1 (en) * | 2014-11-28 | 2016-06-02 | Samsung Electronics Co., Ltd. | Organometallic compound and organic light-emitting device including the same |
KR102466672B1 (en) * | 2014-11-28 | 2022-11-15 | 삼성전자주식회사 | Organometallic compound and organic light emitting device including the same |
KR102307761B1 (en) * | 2014-12-24 | 2021-10-05 | 솔루스첨단소재 주식회사 | Method of preparing iridium complex and organic electroluminescent device using the iridium complex prepared thereby |
KR102409384B1 (en) * | 2015-02-04 | 2022-06-15 | 삼성전자주식회사 | Organometallic compound and organic light emitting device including the same |
KR102456076B1 (en) * | 2015-09-03 | 2022-10-19 | 삼성디스플레이 주식회사 | Compound and Organic light emitting device comprising same |
CN106892925A (en) * | 2015-12-19 | 2017-06-27 | 西安瑞联新材料股份有限公司 | A kind of OLED material based on pyrrolo carbazole derivatives and preparation method thereof |
AR117472A1 (en) | 2018-12-21 | 2021-08-11 | Celgene Corp | RIPK2 TIENOPYRIDINE INHIBITORS |
CN110373182B (en) * | 2019-07-10 | 2023-06-06 | 吉林奥来德光电材料股份有限公司 | Organic light-emitting compound, preparation method thereof and device |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012140367A (en) * | 2010-12-28 | 2012-07-26 | Idemitsu Kosan Co Ltd | Condensed polycyclic compound, material for organic electroluminescent element, and organic electroluminescent element using the material |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3924869B2 (en) * | 1997-11-05 | 2007-06-06 | 東レ株式会社 | Organic thin film light emitting device |
KR101097312B1 (en) * | 2009-08-10 | 2011-12-23 | 삼성모바일디스플레이주식회사 | Organic light emitting device |
EP2556075B1 (en) * | 2010-04-06 | 2019-02-27 | UDC Ireland Limited | Substituted carbazole derivatives and use thereof in organic electronics |
-
2012
- 2012-10-24 KR KR1020120118500A patent/KR101547623B1/en active IP Right Grant
-
2013
- 2013-08-27 WO PCT/KR2013/007669 patent/WO2014065498A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012140367A (en) * | 2010-12-28 | 2012-07-26 | Idemitsu Kosan Co Ltd | Condensed polycyclic compound, material for organic electroluminescent element, and organic electroluminescent element using the material |
Also Published As
Publication number | Publication date |
---|---|
KR20140052418A (en) | 2014-05-07 |
WO2014065498A1 (en) | 2014-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101547623B1 (en) | Organic electroluminescent device | |
KR101488565B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR101506761B1 (en) | Organic compound and organic electroluminescent devices using the same | |
KR101477344B1 (en) | Novel compound and organic electroluminescent device comprising the same | |
KR20180046150A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101571591B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20150047858A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101571589B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101571592B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20150030794A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101641409B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101577121B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101641411B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
JP6228979B2 (en) | Organic light emitting compound and organic electroluminescent device using the same | |
KR20150103968A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20160077941A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20150086069A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101577099B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR101556819B1 (en) | Organic compounds and organic electro luminescence device using the same | |
KR102263843B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR101827039B1 (en) | Organic compound and organic electroluminescent devices using the same | |
KR101612154B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20150086107A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR101571590B1 (en) | Organic compounds and organic electro luminescence device using the same | |
KR101561330B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
REEX | Re-examination | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |